Document:

EX-4.1

 Exhibit 4.1 

 
  

 
 FOREST CITY ENTERPRISES, INC.

 as Issuer 
 and 
  
 THE
BANK OF NEW YORK MELLON TRUST COMPANY, N.A.  
 as Trustee 

INDENTURE 
 Dated
as of July 19, 2011 
 4.25% Convertible Senior Notes due 2018 

 
  

 

 FOREST CITY ENTERPRISES, INC. 

Reconciliation and tie between the Trust Indenture Act of 1939 and 

this Indenture, dated as of July 19, 2011 
  

			
	 Trust Indenture Act Section
	  	 Indenture
Section

	§310(a)(1)	  	6.09
	(a)(2)	  	6.09
	(a)(3)	  	Not Applicable
	(a)(4)	  	Not Applicable
	(a)(5)	  	6.09
	(b)	  	6.08; 6.10; 6.11
	§311(a)	  	6.13
	(b)	  	6.13
	§312(a)	  	4.01; 4.02(a)
	(b)	  	4.02(b)
	(c)	  	4.02(c)
	§313(a)	  	4.03(a)
	(b)	  	4.03(a)
	(c)	  	4.03(a)
	(d)	  	4.03(b)
	§314(a)	  	3.06; 3.08; 4.04(a)
	(b)	  	Not Applicable
	(c)(1)	  	3.08; 15.05
	(c)(2)	  	15.05
	(c)(3)	  	Not Applicable
	(d)	  	Not Applicable
	(e)	  	3.08; 15.05
	§315(a)	  	6.01; 6.02; 6.07
	(b)	  	5.09
	(c)	  	6.01
	(d)	  	6.01; 6.02; 6.07
	(e)	  	5.10
	§316(a)	  	1.02
	(a)(1)(A)	  	5.01; 5.08; 7.01; 7.04
	(a)(1)(B)	  	5.08; 7.04
	(a)(2)	  	Not Applicable
	(b)	  	5.05
	(c)	  	7.01
	§317(a)(1)	  	5.03; 5.06
	(a)(2)	  	5.03
	(b)	  	3.04; 6.05; 11.01; 11.02
	§318(a)	  	1.02
	(c)	  	1.02

 Note: This reconciliation and tie shall not, for any purpose, be deemed to be part of this Indenture. 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	PAGE	 
	
	ARTICLE 1	  
	DEFINITIONS	  
			
	Section 1.01.	  	Definitions	  	 	1	  
	Section 1.02.	  	Incorporation by Reference of Trust Indenture Act	  	 	14	  
	
	ARTICLE 2	  
	ISSUE, DESCRIPTION, EXECUTION, REGISTRATION AND EXCHANGE
OF NOTES	  
			
	Section 2.01.	  	Designation and Amount	  	 	14	  
	Section 2.02.	  	Form of Notes	  	 	14	  
	Section 2.03.	  	Date and Denomination of Notes; Payments of Interest	  	 	15	  
	Section 2.04.	  	Payment of Additional Interest	  	 	16	  
	Section 2.05.	  	Execution, Authentication and Delivery of Notes	  	 	16	  
	Section 2.06.	  	Exchange and Registration of Transfer of Notes; Restrictions on Transfer; Depositary	  	 	18	  
	Section 2.07.	  	Mutilated, Destroyed, Lost or Stolen Notes	  	 	24	  
	Section 2.08.	  	Temporary Notes	  	 	25	  
	Section 2.09.	  	Cancellation of Notes Paid, Etc.	  	 	25	  
	Section 2.10.	  	CUSIP Numbers	  	 	25	  
	Section 2.11.	  	Additional Notes, Repurchases	  	 	26	  
	Section 2.12.	  	Automatic Exchange from Restricted Global Note to Unrestricted Global Note	  	 	26	  
	
	ARTICLE 3	  
	PARTICULAR COVENANTS OF THE COMPANY	  
			
	Section 3.01.	  	Payment of Principal, Interest and Additional Interest	  	 	27	  
	Section 3.02.	  	Maintenance of Office or Agency	  	 	27	  
	Section 3.03.	  	Appointments to Fill Vacancies in Trustee’s Office	  	 	28	  
	Section 3.04.	  	Provisions as to Paying Agent	  	 	28	  
	Section 3.05.	  	Existence	  	 	29	  
	Section 3.06.	  	Rule 144A Information Requirement and Annual Reports	  	 	29	  
	Section 3.07.	  	Stay, Extension and Usury Laws	  	 	30	  
	Section 3.08.	  	Compliance Certificate; Statements as to Defaults	  	 	31	  
	Section 3.09.	  	Further Instruments and Acts	  	 	31	  
	Section 3.10.	  	Additional Interest Notification	  	 	31	  

  
 i 

							
	 	  	 	  	PAGE	 
	
	ARTICLE 4	 
	LISTS OF NOTEHOLDERS AND REPORTS BY THE
COMPANY AND THE TRUSTEE	  

			
	Section 4.01.	  	Lists of Noteholders	  	 	31	  
	Section 4.02.	  	Preservation and Disclosure of Lists	  	 	32	  
	Section 4.03.	  	Reports by Trustee	  	 	32	  
	Section 4.04.	  	Reports by Company	  	 	32	  
	
	ARTICLE 5	  
	DEFAULTS AND REMEDIES	  
			
	Section 5.01.	  	Events of Default	  	 	33	  
	Section 5.02.	  	Additional Interest	  	 	35	  
	Section 5.03.	  	Payments of Notes on Default; Suit Therefor	  	 	36	  
	Section 5.04.	  	Application of Monies Collected by Trustee	  	 	37	  
	Section 5.05.	  	Proceedings by Noteholders	  	 	38	  
	Section 5.06.	  	Proceedings by Trustee	  	 	39	  
	Section 5.07.	  	Remedies Cumulative and Continuing	  	 	39	  
	Section 5.08.	  	Direction of Proceedings and Waiver of Defaults by Majority of Noteholders	  	 	39	  
	Section 5.09.	  	Notice of Defaults	  	 	40	  
	Section 5.10.	  	Undertaking to Pay Costs	  	 	40	  
	
	ARTICLE 6	  
	CONCERNING THE TRUSTEE	  
			
	Section 6.01.	  	Duties and Responsibilities of Trustee	  	 	40	  
	Section 6.02.	  	Reliance on Documents, Opinions, Etc.	  	 	42	  
	Section 6.03.	  	No Responsibility for Recitals, Etc.	  	 	44	  
	Section 6.04.	  	Trustee, Paying Agents, Conversion Agents or Registrar May Own Notes	  	 	44	  
	Section 6.05.	  	Monies to be Held in Trust	  	 	44	  
	Section 6.06.	  	Compensation and Expenses of Trustee	  	 	44	  
	Section 6.07.	  	Officers’ Certificate as Evidence	  	 	45	  
	Section 6.08.	  	Conflicting Interests of Trustee	  	 	45	  
	Section 6.09.	  	Eligibility of Trustee	  	 	45	  
	Section 6.10.	  	Resignation or Removal of Trustee	  	 	46	  
	Section 6.11.	  	Acceptance by Successor Trustee	  	 	47	  
	Section 6.12.	  	Succession by Merger, Etc.	  	 	47	  
	Section 6.13.	  	Limitation on Rights of Trustee as Creditor	  	 	48	  
	Section 6.14.	  	Trustee’s Application for Instructions from the Company	  	 	48	  

  
 ii 

							
	 	  	 	  	PAGE	 
	
	ARTICLE 7	  
	CONCERNING THE NOTEHOLDERS	  
			
	Section 7.01.	  	Action By Noteholders	  	 	48	  
	Section 7.02.	  	Proof of Execution by Noteholders	  	 	49	  
	Section 7.03.	  	Who Are Deemed Absolute Owners	  	 	49	  
	Section 7.04.	  	Company-owned Notes Disregarded	  	 	49	  
	Section 7.05.	  	Revocation of Consents; Future Holders Bound	  	 	50	  
	
	ARTICLE 8	  
	NOTEHOLDERS’ MEETINGS	  
			
	Section 8.01.	  	Purpose of Meetings	  	 	50	  
	Section 8.02.	  	Call of Meetings by Trustee	  	 	51	  
	Section 8.03.	  	Call of Meetings by Company or Noteholders	  	 	51	  
	Section 8.04.	  	Qualifications for Voting	  	 	51	  
	Section 8.05.	  	Regulations	  	 	51	  
	Section 8.06.	  	Voting	  	 	52	  
	Section 8.07.	  	No Delay of Rights by Meeting	  	 	52	  
	
	ARTICLE 9	  
	SUPPLEMENTAL INDENTURES	  
			
	Section 9.01.	  	Supplemental Indentures Without Consent of Noteholders	  	 	52	  
	Section 9.02.	  	Supplemental Indentures With Consent of Noteholders	  	 	53	  
	Section 9.03.	  	Effect of Supplemental Indentures	  	 	55	  
	Section 9.04.	  	Notation on Notes	  	 	55	  
	Section 9.05.	  	Evidence of Compliance of Supplemental Indenture to be Furnished to the Trustee	  	 	55	  
	
	ARTICLE 10	  
	CONSOLIDATION, MERGER, SALE, CONVEYANCE AND LEASE	  
			
	Section 10.01.	  	Company May Consolidate, Etc. on Certain Terms	  	 	55	  
	Section 10.02.	  	Successor Corporation to be Substituted	  	 	56	  
	Section 10.03.	  	Officers’ Certificate and Opinion of Counsel to be Given Trustee	  	 	57	  
	
	ARTICLE 11	  
	SATISFACTION AND DISCHARGE OF INDENTURE	  
			
	Section 11.01.	  	Discharge of Indenture	  	 	57	  
	Section 11.02.	  	Deposited Monies to be Held in Trust by Trustee	  	 	57	  
	Section 11.03.	  	Paying Agent to Repay Monies Held	  	 	57	  
	Section 11.04.	  	Return of Unclaimed Monies	  	 	58	  
	Section 11.05.	  	Reinstatement	  	 	58	  

  
 iii

							
	 	  	 	  	PAGE	 
	
	ARTICLE 12	  
	IMMUNITY OF INCORPORATORS, SHAREHOLDERS, OFFICERS AND
DIRECTORS	  
			
	Section 12.01.	  	Indenture and Notes Solely Corporate Obligations	  	 	58	  
	
	ARTICLE 13	  
	CONVERSION	  
			
	Section 13.01.	  	Right of Convert	  	 	59	  
	Section 13.02.	  	Conversion Procedure	  	 	60	  
	Section 13.03.	  	Adjustment of Conversion Rate	  	 	63	  
	Section 13.04.	  	Shares to Be Fully Paid	  	 	71	  
	Section 13.05.	  	Certain Other Adjustments	  	 	71	  
	Section 13.06.	  	Effect of Reclassification, Consolidation, Merger or Sale	  	 	72	  
	Section 13.07.	  	Certain Covenants	  	 	73	  
	Section 13.08.	  	Responsibility of Trustee	  	 	74	  
	Section 13.09.	  	Notice to Holders Prior to Certain Actions	  	 	74	  
	Section 13.10.	  	Shareholder Rights Plans	  	 	75	  
	Section 13.11.	  	Termination of Conversion Rights by the Company	  	 	75	  
	
	ARTICLE 14	  
	REPURCHASE OF NOTES AT OPTION OF
HOLDERS	  
			
	Section 14.01.	  	Repurchase at Option of Holders Upon a Fundamental Change	  	 	77	  
	
	ARTICLE 15	  
	MISCELLANEOUS PROVISIONS	  
			
	Section 15.01.	  	Provisions Binding on Company’s Successors	  	 	81	  
	Section 15.02.	  	Official Acts by Successor Corporation	  	 	81	  
	Section 15.03.	  	Addresses for Notices, Etc.	  	 	81	  
	Section 15.04.	  	Governing Law	  	 	82	  
	Section 15.05.	  	Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee	  	 	82	  
	Section 15.06.	  	Legal Holidays	  	 	82	  
	Section 15.07.	  	No Security Interest Created	  	 	82	  
	Section 15.08.	  	Benefits of Indenture	  	 	83	  
	Section 15.09.	  	Table of Contents, Headings, Etc.	  	 	83	  
	Section 15.10.	  	Authenticating Agent	  	 	83	  
	Section 15.11.	  	Execution in Counterparts	  	 	84	  
	Section 15.12.	  	Waiver Of Jury Trial	  	 	84	  
	Section 15.13.	  	Force Majeure	  	 	84	  

  
 iv 

 INDENTURE dated as of July 19, 2011 between Forest City Enterprises, Inc., an Ohio
corporation, as issuer (hereinafter sometimes called the “Company,” as more fully set forth in Section 1.01), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (hereinafter
sometimes called the “Trustee,” as more fully set forth in Section 1.01). 
 WITNESSETH: 

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the issue of its 4.25% Convertible Senior Notes due 2018
(hereinafter sometimes called the “Notes”), initially in an aggregate principal amount not to exceed $350,000,000, and in order to provide the terms and conditions upon which the Notes are to be authenticated, issued and delivered,
the Company has duly authorized the execution and delivery of this Indenture; and 
 WHEREAS, the Notes, the certificate of
authentication to be borne by the Notes, the Form of Assignment and Transfer, the Form of Fundamental Change Repurchase Notice, the Form of Conversion Notice are to be substantially in the forms hereinafter provided for; and 

WHEREAS, all acts and things necessary to make the Notes, when executed by the Company and authenticated and delivered by the Trustee or
a duly authorized authenticating agent, as in this Indenture provided, the valid, binding and legal obligations of the Company, and to constitute these presents a valid and legally binding agreement according to its terms, have been done and
performed, and the execution of this Indenture and the issue hereunder of the Notes have in all respects been duly authorized. 

NOW, THEREFORE, THIS INDENTURE WITNESSETH: 
 That in order to declare the terms and conditions upon which the Notes are, and are to be, authenticated, issued and delivered, and in consideration of the premises and of the purchase and acceptance of
the Notes by the holders thereof, the Company covenants and agrees with the Trustee for the equal and proportionate benefit of the respective holders from time to time of the Notes (except as otherwise provided below), as follows: 

ARTICLE 1 

DEFINITIONS 
 Section 1.01.    Definitions. 
 (a)
      The terms defined in this Section 1.01 (except as herein otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture and of any indenture supplemental hereto
shall have the respective meanings specified in this Section 1.01. All other terms used in this Indenture, which are defined in the Trust Indenture Act or which are by reference therein defined in the Securities Act (except as herein otherwise
expressly provided or unless the context otherwise requires) shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date of the execution of this Indenture. The words
“herein,” “hereof,” “hereunder,” and words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other Subdivision. The terms defined in this
Article include the plural as well as the singular. 

 “Additional Interest” means all amounts, if any, payable pursuant to
Sections 3.06(d), 3.06(e) and 5.02. 
 “Additional Shares” shall have the meaning specified in
Section 13.01(b)(i). 
 “Affiliate” of any specified Person means any other Person directly or indirectly
controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control,” when used with respect to any specified Person means the power to direct or cause
the direction of the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have
meanings correlative to the foregoing. 
 “Automatic Exchange” shall have the meaning specified in
Section 2.12. 
 “Automatic Exchange Notice” shall have the meaning specified in Section 2.12.

 “Beneficial Owner” and “Beneficial Ownership” means as determined in accordance with
Rule 13d-3 under the Exchange Act. 
 “Board of Directors” means the Board of Directors of the Company or
a committee of such Board duly authorized to act for it hereunder. 
 “Board Resolution” means a copy of a
resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors, or duly authorized committee thereof (to the extent permitted by applicable law), and to be in full force and effect
on the date of such certification, and delivered to the Trustee. 
 “Business Day” means any day, except a
Saturday, Sunday or legal holiday on which the banking institutions in The City of New York or the city in which the Corporate Trust Office is located are authorized or obligated by law or executive order to close. 

“Capital Lease” means a lease that, in accordance with accounting principles generally accepted in the United States of
America, would be recorded as a capital lease on the balance sheet of the lessee. 
 “Capital Lease
Obligation” of any Person means the obligation to pay rent or other payment amounts under a lease of (or other Debt arrangements conveying the right to use) real or personal property of such Person which is required to be classified and
accounted for as a capital lease or a liability on the face of a balance sheet of such Person in accordance with generally accepted accounting principles. The stated maturity of such obligation shall be the date of the last payment of rent or any
other amount due under such lease prior to the first date upon which such lease may be terminated by the lessee without payment of a penalty. The principal amount of such obligation shall be the capitalized amount thereof that would appear on the
face of a balance sheet of such Person prepared in accordance with generally accepted accounting principles. 

  
 2 

 “capital stock” means, for any Person, any and all shares, interests,
participations or other equivalents of or interests in (however designated) stock issued by that Person. 
 “close of
business” means 5:00 p.m. (New York City time). 
 “Code” means the Internal Revenue Code of 1986, as
amended. 
 “Commission” means the Securities and Exchange Commission. 

“Common Stock” means, subject to Section 13.06, shares of Class A common stock of the Company, par value
$0.33 1/3 per share, at the date of this Indenture or shares of any class or classes resulting from any reclassification or reclassifications thereof and that have no preference in respect of dividends or of amounts payable in the event of any
voluntary or involuntary liquidation, dissolution or winding up of the Company and that are not subject to redemption by the Company; provided that if at any time there shall be more than one such resulting class, the shares of each such
class then so issuable shall be substantially in the proportion which the total number of shares of such class resulting from all such reclassifications bears to the total number of shares of all such classes resulting from all such
reclassifications. 
 “Company” means Forest City Enterprises, Inc., an Ohio corporation, and subject to the
provisions of Article 10, shall include its successors and assigns and, to the extent the obligations hereunder shall be to more than one entity pursuant to Section 13.06, shall include each of such entities. 

“Company Order” means a written order of the Company, signed by (a) the Company’s Chief Executive Officer,
President, Executive or Senior Vice President, Managing Director or any Vice President (whether or not designated by a number or numbers or word or words added before or after the title “Vice President”) and (b) any such other officer
designated in clause (a) of this definition or the Company’s Treasurer or Assistant Treasurer or Secretary or any Assistant Secretary, and delivered to the Trustee. 
 “Conversion Agent” shall have the meaning specified in Section 3.02. 
 “Conversion Date” shall have the meaning specified in Section 13.02(b). 
 “Conversion Notice” shall have the meaning specified in Section 13.02(b). 
 “Conversion Price” means the quotient of $1,000 and the Conversion Rate. 
 “Conversion Rate” shall have the meaning specified in Section 13.01(a). 
 “Conversion Rights” shall have the meaning specified in Section 13.11(a). 
 “Conversion Rights Termination Notice” shall have the meaning specified in Section 13.11(a). 
 “Conversion Rights Termination Notice Date” shall have the meaning specified in Section 13.11(a). 

  
 3 

 “Conversion Rights Termination Trigger Event” shall have the meaning
specified in Section 13.11(a). 
 “Conversion Termination Date” shall have the meaning specified in
Section 13.11(a). 
 “Corporate Trust Office” or other similar term means a corporate trust office of the
Trustee at which at any particular time its corporate trust business shall be administered, which office is, at the date as of which this Indenture is dated, located at The Bank of New York Mellon Trust Company, N.A., 2 North LaSalle Street,
Chicago, Illinois 60602, Attention: Corporate Trust Administration; Forest City Enterprises, Inc. or such other address as the Trustee may designate from time to time by notice to the holders and the Company. 

“Custodian” means The Bank of New York Mellon Trust Company, N.A., as custodian for The Depository Trust Company, with
respect to the Notes in global form, or any successor entity thereto. 
 “Daily VWAP” for the Common Stock
means, for any Trading Day, the per share volume-weighted average price as displayed under the heading “Bloomberg VWAP” on Bloomberg page FCE/A VAP (or any successor page) in respect of the period from 9:30 a.m. to 4:00 p.m. (New York City
time) on such Trading Day, or, in the case of Reference Property, the per unit volume-weighted average price as displayed by Bloomberg (or if such volume-weighted average price is unavailable, the market value of one share of Common Stock (or such
unit of Reference Property) on such Trading Day as the Board of Directors determines in good faith using a volume-weighted method). 
 “Debt” means (without duplication), with respect to any Person, whether recourse is to all or a portion of the assets of such Person and whether or not contingent, (i) every
obligation of such Person for money borrowed, (ii) every obligation of such Person evidenced by bonds, debentures, notes or other similar instruments, including obligations incurred in connection with the acquisition of property, assets or
businesses, (iii) every reimbursement obligation of such Person with respect to letters of credit, bankers’ acceptances or similar facilities issued for the account of such Person, (iv) every obligation of such Person issued or
assumed as the deferred purchase price of property or services (including securities repurchase agreements but excluding trade accounts payable or accrued liabilities arising in the ordinary course of business which are not overdue or which are
being contested in good faith), (v) every Capital Lease Obligation of such Person, (vi) all Receivables Sales of such Person, together with any obligation of such Person to pay any discount, interest, fees, indemnities, penalties,
recourse, expenses or other amounts in connection therewith, (vii) all Redeemable Stock issued by such Person, (viii) every obligation to pay rent or other payment amounts of such Person with respect to any Sale and Leaseback Transaction
to which such Person is a party (including, if applicable, the full payment obligation of that Person at expiry of the lease arrangement assuming no refinancing or third party sale), (ix) every obligation under Interest Rate, Currency or
Commodity Price Agreements of such Person and (x) every obligation of the type referred to in clauses (i) through (ix) of another Person and all dividends of another Person the payment of which, in either case, such Person has
guaranteed or for which such Person is responsible or liable, directly or indirectly, as obligor, guarantor or otherwise. The “amount” or “principal 

  
 4 

 
amount” of Debt at any time of determination as used herein represented by (a) any contingent Debt, shall be the maximum liability upon the occurrence of the contingency giving
rise to the obligation (unless the underlying contingency has not occurred and the occurrence of the underlying contingency is entirely within the control of the Company), (b) any Debt issued at a price that is less than the principal amount at
maturity thereof, shall be the amount of the liability in respect thereof determined in accordance with generally accepted accounting principles, (c) any Receivables Sale, shall be the amount of the unrecovered capital or principal investment
of the purchaser (other than the Company or a Wholly Owned Subsidiary of the Company) thereof as of such time of determination, excluding amounts representative of yield or interest earned on such investment and (d) any Redeemable Stock, shall
be the maximum fixed redemption or repurchase price in respect thereof. 
 “Default” means any event that is,
or after notice or passage of time, or both, would be, an Event of Default. 
 “Defaulted Interest” shall have
the meaning specified in Section 2.03. 
 “Depositary” means, with respect to the Notes issuable or
issued in whole or in part in global form, the Person specified in Section 2.06(c) as the Depositary with respect to such Notes, until a successor shall have been appointed and become such pursuant to the applicable provisions of this
Indenture, and thereafter, “Depositary” shall mean or include such successor. 
 “Distributed
Property” shall have the meaning specified in Section 13.03(c). 
 “Effective Date” shall have
the meaning specified in Section 13.01(b)(ii). 
 “Event of Default” means, with respect to the Notes,
any event specified in Section 5.01, continued for the period of time, if any, and after the giving of notice, if any, therein designated. 
 “Ex-Date” means, with respect to any issuance or distribution on the Common Stock or any other equity security, the first date on which the shares of Common Stock or such other equity
security trade on the relevant exchange or in the relevant market, regular way, without the right to receive such issuance or distribution. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. 

“expiration date” shall have the meaning specified in Section 13.03(e). 

“Fiscal Year” means a fiscal year of the Company ending on January 31 of each calendar year. 

“Fundamental Change” will be deemed to have occurred at the time after the Notes are originally issued that any of the
following occurs: 
 (1) any Person, including any syndicate or group deemed to be a “person” under
Section 13(d)(3) of the Exchange Act (other than the members of the Ratner, Miller or 

  
 5 

 
Shafran families who are general partners of RMSLP (the “family interests”) and/or RMSLP), acquires Beneficial Ownership, directly or indirectly, through a purchase, merger or
other acquisition transaction or series of transactions, of (A) shares of the Company’s capital stock entitling the person to exercise 50% or more of the total voting power of all shares of the Company’s capital stock entitled to vote
generally in elections of directors or (B) 50% or more of the voting interest in RMSLP, other than an acquisition by the Company, any of the Company’s Subsidiaries or any of the Company’s employee benefit plans; 

(2) there exists an aggregate Beneficial Ownership of more than 30% of Common Stock then outstanding by the family
interests and/or RMSLP other than upon the conversion of shares of Class B common stock into Common Stock; 

(3) the Company merges, or consolidates with or into any other Person (other than a Subsidiary), another Person merges
with or into the Company, or the Company conveys, sells, transfers or leases all or substantially all of the Company’s assets to another Person, other than any transaction: 

(i)     that does not result in a reclassification, conversion, exchange or cancellation of the
outstanding Common Stock; 
 (ii)     pursuant to which the holders of the Common Stock
immediately prior to the transaction have the entitlement to exercise, directly or indirectly, 50% or more of the voting power of all shares of the Company’s capital stock entitled to vote generally in the election of directors of the
continuing or surviving corporation immediately after the transaction; or 
 (iii)    
which is effected solely to change the Company’s jurisdiction of incorporation and results in a reclassification, conversion or exchange of outstanding shares of the Common Stock solely into shares of Common Stock of the surviving corporation;

 (4) the Company’s stockholders approve any plan or proposal for the Company’s liquidation or
dissolution; and 
 (5) Common Stock (or other common stock underlying the Notes) ceases to be listed or quoted
on The New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ Global Market (or any of their respective successors). 
 “Fundamental Change Expiration Time” shall have the meaning specified in Section 14.01(a)(i). 

“Fundamental Change Repurchase Date” shall have the meaning specified in Section 14.01(a).

 “Fundamental Change Repurchase Notice” shall have the meaning specified in
Section 14.01(a)(i). 

  
 6 

 “Fundamental Change Repurchase Price” shall have the
meaning specified in Section 14.01(a). 
 “Fundamental Change Repurchase Right Notice”
shall have the meaning specified in Section 14.01(b). 
 “Global Note” shall have the meaning specified
in Section 2.06(b). 
 “Indenture” means this instrument as originally executed or, if amended or
supplemented as herein provided, as so amended or supplemented. 
 “Initial Purchasers” means Goldman,
Sachs & Co., Barclays Capital Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and the other several initial purchasers named in Schedule I to the Purchase Agreement. 

“Interest Payment Date” means February 15 and August 15 of each year, beginning on February 15, 2012.

 “Interest Rate, Currency or Commodity Price Agreement” of any Person means any forward contract, futures
contract, swap, option or other financial agreement or arrangement (including, without limitation, caps, floors, collars and similar agreements) relating to, or the value of which is dependent upon, interest rates, currency exchange rates or
commodity prices or indices (excluding contracts for the purchase or sale of goods in the ordinary course of business). 

“Last Reported Sale Price” means, with respect to the Common Stock or any other security for which a Last Reported Sale
Price must be determined, on any date, the closing sale price per share of the Common Stock or unit of such other security (or, if no closing sale price is reported, the average of the last bid and last ask prices or, if more than one in either
case, the average of the average last bid and the average last ask prices) on such date as reported in composite transactions for the principal U.S. national or regional securities exchange on which it is then traded. If the Common Stock or such
other security is not listed for trading on a United States national or regional securities exchange on the relevant date, the Last Reported Sale Price shall be the average of the last quoted bid and ask prices per share of Common Stock or such
other security in the over-the-counter market on the relevant date, as reported by the OTC Markets Group Inc. or similar organization. In absence of such quotation, the Last Reported Sale Price shall be the average of the mid-point of the last bid
and ask prices for the Common Stock or such other security on the relevant date from each of at least three (3) nationally recognized independent investment banking firms, which may include any or all of the Initial Purchasers, selected from
time to time by the Board of Directors of the Company for this purpose. The Last Reported Sale Price shall be determined without reference to extended or after hours trading. Any such determination by the Company will be conclusive absent manifest
error. 
 “Make-Whole Fundamental Change” means any transaction or event that constitutes a Fundamental Change
(determined after giving effect to any exceptions to or exclusions from such definition, but without regard to the exception in clause (3)(ii) of the definition thereof). 

  
 7 

 “Make-Whole Fundamental Change Notice” shall have the meaning specified in
Section 13.01(b)(i). 
 “Make-Whole Premium Payment” shall have the meaning specified in
Section 13.11(b). 
 “Market Disruption Event” means the occurrence or existence on any Trading Day for
the Common Stock or Reference Property of any suspension of or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant securities exchange or otherwise) in the Common Stock or Reference Property on
the relevant securities exchange or in any options contracts or futures contracts relating to the Common Stock or Reference Property on any relevant exchange if, in any such case, such suspension or limitation occurs or exists at any time within the
thirty (30) minutes prior to the closing time of the relevant exchange on such day. 
 “Maturity Date”
means August 15, 2018, unless earlier repurchased or converted. 
 “Merger Event” shall have the meaning
specified in Section 13.06. 
 “Nonrecourse” as applied to any Debt means Debt of a Person (or any
portion thereof) to the extent that, under the terms thereof, no personal recourse may be had against such Person or any Affiliate of such Person for the payment of all or a portion of the principal of or interest or premium on such Debt, and
enforcement of obligations on such Debt (except with respect to fraud, willful misconduct, intentional misrepresentation, misapplication of funds, waste and undertakings with respect to environmental matters) is limited only to recourse against
interests in specified assets and properties owned by such Person (the “Subject Assets”), accounts and proceeds arising therefrom, and rights under purchase agreements or other agreements relating to such Subject Assets. 

“Note” or “Notes” means any note or notes, as the case may be, authenticated and delivered under this
Indenture. 
 “Noteholder” or “holder,” as applied to any Note, or other similar terms (but
excluding the term “beneficial holder”), means any person in whose name at the time a particular Note is registered on the Note Register. 
 “Note Register” shall have the meaning specified in Section 2.06(a). 
 “Note Registrar” shall have the meaning specified in Section 2.06(a). 
 “Offering Circular” means the final offering circular dated July 13, 2011 with respect to offering and sale of the Notes. 

“Officers’ Certificate,” when used with respect to the Company, means a certificate signed by (a) one of the
President, the Chief Executive Officer, any Executive or Senior Vice President, or any Vice President (whether or not designated by a number or numbers or word added before or after the title “Vice President”) and (b) by any such
other officer 

  
 8 

 
designated in (a) or by one of the Treasurer or any Assistant Treasurer, Secretary or any Assistant Secretary or Controller of the Company, which is delivered to the Trustee. Each such
certificate shall include the statements provided for in Section 15.05 if and to the extent required by the provisions of such Section. One of the officers giving an Officers’ Certificate pursuant to Section 3.08 shall be the
principal executive, financial or accounting officer of the Company. 
 “opening of business” means 9:00 a.m.
(New York City time). 
 “Opinion of Counsel” means an opinion in writing signed by legal counsel, who may be
an employee of or counsel to the Company, which is delivered to the Trustee. Each such opinion shall include the statements provided for in Section 15.05 if and to the extent required by the provisions of such Section. 

“outstanding,” when used with reference to Notes, shall, subject to the provisions of Section 7.04, mean, as of
any particular time, all Notes authenticated and delivered by the Trustee under this Indenture, except: 

(i)     Notes theretofore canceled by the Trustee or accepted by the Trustee for cancellation;

 (ii)     Notes, or portions thereof, for the payment or purchase of which monies in the
necessary amount shall have been deposited in trust with the Trustee or with any Paying Agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its own Paying Agent);

 (iii)     Notes in lieu of which, or in substitution for which, other Notes shall have
been authenticated and delivered pursuant to the terms of Section 2.07 unless proof satisfactory to the Trustee is presented that any such Notes are held by protected purchasers in due course; and 

(iv)     Notes converted pursuant to Article 13. 

“Paying Agent” shall have the meaning specified in Section 3.02. 

“Person” means an individual, a corporation, a limited liability company, an association, a partnership, a joint
venture, a joint stock company, a trust, an unincorporated organization or a government or an agency or a political subdivision thereof, including any syndicate or group that would be deemed to be a “person” under Section 13(d)(3) of
the Exchange Act. 
 “Predecessor Note” of any particular Note means every previous Note evidencing all or a
portion of the same debt as that evidenced by such particular Note; and, for the purposes of this definition, any Note authenticated and delivered under Section 2.07 in lieu of or in exchange for a mutilated, lost, destroyed or stolen Note
shall be deemed to evidence the same debt as the mutilated, lost, destroyed or stolen Note that it replaces. 

“Purchase Agreement” means that certain Purchase Agreement, dated July 13, 2011, among the Company and Goldman,
Sachs & Co., Barclays Capital Inc., Merrill Lynch, 

  
 9 

 
Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. LLC, as representatives of the several Initial Purchasers. 

“Qualified Institutional Buyer” or “QIB” shall have the meaning specified in Rule 144A.

 “Receivables” means receivables, chattel paper, instruments, documents or intangibles evidencing or
relating to the right to payment of money. 
 “Receivables Sale” of any Person means any sale of Receivables
of such Person (pursuant to a purchase facility or otherwise), other than in connection with a disposition of the business operations of such Person relating thereto or a disposition of defaulted Receivables for purposes of collection and not as a
financing arrangement. 
 “record date,” with respect to the payment of interest on any Interest Payment Date,
shall have the meaning specified in Section 2.03. 
 “Redeemable Stock” of any Person means any capital
stock of such Person that by its terms (or by the terms of any security into which it is convertible or for which it is exchangeable) or otherwise (including upon the occurrence of an event) matures or is required to be redeemed (pursuant to any
sinking fund obligation or otherwise) or is convertible into or exchangeable for Debt or is redeemable at the option of the holder thereof, in whole or in part, at any time on or prior to the date that is 91 days after the Maturity Date. 

“Reference Property” shall have the meaning specified in Section 13.06(b). 

“Related Party” means a director, officer or substantial security holder of the Company, as defined in
Section 312.03 of the Listed Company Manual of The New York Stock Exchange (or any successor provision). 

“Resale Restriction Termination Date” shall have the meaning specified in Section 2.06(c). 

“Responsible Officer” when used with respect to the Trustee, shall mean an officer of the Trustee in the Corporate
Trust Office, having direct responsibility for the administration of this Indenture, and also, with respect to a particular matter, any other officer to whom such matter is referred because of such officer’s knowledge of and familiarity with
the particular subject and who shall have direct responsibility for the administration of this Indenture. 

“Restricted Common Stock” shall have the meaning specified in Section 2.12. 

“Restricted Global Note” shall have the meaning specified in Section 2.12. 

“Restricted Security” or “Restricted Securities” has the meaning specified in Section 2.06(c).

 “Rights Plan” shall have the meaning specified in Section 13.10. 

  
 10 

 “RMSLP” means RMS, Limited Partnership, an Ohio limited partnership.

 “Rule 144A” means Rule 144A as promulgated under the Securities Act. 

“Sale and Leaseback Transaction” of any Person means an arrangement with any lender or investor or to which such lender
or investor is a party providing for the leasing by such Person of any property or asset of such Person which has been or is being sold or transferred by such Person more than 270 days after the acquisition thereof or the completion of construction
or commencement of operation thereof to such lender or investor or to any person to whom funds have been or are to be advanced by such lender or investor on the security of such property or asset. The stated maturity of such arrangement shall be the
date of the last payment of rent or any other amount due under such arrangement prior to the first date on which such arrangement may be terminated by the lessee without payment of a penalty. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 “Significant Subsidiary” means such Subsidiary of the Company as meets the definition of
“significant subsidiary” in Rule 1-02 of Regulation S-X promulgated by the Commission as in effect on the original date of issuance of the Notes. 
 “Shelf Registration Statement” shall have the meaning specified in Section 13.11(a). 
 “SPE Recourse Debt” as applied to any Person means Debt of a Person (or any portion thereof) whose sole assets consist of contiguous parcels of land that are being purchased or developed
with such Debt, the improvements, if any, thereon, furniture, fixtures and other equipment used in connection therewith, receivables arising from tenants in connection therewith and the proceeds of such receivables and other property directly
obtained from the ownership of such assets. 
 “Spin-Off” shall have the meaning specified in
Section 13.03(c). 
 “Stock Price” means the price paid per share of Common Stock in connection with a
Make-Whole Fundamental Change pursuant to which Additional Shares shall be added to the Conversion Rate as set forth in Section 13.01(b) hereof, which shall be equal to the average of the Last Reported Sale Prices of the Common Stock over
the ten (10) consecutive Trading Day period ending on the Trading Day preceding the Effective Date of the Make-Whole Fundamental Change. If holders receive only cash in the Make-Whole Fundamental Change, the Stock Price shall be the cash amount
paid per share. 
 “Subject Assets” shall have the meaning specified in the definition of
“Nonrecourse” in this Section 1.01. 
 “Subsidiary” of the Company means (i) a corporation
a majority of whose capital stock with voting power, under ordinary circumstances, to elect directors is at the time, directly or indirectly, owned by the Company, by the Company and one or more Subsidiaries of the Company or by one or more
Subsidiaries of the Company or (ii) any other Person (other than a 

  
 11 

 
corporation) in which the Company, one or more Subsidiaries of the Company or the Company and one or more Subsidiaries of the Company, directly or indirectly, at the date of determination
thereof, has greater than a 50% ownership interest. 
 “subsidiary” of any Person means (i) a corporation
more than 50% of the combined voting power of the outstanding Voting Stock of which is owned, directly or indirectly, by such Person or by one or more other subsidiaries of such Person or by such Person and one or more subsidiaries thereof,
(ii) a partnership of which such Person, or one or more other subsidiaries of such Person or such Person and one or more other subsidiaries thereof, directly or indirectly, is the general partner and has the power to direct the policies,
management and affairs of the partnership, (iii) a limited liability company of which such Person or one or more subsidiaries of such Person or such Person and one or more subsidiaries of such Person, directly or indirectly, is the managing
member and has the power to direct the policies, management and affairs of the company, or (iv) any other Person (other than a corporation, partnership or limited liability company) in which such Person, or one or more other subsidiaries of
such Person or such Person and one or more other subsidiaries thereof, directly or indirectly, has at least a majority ownership and power to direct the policies, management and affairs thereof. 

“Successor Company” shall have the meaning specified in Section 10.01(a). 

“Trading Day” means a day during which (a) trading in Common Stock or Reference Property generally occurs and
(b) there is no Market Disruption Event. 
 “transfer” shall have the meaning specified in
Section 2.06(c). 
 “Trigger Event” shall have the meaning specified in Section 13.03(c).

 “Trust Indenture Act” means the Trust Indenture Act of 1939, as amended, as it was in force at the date of
execution of this Indenture; provided however, that in the event the Trust Indenture Act of 1939 is amended after the date hereof, the term “Trust Indenture Act” shall mean, to the extent required by such amendment, the Trust
Indenture Act of 1939, as so amended. 
 “Trustee” means The Bank of New York Mellon Trust Company, N.A., and
its successors and any corporation resulting from or surviving any consolidation or merger to which it or its successors may be a party and any successor trustee at the time serving as successor trustee hereunder. 

“Unrestricted Common Stock” shall have the meaning specified in Section 2.12. 

“Unrestricted Global Note” shall have the meaning specified in Section 2.12. 

“valuation period” shall have the meaning specified in Section 13.03(c). 

“Voting Stock” of any Person means capital stock of such Person which ordinarily has voting power for the election of
directors (or persons performing similar 

  
 12 

 
functions) of such Person, whether at all times or only so long as no senior class of securities has such voting power by reason of any contingency. 

“Wholly Owned Subsidiary” of any Person means a subsidiary of such Person all of the outstanding capital stock or other
ownership interests of which (other than directors’ qualifying shares) shall at the time be owned by such Person or by one or more Wholly Owned Subsidiaries of such Person or by such Person and one or more Wholly Owned Subsidiaries of such
Person. 

  
 13 

 Section 1.02.     Incorporation by Reference of Trust Indenture
Act. 
 This Indenture is subject to the mandatory provisions of the Trust Indenture Act, which are incorporated by
reference in and made a part of this Indenture. The following Trust Indenture Act terms have the following meanings: 

“indenture securities” means the Notes. 
 “indenture security holder” means a holder. 
 “indenture
to be qualified” means this Indenture. 
 “indenture trustee” or “institutional
trustee” means the Trustee. 
 All other terms in this Indenture that are defined by the Trust Indenture Act, defined
by it by reference to another statute or defined by Commission rule have the meanings assigned to them by such definitions. If any provision hereof limits, qualifies or conflicts with another provision hereof which is required to be included in this
Indenture by the Trust Indenture Act, such required provision shall control. 
 ARTICLE 2 

ISSUE, DESCRIPTION, EXECUTION, REGISTRATION AND
EXCHANGE OF NOTES 
 Section 2.01.     Designation and
Amount. The Notes shall be designated as the “4.25% Convertible Senior Notes due 2018.” The aggregate principal amount of Notes that may be authenticated and delivered under this Indenture is initially limited to
$350,000,000, subject to Section 2.11 and except for Notes authenticated and delivered upon registration or transfer of, or in exchange for, or in lieu of other Notes pursuant to Section 2.06, Section 2.07, Section 2.12 and
Section 9.04. 
 Section 2.02.     Form of Notes. The Notes and the Trustee’s
certificate of authentication to be borne by such Notes shall be substantially in the respective forms set forth in Exhibit A. 

Any Global Note may be endorsed with or have incorporated in the text thereof such legends or recitals or changes not inconsistent with
the provisions of this Indenture as may be required by the Custodian or the Depositary or to indicate any special limitations or restrictions to which any particular Notes are subject. 

Any of the Notes may have such letters, numbers or other marks of identification and such notations, legends or endorsements as the
officers executing the same may approve (execution thereof to be conclusive evidence of such approval) and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation
made pursuant thereto or to conform to usage or to indicate any special limitations or restrictions to which any particular Notes are subject. 

  
 14 

 Each Global Note shall represent such principal amount of the outstanding Notes as shall be
specified therein and shall provide that it shall represent the aggregate principal amount of outstanding Notes from time to time endorsed thereon and that the aggregate principal amount of outstanding Notes represented thereby may from time to time
be increased or reduced to reflect repurchases, conversions, transfers or exchanges permitted hereby. Any endorsement of any Global Note to reflect the amount of any increase or decrease in the amount of outstanding Notes represented thereby shall
be made by the Trustee or the Custodian, at the direction of the Trustee, in such manner and upon instructions given by the holder of such Notes in accordance with this Indenture. Payment of principal and accrued and unpaid interest (including
Additional Interest, if any) on each Global Note shall be made to the Depositary or its nominee of such Note on the date of payment, unless a record date or other means of determining holders eligible to receive payment is provided for herein.

 The terms and provisions contained in the form of Note attached as Exhibit A hereto are incorporated herein and shall
constitute, and are hereby expressly made, a part of this Indenture and to the extent applicable, the Company and the Trustee, by their execution and delivery of this Indenture, expressly agree to such terms and provisions and to be bound thereby.

 Section 2.03.     Date and Denomination of Notes; Payments of Interest. The Notes shall be
issuable in registered form without coupons in denominations of $1,000 principal amount and integral multiples thereof. Each Note shall be dated the date of its authentication and shall bear interest from the date specified on the face of the form
of Note attached as Exhibit A hereto. Interest on the Notes shall be computed on the basis of a 360-day year comprised of twelve 30-day months. 
 The Person in whose name any Note (or its Predecessor Note) is registered on the Note Register at the close of business on any record date with respect to any Interest Payment Date shall be entitled to
receive the interest payable on such Interest Payment Date. Interest (including Additional Interest, if any) on Notes in definitive form shall be payable at the office of the Company maintained by the Company for such purposes in the Borough of
Manhattan, City of New York, which shall initially be an office or agency of the Trustee. The Company shall pay interest (including Additional Interest, if any) (i) on any Notes in definitive form by check mailed to the address of the Person
entitled thereto as it appears in the Note Register (or upon written application by such Person to the Note Registrar not later than the relevant record date, by wire transfer in immediately available funds to such Person’s account within the
United States, if such Person is entitled to interest on an aggregate principal in excess of $1,000,000) or (ii) on any Global Note by wire transfer of immediately available funds to the account of the Depositary or its nominee. The term
“record date” with respect to any Interest Payment Date shall mean the January 31 or July 31 preceding the applicable February 15 or August 15 Interest Payment Date, respectively. 

Any interest on any Note which is payable, but is not punctually paid or duly provided for, on any Interest Payment Date (herein called
“Defaulted Interest”) shall forthwith cease to be payable to the Noteholder on the relevant record date by virtue of its having been such Noteholder, and such Defaulted Interest shall be paid by the Company, at its election in each
case, as provided in clause (a) or (b) below: 

  
 15 

 (a)     The Company may elect to make payment of any Defaulted Interest
to the Persons in whose names the Notes (or their respective Predecessor Notes) are registered at the close of business on a special record date for the payment of such Defaulted Interest, which shall be fixed in the following manner. The Company
shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each Note and the date of the proposed payment (which shall be not less than twenty-five (25) days after the receipt by the Trustee of such notice,
unless the Trustee shall consent to an earlier date), and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount to be paid in respect of such Defaulted Interest or shall make arrangements
satisfactory to the Trustee for such deposit on or prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided. Thereupon the
Company shall fix a special record date for the payment of such Defaulted Interest which shall be not more than fifteen (15) days and not less than ten (10) days prior to the date of the proposed payment, and not less than ten
(10) days after the receipt by the Trustee of the notice of the proposed payment. The Company shall promptly notify the Trustee in writing of such special record date and the Trustee, in the name and at the expense of the Company, shall cause
notice of the proposed payment of such Defaulted Interest and the special record date therefor to be mailed, first-class postage prepaid, to each holder at its address as it appears in the Note Register, not less than ten (10) days prior to
such special record date. Notice of the proposed payment of such Defaulted Interest and the special record date therefor having been so mailed, such Defaulted Interest shall be paid to the Persons in whose names the Notes (or their respective
Predecessor Notes) are registered at the close of business on such special record date and shall no longer be payable pursuant to the following clause (b) of this Section 2.03. 

(b)     The Company may make payment of any Defaulted Interest in any other lawful manner not inconsistent with the
requirements of any securities exchange or automated quotation system on which the Notes may be listed or designated for issuance, and upon such notice as may be required by such exchange or automated quotation system, if, after notice given by the
Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee. 
 Section 2.04.     Payment of Additional Interest. If required by Sections 3.06(d), 3.06(e) or 5.02 of this Indenture, each Note shall pay Additional Interest in the
manner and to the Persons set forth by such Sections. Whenever in this Indenture there is mentioned, in any context, the payment of the principal of, premium, if any, or interest on, or in respect of, any Note, such mention shall be deemed to
include mention of the payment of “Additional Interest” provided for in Sections 3.06(d), 3.06(e) and 5.02 to the extent that, in such context, Additional Interest is, was or would be payable in respect thereof pursuant to the provisions
of such Sections, and express mention of the payment of Additional Interest (if applicable) in any provisions hereof shall not be construed as excluding Additional Interest in those provisions hereof where such express mention is not made.

 Section 2.05.     Execution, Authentication and Delivery of Notes. The Notes shall be
signed in the name and on behalf of the Company by the manual or facsimile signature of its Chairman or Vice-Chairman of the Board of Directors, Chief Executive Officer, President, any of its Executive or Senior Vice Presidents, or any of its Vice
Presidents (whether or not 

  
 16 

 
designated by a number or numbers or word or words added before or after the title “Vice President”). The signature of any of these officers on the Notes shall be manual, facsimile, in
the form of a .pdf attachment or by other means of electronic transmission. Notes shall be dated the date of their authentication. 
 At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver additional Notes executed by the Company to the Trustee for authentication, together with a
Company Order for the authentication and delivery of such Notes, and the Trustee in accordance with such Company Order shall authenticate and deliver such Notes, without any further action by the Company hereunder. 

Only such Notes as shall bear thereon a certificate of authentication substantially in the form set forth on the form of Note attached
as Exhibit A hereto, manually executed by the Trustee (or an authenticating agent appointed by the Trustee as provided by Section 15.10), shall be entitled to the benefits of this Indenture or be valid or obligatory for any purpose. Such
certificate by the Trustee (or such an authenticating agent) upon any Note executed by the Company shall be conclusive evidence that the Note so authenticated has been duly authenticated and delivered hereunder and that the holder is entitled to the
benefits of this Indenture. 
 In authenticating additional Notes after the date hereof, and accepting the additional
responsibilities under this Indenture in relation to such Notes, the Trustee shall receive, and, shall be fully protected in relying upon: 
 (a)     A copy of the resolution or resolutions of the Board of Directors in or pursuant to which the terms and form of the Notes were established, certified by the Secretary or an
Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect as of the date of such certificate, and if the terms and form of such Notes are established by an Officers’ Certificate
pursuant to general authorization of the Board of Directors, such Officers’ Certificate; 
 (b)     an
executed supplemental indenture, if any; 
 (c)     an Officers’ Certificate delivered in accordance
with Section 15.05; and 
 (d)     an Opinion of Counsel which shall state: 

(i)     that the form of such Notes has been established by a supplemental indenture or by or
pursuant to a resolution of the Board of Directors in accordance with Section 2.01 and Section 2.02 and in conformity with the provisions of this Indenture; 

(ii)     that the terms of such Notes have been established in accordance with Section 2.01 and
in conformity with the other provisions of this Indenture; 
 (iii)     that such Notes,
when authenticated and delivered by the Trustee and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute valid and legally binding obligations of the Company, enforceable in
accordance with their terms, subject to bankruptcy, insolvency, 

  
 17 

 
reorganization, fraudulent transfer, moratorium or other laws of general applicability relating to or affecting the enforcement of creditors’ rights and to general equity principles
regardless of whether such enforceability is considered in a proceeding of law or equity; and 

(iv)     that all laws and requirements in respect of the execution and delivery by the Company of
such Notes have been complied with. 
 In case any officer of the Company who shall have signed any of the Notes shall cease to
be such officer before the Notes so signed shall have been authenticated and delivered by the Trustee, or disposed of by the Company, such Notes nevertheless may be authenticated and delivered or disposed of as though the Person who signed such
Notes had not ceased to be such officer of the Company; and any Note may be signed on behalf of the Company by such Persons as, at the actual date of the execution of such Note, shall be the proper officers of the Company, although at the date of
the execution of this Indenture any such person was not such an officer. 
 Section 2.06.     Exchange
and Registration of Transfer of Notes; Restrictions on Transfer; Depositary. 
 (a)     The Company
shall cause to be kept at the Corporate Trust Office a register (the register maintained in such office and in any other office or agency of the Company designated pursuant to Section 3.02 being herein sometimes collectively referred to as the
“Note Register”) in which, subject to such reasonable regulations as it may prescribe, the Company shall provide for the registration of Notes and of transfers of Notes. Such register shall be in written form or in any form capable
of being converted into written form within a reasonable period of time. The Trustee is hereby appointed “Note Registrar” for the purpose of registering Notes and transfers of Notes as herein provided. The Company may appoint one or
more co-registrars in accordance with Section 3.02. 
 Upon surrender for registration of transfer of any Note to the Note
Registrar or any co-registrar, and satisfaction of the requirements for such transfer set forth in this Section 2.06, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee or
transferees, one or more new Notes of any authorized denominations and of a like aggregate principal amount and bearing such restrictive legends as may be required by this Indenture. 

Notes may be exchanged for other Notes of any authorized denominations and of a like aggregate principal amount, upon surrender of the
Notes to be exchanged at any such office or agency maintained by the Company pursuant to Section 3.02. Whenever any Notes are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Notes
which the Noteholder making the exchange is entitled to receive, bearing registration numbers not contemporaneously outstanding. 
 All Notes presented or surrendered for registration of transfer or for exchange, repurchase or conversion shall (if so required by the Company, the Trustee, the Note Registrar or any co-registrar) be duly
endorsed, or be accompanied by a written instrument or instruments of 

  
 18 

 
transfer in form satisfactory to the Company and duly executed, by the Noteholder thereof or his attorney-in-fact duly authorized in writing. 

No service charge shall be charged to the Noteholder for any exchange or registration of transfer of Notes, but the Company or the
Trustee may require payment of a sum sufficient to cover any tax, assessments or other governmental charges that may be imposed in connection therewith. 
 None of the Company, the Trustee, the Note Registrar or any co-registrar shall be required to exchange or register a transfer of (a) any Notes surrendered for conversion or, if a portion of any Note
is surrendered for conversion, such portion thereof surrendered for conversion or (b) any Notes, or a portion of any Note, surrendered for repurchase (and not withdrawn) except in accordance with Article 13 for conversion and
Article 14 for repurchase hereof, respectively. 
 All Notes issued upon any registration of transfer or exchange of Notes
in accordance with this Indenture shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture as the Notes surrendered upon such registration of transfer or exchange. 

(b)     So long as the Notes are eligible for book-entry settlement with the Depositary, unless otherwise required
by law, all Notes shall be represented by one or more Notes in global form (each, a “Global Note”) registered in the name of the Depositary or the nominee of the Depositary. The transfer and exchange of beneficial interests in a
Global Note, which does not involve the issuance of a definitive Note, shall be effected through the Depositary (but not the Trustee or the Custodian) in accordance with this Indenture (including the restrictions on transfer set forth herein) and
the procedures of the Depositary therefor. 
 (c)     Every Note that bears or is required under this
Section 2.06(c) to bear the legend set forth in this Section 2.06(c) (together with any Common Stock issued upon the conversion of the Notes and required to bear the legend set forth in Section 2.06(d), collectively, the
“Restricted Securities”) shall be subject to the restrictions on transfer set forth in this Section 2.06(c) (including the legend set forth below), unless such restrictions on transfer shall be waived by written consent of
the Company, and the holder of each such Restricted Security, by such holder’s acceptance thereof, agrees to be bound by all such restrictions on transfer. As used in this Section 2.06(c) and Section 2.06(d), the term
“transfer” encompasses any sale, pledge, transfer or other disposition whatsoever of any Restricted Security. 

Until the date (the “Resale Restriction Termination Date”) that is one year after the last date of original issuance of
the Notes, or such other period of time as permitted by Rule 144 under the Securities Act or any successor provision thereto, any certificate evidencing such Note (and all securities issued in exchange therefor or substitution thereof, other
than Common Stock, if any, issued upon conversion thereof which shall bear the legend set forth in Section 2.06(d), if applicable) shall bear a legend in substantially the following form (unless such Notes have been transferred pursuant to a
registration statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer, pursuant to the exemption from registration provided by Rule 144 or any similar

  
 19 

 
provision then in force under the Securities Act, or unless otherwise agreed by the Company in writing, with notice thereof to the Trustee): 

THE NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT IT IS A “QUALIFIED INSTITUTIONAL BUYER”
(AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT); (2) AGREES THAT IT WILL NOT WITHIN THE LATER OF (X) SIX MONTHS (OR, IF THE COMPANY HAS NOT SATISFIED THE CURRENT PUBLIC INFORMATION REQUIREMENTS OF RULE 144, ONE YEAR) AFTER THE LAST DATE
OF ORIGINAL ISSUANCE OF NOTES (INCLUDING THROUGH THE EXERCISE OF THE OPTION TO PURCHASE ADDITIONAL NOTES) AND (Y) 90 DAYS AFTER IT CEASES TO BE AN AFFILIATE (WITHIN THE MEANING OF RULE 144 UNDER THE SECURITIES ACT) OF FOREST CITY ENTERPRISES,
INC. (THE “COMPANY”), OFFER, RESELL, PLEDGE OR OTHERWISE TRANSFER THE NOTE EVIDENCED HEREBY OR THE CLASS A COMMON STOCK ISSUABLE UPON CONVERSION OF SUCH NOTE, EXCEPT (A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF, (B) TO A
QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, (C) UNDER ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, INCLUDING RULE 144 (IF AVAILABLE), OR (D) PURSUANT TO A
REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT (AND THAT CONTINUES TO BE EFFECTIVE AT THE TIME OF SUCH TRANSFER); (3) PRIOR TO SUCH TRANSFER (OTHER THAN A TRANSFER PURSUANT TO CLAUSES 2(A), 2(B) AND 2(D)
ABOVE), IT WILL FURNISH TO THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS TRUSTEE (OR A SUCCESSOR TRUSTEE, AS APPLICABLE), SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS THE TRUSTEE MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH
TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT; AND (4) AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THIS NOTE IS TRANSFERRED (OTHER THAN A
TRANSFER PURSUANT TO CLAUSE 2(D) ABOVE ) PRIOR TO EXPIRATION OF THE HOLDING PERIOD APPLICABLE TO SALES OF THE NOTE EVIDENCED HEREBY UNDER RULE 144 UNDER THE SECURITIES ACT (OR ANY SUCCESSOR PROVISION) A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS
LEGEND. THIS LEGEND WILL BE REMOVED UPON THE EARLIER OF THE TRANSFER OF THIS NOTE PURSUANT TO CLAUSE 2(D) ABOVE OR UPON ANY TRANSFER OF THIS NOTE UNDER RULE 144 SUCH THAT THE NOTE IS NO LONGER CONSIDERED “RESTRICTED SECURITIES” AS DEFINED
UNDER RULE 144 (OR ANY SUCCESSOR PROVISION). THE INDENTURE CONTAINS A PROVISION REQUIRING THE TRUSTEE TO REFUSE TO REGISTER ANY TRANSFER OF THIS NOTE IN VIOLATION OF THE FOREGOING RESTRICTION. 

  
 20 

 No transfer of any Note prior to the Resale Restriction Termination Date will be registered
by the Note Registrar unless the applicable box on the Form of Assignment and Transfer has been checked. 
 Any Note (or
security issued in exchange or substitution therefor) as to which such restrictions on transfer shall have expired in accordance with their terms may, upon surrender of such Note for exchange to the Note Registrar in accordance with the provisions
of this Section 2.06, be exchanged for a new Note or Notes, of like tenor and aggregate principal amount, which shall not bear the restrictive legend required by this Section 2.06(c). The Company shall notify the Trustee upon the
occurrence of the Resale Restriction Termination Date and promptly after a Registration Statement with respect to the Notes or the Common Stock has been declared effective under the Securities Act. 

Notwithstanding any other provisions of this Indenture, a Global Note may not be transferred as a whole or in part except (i) by
the Depositary to a nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary and
(ii) for transfers of portions of a Global Note in definitive form made upon request of a member of, or a participant in, the Depositary (for itself or on behalf of a Beneficial Owner) by written notice given to the Trustee by or on behalf of
the Depositary in accordance with customary procedures of the Depositary and in compliance with this Section. 
 The Depositary
shall be a clearing agency registered under the Exchange Act. The Company initially appoints The Depository Trust Company to act as Depositary with respect to each Global Note. Initially, the Global Note shall be issued to the Depositary, registered
in the name of Cede & Co., as the nominee of the Depositary, and deposited with the Trustee as custodian for the Depositary. 
 If at any time the Depositary for a Global Note (i) notifies the Company that it is unwilling or unable to continue as depositary for such Note or (ii) ceases to be registered as a clearing
agency under the Exchange Act, the Company may appoint a successor Depositary with respect to such Note. If (A) a successor Depositary for such Global Note is not appointed by the Company within ninety (90) days after the Company receives
such notice or the Depositary ceases to be a registered clearing agency, (B) the Company, at its option, notifies the Trustee that it elects to cause the issuance of Notes in definitive form in exchange for all or any part of the Notes
represented by a Global Note, subject to the procedures of the Depositary, or (C) an Event of Default has occurred and is continuing and the Note Registrar has received a request from the Depositary for the issuance of Notes in definitive form
in exchange for a Global Note, the Company will execute, and the Trustee, upon receipt of an Officers’ Certificate for the authentication and delivery of Notes, will authenticate and deliver Notes in definitive form in an aggregate principal
amount equal to the principal amount of such Global Note, in exchange for such Global Note, and upon delivery of the Global Note to the Trustee such Global Note shall be canceled. 

Definitive Notes issued in exchange for all or a part of the Global Note pursuant to this Section 2.06(c) shall be registered
in such names and in such authorized denominations as the Depositary, pursuant to instructions from its direct or indirect participants or otherwise, shall 

  
 21 

 
instruct the Trustee. Upon execution and authentication, the Trustee shall deliver such definitive Notes to the Persons in whose names such definitive Notes are so registered. 

At such time as all interests in a Global Note have been converted, canceled, repurchased or transferred, such Global Note shall be,
upon receipt thereof, canceled by the Trustee in accordance with standing procedures and instructions existing between the Depositary and the Custodian. At any time prior to such cancellation, if any interest in a Global Note is exchanged for
definitive Notes, converted, canceled, repurchased or transferred to a transferee who receives definitive Notes therefor or any definitive Note is exchanged or transferred for part of such Global Note, the principal amount of such Global Note shall,
in accordance with the standing procedures and instructions existing between the Depositary and the Custodian, be appropriately reduced or increased, as the case may be, and an endorsement shall be made on such Global Note, by the Trustee or the
Custodian, at the direction of the Trustee, to reflect such reduction or increase. 
 None of the Company, the Trustee nor any
agent of the Company or the Trustee will have any responsibility or liability for any aspect of the records relating to or payments made on account of Beneficial Ownership interests of a Global Note or maintaining, supervising or reviewing any
records relating to such Beneficial Ownership interests. 
 (d)     Until the Resale Restriction
Termination Date, any stock certificate representing Common Stock issued upon conversion of the Note shall bear a legend in substantially the following form (unless such Note or such Common Stock has been transferred pursuant to a registration
statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer or pursuant to the exemption from registration provided by Rule 144 under the Securities Act or any
similar provision then in force under the Securities Act, or such Common Stock has been issued upon conversion of the Notes that have been transferred pursuant to a registration statement that has become or been declared effective under the
Securities Act and that continues to be effective at the time of such transfer or pursuant to the exemption from registration provided by Rule 144 under the Securities Act, or unless otherwise agreed by the Company with written notice thereof
to the Trustee and any transfer agent for the Common Stock): 
 THE CLASS A COMMON STOCK EVIDENCED HEREBY HAS NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. THE HOLDER HEREOF
AGREES THAT (1) IT WILL NOT WITHIN THE LATER OF (X) SIX MONTHS (OR, IF THE COMPANY HAS NOT SATISFIED THE CURRENT PUBLIC INFORMATION REQUIREMENTS OF RULE 144, ONE YEAR) AFTER THE LAST DATE OF ORIGINAL ISSUANCE OF THE NOTES (INCLUDING
THROUGH THE EXERCISE OF THE OPTION TO PURCHASE ADDITIONAL NOTES) UPON THE CONVERSION OF WHICH THIS SECURITY WAS ISSUED AND (Y) 90 DAYS AFTER IT CEASES TO BE AN AFFILIATE (WITHIN THE MEANING OF RULE 144 UNDER THE SECURITIES ACT) OF FOREST CITY
ENTERPRISES, INC. (THE “COMPANY”), OFFER, RESELL, PLEDGE OR OTHERWISE TRANSFER THE CLASS A COMMON STOCK 

  
 22 

 
EVIDENCED HEREBY, EXCEPT (A) TO THE COMPANY OR TO ANY SUBSIDIARY THEREOF, (B) UNDER ANY AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, INCLUDING RULE 144
(IF AVAILABLE), OR (C) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT (AND THAT CONTINUES TO BE EFFECTIVE AT THE TIME OF SUCH TRANSFER); (2) PRIOR TO SUCH TRANSFER (OTHER THAN A TRANSFER
PURSUANT TO CLAUSES 1(A) OR 1(C) ABOVE), IT WILL FURNISH TO WELLS FARGO SHAREOWNER SERVICES, AS TRANSFER AGENT (OR A SUCCESSOR TRANSFER AGENT), SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS THE TRANSFER AGENT MAY REASONABLY REQUIRE TO
CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT; AND (3) IT WILL DELIVER TO EACH PERSON TO WHOM THE CLASS A COMMON STOCK EVIDENCED
HEREBY IS TRANSFERRED (OTHER THAN A TRANSFER PURSUANT TO CLAUSE 1(C) ABOVE) PRIOR TO EXPIRATION OF THE HOLDING PERIOD APPLICABLE TO SALES OF THE CLASS A COMMON STOCK EVIDENCED HEREBY UNDER RULE 144 UNDER THE SECURITIES ACT (OR ANY SUCCESSOR
PROVISION) A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. THIS LEGEND WILL BE REMOVED UPON THE EARLIER OF THE TRANSFER OF THE CLASS A COMMON STOCK EVIDENCED HEREBY PURSUANT TO CLAUSE 1(C) ABOVE OR UPON ANY TRANSFER OF THE CLASS A COMMON STOCK
EVIDENCED HEREBY UNDER RULE 144 SUCH THAT THE CLASS A COMMON STOCK EVIDENCED HEREBY IS NO LONGER CONSIDERED “RESTRICTED SECURITIES” AS DEFINED UNDER RULE 144 (OR ANY SUCCESSOR PROVISION). 

Any such Common Stock as to which such restrictions on transfer shall have expired in accordance with their terms may, upon surrender of
the certificates representing such shares of Common Stock for exchange in accordance with the procedures of the transfer agent for the Common Stock, be exchanged for a new certificate or certificates for a like aggregate number of shares of Common
Stock, which shall not bear the restrictive legend required by this Section 2.06(d). 
 (e)     Any
Note or Common Stock issued upon conversion of the Notes that, prior to the expiration of the holding period applicable to sales thereof under Rule 144 under the Securities Act (or any successor provision), is purchased or owned by the Company
or any Affiliate thereof may not be resold by the Company or such Affiliate unless registered under the Securities Act in a transaction that results in such Notes or Common Stock, as the case may be, no longer being “Restricted Securities”
(as defined under Rule 144). 
 (f)     Notwithstanding any provision of Section 2.06 to the
contrary, in the event Rule 144 as promulgated under the Securities Act (or any successor rule) is amended to change the one-year period under Rule 144 (or the corresponding period under any successor rule), from and after receipt by the
Trustee of the Officers’ Certificate and Opinion of Counsel provided for in this Section 2.06(f), (i) each reference in Section 2.06(c) to “one year” and in the restrictive legend set forth in such paragraph to
“ONE YEAR” shall be deemed for all purposes hereof to be 

  
 23 

 
references to such changed period, (ii) each reference in Section 2.06(d) to “one year” and in the restrictive legend set forth in such paragraph to “ONE YEAR”
shall be deemed for all purposes hereof to be references to such changed period and (iii) all corresponding references in the Notes (including the definition of Resale Restriction Termination Date) and the restrictive legends thereon shall be
deemed for all purposes hereof to be references to such changed period, provided that such changes shall not become effective if they are otherwise prohibited by, or would otherwise cause a violation of, the then-applicable federal securities
laws. The provisions of this Section 2.06(f) will not be effective until such time as the Opinion of Counsel and Officers’ Certificate have been received by the Trustee hereunder. This Section 2.06(f) shall apply to
successive amendments to Rule 144 (or any successor rule) changing the holding period thereunder. 
 Section
2.07.    Mutilated, Destroyed, Lost or Stolen Notes. In case any Note shall become mutilated or be destroyed, lost or stolen, the Company in its discretion may execute, and upon its written request the Trustee or an
authenticating agent appointed by the Trustee shall authenticate and deliver, a new Note, bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Note, or in lieu of and in substitution for the Note so
destroyed, lost or stolen. In every case the applicant for a substituted Note shall furnish to the Company, to the Trustee and, if applicable, to such authenticating agent such security or indemnity as may be required by them to save each of them
harmless from any loss, liability, cost or expense caused by or connected with such substitution, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company, to the Trustee and, if applicable, to such
authenticating agent evidence to their satisfaction of the destruction, loss or theft of such Note and of the ownership thereof. 
 The Trustee or such authenticating agent may authenticate any such substituted Note and deliver the same upon the receipt of such security or indemnity as the Trustee, the Company and, if applicable, such
authenticating agent may require. Upon the issuance of any substituted Note, the Company or the Trustee may require the payment by the holder of a sum sufficient to cover any tax, assessment or other governmental charge that may be imposed in
relation thereto and any other expenses connected therewith. In case any Note which has matured or is about to mature or has been tendered for repurchase upon a Fundamental Change or is about to be converted shall become mutilated or be destroyed,
lost or stolen, the Company may, in its sole discretion, instead of issuing a substitute Note, pay or authorize the payment or the conversion of the same (without surrender thereof except in the case of a mutilated Note), as the case may be, if the
applicant for such payment or conversion shall furnish to the Company, to the Trustee and, if applicable, to such authenticating agent such security or indemnity as may be required by them to save each of them harmless for any loss, liability, cost
or expense caused by or connected with such substitution, and, in every case of destruction, loss or theft, evidence satisfactory to the Company, the Trustee and, if applicable, any Paying Agent or Conversion Agent evidence of their satisfaction of
the destruction, loss or theft of such Note and of the ownership thereof. 
 Every substitute Note issued pursuant to the
provisions of this Section 2.07 by virtue of the fact that any Note is destroyed, lost or stolen shall constitute an additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Note shall be found at any time,
and shall be entitled to all the benefits of (but shall be subject to all the 

  
 24 

 
limitations set forth in) this Indenture equally and proportionately with any and all other Notes duly issued hereunder. To the extent permitted by law, all Notes shall be held and owned upon the
express condition that the foregoing provisions are exclusive with respect to the replacement or payment or conversion or repurchase of mutilated, destroyed, lost or stolen Notes and shall preclude any and all other rights or remedies
notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment or conversion of negotiable instruments or other securities without their surrender. 

Section 2.08.    Temporary Notes. Pending the preparation of Notes in definitive form, the Company may
execute and the Trustee or an authenticating agent appointed by the Trustee shall, upon written request of the Company, authenticate and deliver temporary Notes (printed or lithographed). Temporary Notes shall be issuable in any authorized
denomination, and substantially in the form of the Notes in definitive form but with such omissions, insertions and variations as may be appropriate for temporary Notes, all as may be determined by the Company. Every such temporary Note shall be
executed by the Company and authenticated by the Trustee or such authenticating agent upon the same conditions and in substantially the same manner, and with the same effect, as the Notes in definitive form. Without unreasonable delay the Company
will execute and deliver to the Trustee or such authenticating agent Notes in definitive form (other than in the case of Notes in global form) and thereupon any or all temporary Notes (other than any Global Note) may be surrendered in exchange
therefor, at each office or agency maintained by the Company pursuant to Section 3.02 and the Trustee or such authenticating agent shall authenticate and deliver in exchange for such temporary Notes an equal aggregate principal amount of Notes
in definitive form. Such exchange shall be made by the Company at its own expense and without any charge therefor. Until so exchanged, the temporary Notes shall in all respects be entitled to the same benefits and subject to the same limitations
under this Indenture as Notes in definitive form authenticated and delivered hereunder. 
 Section
2.09.    Cancellation of Notes Paid, Etc. All Notes surrendered for the purpose of payment, repurchase, conversion, exchange or registration of transfer, shall, if surrendered to the Company or any Paying Agent or any Note
Registrar or any Conversion Agent, be surrendered to the Trustee and promptly canceled by it, or, if surrendered to the Trustee, shall be promptly canceled by it, and no Notes shall be issued in lieu thereof except as expressly permitted by any of
the provisions of this Indenture. The Trustee shall dispose of canceled Notes in accordance with its customary procedures and, after such disposal, shall deliver a certificate of such disposal to the Company, at the Company’s written request.
If the Company shall acquire any of the Notes, such acquisition shall not operate as satisfaction of the debt represented by such Notes unless and until the same are delivered to the Trustee for cancellation. 

Section 2.10.    CUSIP Numbers. The Company in issuing the Notes may use “CUSIP” numbers (if
then generally in use), and, if so, the Trustee shall use “CUSIP” numbers in all notices to Noteholders as a convenience to holders of the Notes; provided that any such notice may state that no representation is made as to
the correctness of such numbers either as printed on the Notes or on such notice and that reliance may be placed only on the other identification numbers printed on the Notes. The Company will promptly notify the Trustee in writing of any change in
the “CUSIP” numbers. Until such time as the Company notifies the 

  
 25 

 
Trustee to remove the restrictive legend as set forth in Section 2.06(c) from the Notes or a transfer of Notes from a Restricted Global Note to an Unrestricted Global Note is otherwise made
pursuant to the terms hereof, the restricted CUSIP will be the CUSIP number for the Notes. At such time as the Company notifies the Trustee to remove the restrictive legend as set forth in Section 2.06(c) from the Notes, such legend shall be
deemed removed from any Global Notes and an unrestricted CUSIP number for the Notes shall be deemed to be the CUSIP number for the Notes. 
 Section 2.11.    Additional Notes, Repurchases. The Company may, without the consent of the Noteholders and notwithstanding Section 2.01, reopen this Indenture and issue
additional Notes hereunder with the same terms as the Notes initially issued hereunder in an unlimited aggregate principal amount, which will form the same series with the Notes initially issued hereunder; provided that, if any such
additional Notes are not fungible with the Notes initially issued hereunder for U.S. federal income tax purposes, such additional notes will have a separate CUSIP number. The Company may also from time to time repurchase the Notes in tender offers,
open market purchases or negotiated transactions without prior notice to Noteholders. 
 Section
2.12.    Automatic Exchange from Restricted Global Note to Unrestricted Global Note. Beneficial interests in a Global Note or Common Stock issued upon conversion of Notes that is subject to restrictions set out in
Section 2.06(c) or Section 2.06(d), as applicable (including the legend set forth in Section 2.06(c) or Section 2.06(d), as applicable) (the “Restricted Global Note” or “Restricted Common Stock,”
as applicable), shall be automatically exchanged into beneficial interests in an unrestricted Global Note or stock certificate representing unrestricted Common Stock, as applicable, that is no longer subject to the restrictions set out in
Section 2.06(c) or Section 2.06(d), as applicable (including removal of the legend set forth in Section 2.06(c) or Section 2.06(d), as applicable) (the “Unrestricted Global Note” or “Unrestricted Common
Stock,” as applicable), without any action required by or on behalf of the holder (the “Automatic Exchange”). In order to effect such exchange, the Company shall at least fifteen (15) days but not more than thirty
(30) days prior to the Resale Restriction Termination Date, deliver a notice of Automatic Exchange (an “Automatic Exchange Notice”) to each holder at such holder’s address appearing in the Note Register or register
maintained at the registrar for Common Stock, as applicable, with a copy to the Trustee or transfer agent for Common Stock, as applicable. The Automatic Exchange Notice shall identify the Notes or Common Stock , as applicable, subject to the
Automatic Exchange and shall state: (1) the date of the Automatic Exchange; (2) the section of this Indenture pursuant to which the Automatic Exchange shall occur; (3) the “CUSIP” number of the Restricted Global Note or
Restricted Common Stock, as applicable, from which such holders’ beneficial interests shall be transferred and (4) the “CUSIP” number of the Unrestricted Global Note or Unrestricted Common Stock, as applicable, into which such
holders’ beneficial interests shall be transferred. At the Company’s request on no less than five (5) days’ prior notice, the Trustee shall deliver, or, with respect to Common Stock, the Company shall cause the transfer agent to
deliver, in the Company’s name and at its expense, the Automatic Exchange Notice to each holder at such holder’s address appearing in the Note Register or register maintained at the registrar for Common Stock, as applicable; provided,
however, that the Company shall have delivered to the Trustee or transfer agent, as applicable, a Company Order and an Officers’ Certificate requesting that the Trustee or transfer agent, as applicable, give the Automatic Exchange Notice
(in the 

  
 26 

 
name and at the expense of the Company) and setting forth the information to be stated in the Automatic Exchange Notice as provided in the preceding sentence. As a condition to any such exchange
pursuant to this Section 2.12, the Trustee or transfer agent, as applicable, shall be entitled to receive from the Company, and rely conclusively without any liability, upon an Officers’ Certificate and an Opinion of Counsel to the
Company, in form and in substance reasonably satisfactory to the Trustee or transfer agent, as applicable, to the effect that such transfer of beneficial interests to the Unrestricted Global Note or Unrestricted Common Stock, as applicable, shall be
effected in compliance with the Securities Act. Upon such exchange of beneficial interests pursuant to this Section 2.12, (i) with respect to the Notes, the Note Registrar shall endorse the schedule of increases and decreases in the Global
Note to the relevant Notes and reflect on its books and records the date of such transfer and a decrease and increase, respectively, in the principal amount of the applicable Restricted Global Note and the Unrestricted Global Note, respectively,
equal to the principal amount of beneficial interests transferred or (ii) with respect to Common Stock, the registrar for Common Stock shall reflect on its books and records the date of such transfer and a decrease and increase, respectively,
in the number of shares of the applicable Restricted Common Stock and the Unrestricted Common Stock, respectively, equal to the beneficial interests transferred. If an Unrestricted Global Note is not then outstanding at the time of the Automatic
Exchange, the Company shall execute and the Trustee shall authenticate and deliver an Unrestricted Global Note to the Depositary. Following any such transfer pursuant to this Section 2.12, the relevant Restricted Global Note or Restricted
Common Stock, as applicable, shall be cancelled. 
 ARTICLE 3 

PARTICULAR COVENANTS OF THE COMPANY 

Section 3.01.    Payment of Principal, Interest and Additional Interest. The Company covenants and agrees
that it will cause to be paid the principal of, and accrued and unpaid interest (including Additional Interest, if any) on, each of the Notes and if applicable, deliver shares of Common Stock (together with any cash in lieu of fractional shares)
upon conversion, at the places, at the respective times and in the manner provided herein and in the Notes. Each installment of accrued and unpaid interest (including Additional Interest, if any) on the Notes in definitive form due on any Interest
Payment Date may be paid by mailing checks for the amount payable to or upon the written order of the Noteholders entitled thereto as they shall appear on the registry books of the Company, provided that, with respect to any Noteholder with
an aggregate principal amount in excess of $1,000,000, at the application of such holder in writing to the Note Registrar not later than the relevant record date, accrued and unpaid interest (including Additional Interest, if any) on such
holder’s Notes shall be paid by wire transfer in immediately available funds to such holder’s account in the United States supplied by such holder from time to time to the Trustee and Paying Agent (if different from Trustee); provided
further that payment of accrued and unpaid interest (including Additional Interest, if any) on the Notes in global form shall be made to the Depositary and be paid by wire transfer in immediately available funds in accordance with such wire
transfer instructions and other procedures provided by the Depositary from time to time. 
 Section
3.02.    Maintenance of Office or Agency. The Company will maintain in the Borough of Manhattan, The City of New York, an office or agency where the Notes may be surrendered for registration of transfer or exchange or for
presentation for payment or repurchase 

  
 27 

 
(“Paying Agent”) or for conversion (“Conversion Agent”) and where notices and demands to or upon the Company in respect of the Notes and this Indenture may be
served. The Company will give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency not designated or appointed by the Trustee. If at any time the Company shall fail to maintain any such
required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office or the office or agency of the Trustee in the Borough of
Manhattan, The City of New York. 
 The Company may also from time to time designate one or more other offices or agencies
where the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided that no such designation or rescission shall in any manner relieve the Company of its obligation to
maintain an office or agency in the Borough of Manhattan, The City of New York, for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other
office or agency. The terms “Paying Agent” and “Conversion Agent” include any such additional or other offices or agencies, as applicable. 
 The Company hereby initially designates the Trustee as the Paying Agent, Note Registrar, Custodian and Conversion Agent and the Corporate Trust Office and the office or agency of the Trustee in the
Borough of Manhattan shall be considered as one such office or agency of the Company for each of the aforesaid purposes. 
 So
long as the Trustee is the Note Registrar, the Trustee agrees to mail, or cause to be mailed, the notices set forth in Section 6.10(a) and the third paragraph of Section 6.11. 

Section 3.03.    Appointments to Fill Vacancies in Trustee’s Office. The Company, whenever necessary to
avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 6.10, a Trustee, so that there shall at all times be a Trustee hereunder. 

Section 3.04.    Provisions as to Paying Agent. 

(a)     If the Company shall appoint a Paying Agent other than the Trustee or if the Trustee shall appoint such a
Paying Agent, the Company will cause such Paying Agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this Section 3.04: 

(i)     that it will hold all sums held by it as such agent for the payment of the principal of, and
accrued and unpaid interest (including Additional Interest, if any) on, the Notes (whether such sums have been paid to it by the Company) in trust for the benefit of the holders of the Notes; 

(ii)     that it will give the Trustee notice of any failure by the Company to make any payment of
the principal of, and accrued and unpaid interest (including Additional Interest, if any) on, the Notes when the same shall be due and payable; and 

  
 28 

 (iii)     that at any time during the continuance of an
Event of Default, upon request of the Trustee, it will forthwith pay to the Trustee all sums so held in trust. 
 The Company
shall, on or before each due date of the principal of, or accrued and unpaid interest (including Additional Interest, if any) on the Notes, deposit with the Paying Agent a sum sufficient to pay such principal or accrued and unpaid interest
(including Additional Interest, if any) and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee in writing of any failure to take such action, provided that if such deposit is made on the due date, such
deposit must be received by the Paying Agent by 11:00 a.m., New York City time, on such date. 
 (b)
    If the Company shall act as its own Paying Agent, it will, on or before each due date of the principal of and accrued and unpaid interest (including Additional Interest, if any) on the Notes, set aside, segregate and hold in
trust for the benefit of the holders of the Notes a sum sufficient to pay such principal and accrued and unpaid interest (including Additional Interest, if any) so becoming due and will notify the Trustee in writing of any failure to take such
action and of any failure by the Company to make any payment of the principal of and accrued and unpaid interest (including Additional Interest, if any) on the Notes, when the same shall become due and payable. 

(c)     Anything in this Section 3.04 to the contrary notwithstanding, the Company may, at any time, for the
purpose of obtaining a satisfaction and discharge of this Indenture, or for any other reason, pay or cause to be paid to the Trustee all sums held in trust by the Company or any Paying Agent hereunder as required by this Section 3.04, such sums
to be held by the Trustee upon the trusts herein contained and upon such payment by the Company or any Paying Agent to the Trustee, the Company or such Paying Agent shall be released from all further liability with respect to such sums. 

(d)     Anything in this Section 3.04 to the contrary notwithstanding, the agreement to hold sums in trust as
provided in this Section 3.04 is subject to Section 11.03 and Section 11.04. 
 Section
3.05.    Existence. Subject to Article 10, the Company will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence. 

Section 3.06.    Rule 144A Information Requirement and Annual Reports. 

(a)     At any time the Company is not subject to Sections 13 or 15(d) of the Exchange Act, the Company shall,
so long as any of the Notes shall, at such time, constitute “Restricted Securities” within the meaning of Rule 144(a)(3) under the Securities Act, promptly provide to the Trustee and shall, upon written request, provide to any holder,
Beneficial Owner or prospective purchaser of such Notes, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act to facilitate the resale of such Notes pursuant to Rule 144A under the Securities Act.
The Company shall take such further action as any holder or Beneficial Owner of such Notes may reasonably request to the extent required from time to time to enable such holder or beneficial holder to sell such Notes in accordance with
Rule 144A under the Securities Act, as such rule may be amended from time to time. 

  
 29 

 (b)     The Company shall deliver to the Trustee within fifteen
(15) days after the filing of the same with the Commission, copies of the quarterly and annual reports and of the information, documents and other reports, if any, which the Company is required to file with the Commission pursuant to
Section 13 or 15(d) of the Exchange Act, and shall otherwise comply with the requirements of Trust Indenture Act Section 314(a). 
 (c)     Delivery of such reports, information and documents to the Trustee is for informational purposes only, and the Trustee’s receipt of such shall not constitute constructive
notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to conclusively rely exclusively on an
Officers’ Certificate). 
 (d)     If, at any time during the six-month period beginning on, and
including, the date which is six (6) months after the date of original issuance of the Notes, the Company fails to timely file any document or report that the Company is required to file with the Commission pursuant to Section 13 or 15(d)
of the Exchange Act, as applicable (other than current reports on Form 8-K), and the Notes are not otherwise freely tradable by holders other than the Company’s affiliates (as a result of restrictions pursuant to U.S. securities law or the
terms of this Indenture or the Notes), the Company shall pay Additional Interest on the Notes. Such Additional Interest will accrue on the Notes at an annual rate of 0.50% per annum of the principal amount of Notes outstanding for each day
during such period for which the Company’s failure to file continues; provided that the Company shall have fourteen (14) days, in the aggregate, to cure any such late filings before any Additional Interest shall accrue. 

(e)     If, at any time after the 365th day after the last date of original issuance of the Notes pursuant to the
Purchase Agreement, (i) the restrictive legend on the Notes has not been removed in accordance with Section 2.06(c) or 2.12, and (ii) the Notes are not freely tradable pursuant to Rule 144 without volume restrictions by holders other
than the Company’s affiliates (without restrictions pursuant to U.S. securities law or the terms of this Indenture or the Notes), the Company shall pay Additional Interest on the Notes. Such Additional Interest will accrue on the Notes at an
annual rate of 0.50% per annum of the principal amount of Notes outstanding for each day after the 365th day after the last date of original issuance of the Notes until (i) the restrictive legend on the Notes has been removed in accordance
with Section 2.06(c) or 2.12, and (ii) the Notes are freely tradable pursuant to Rule 144 without volume restrictions by holders other than the Company’s affiliates (without restrictions pursuant to U.S. securities law or the terms of
this Indenture or the Notes). 
 (f)     Additional Interest payable in accordance with
Section 3.06(d) or 3.06(e) will be payable in arrears on each Interest Payment Date following accrual in the same manner as regular interest on the Notes. 
 Section 3.07.    Stay, Extension and Usury Laws. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any
manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit or forgive the Company from paying all or any portion of the principal of, or interest on, the Notes as contemplated
herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Indenture; and 

  
 30 

 
the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and covenants that it will not, by resort to any such law, hinder, delay or
impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted. 
 Section 3.08.    Compliance Certificate; Statements as to Defaults. The Company shall deliver to the Trustee within 120 calendar days after the end of each Fiscal Year of the
Company (beginning with the Fiscal Year ending on January 31, 2012) an Officers’ Certificate stating whether or not the signer thereof has knowledge of any failure by the Company to comply with all conditions and covenants then required to
be performed under this Indenture and, if so, specifying each such failure and the nature thereof. 
 In addition, the Company
shall deliver to the Trustee, as soon as possible and in any event within thirty (30) days after the Company becomes aware of the occurrence of any Event of Default or Default, an Officers’ Certificate setting forth the details of such
Event of Default or Default, its status and the action which the Company proposes to take with respect thereto. 
 Section
3.09.    Further Instruments and Acts. Upon request of the Trustee or as necessary, the Company will execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry
out more effectively the purposes of this Indenture. 
 Section 3.10.    Additional Interest
Notification. If Additional Interest is payable by the Company, the Company shall deliver to the Trustee an Officers’ Certificate to that effect stating the amount of such Additional Interest that is payable and the date on which such
Additional Interest is payable. Unless and until a Responsible Officer of the Trustee receives at the Corporate Trust Office such a certificate, the Trustee may assume without inquiry that no such Additional Interest is payable. If the Company has
paid Additional Interest directly to the Persons entitled to them, the Company shall deliver to the Trustee an Officers’ Certificate setting forth the particulars of such payment. 

ARTICLE 4 

LISTS OF NOTEHOLDERS AND REPORTS BY
THE COMPANY AND THE TRUSTEE 
 Section
4.01.    Lists of Noteholders. The Company covenants and agrees that it will furnish or cause to be furnished to the Trustee, semi-annually, not more than fifteen (15) days after each March 31 and
September 30 in each year beginning with March 31, 2012, and at such other times as the Trustee may request in writing, within thirty (30) days after receipt by the Company of any such request (or such lesser time as the Trustee may
reasonably request in order to enable it to timely provide any notice to be provided by it hereunder), a list in such form as the Trustee may reasonably require of the names and addresses of the Noteholders as of a date not more than fifteen
(15) days (or such other date as the Trustee may reasonably request in order to so provide any such notices) prior to the time such information is furnished, except that no such list need be furnished so long as the Trustee is acting as Note
Registrar. 

  
 31 

 Section 4.02.    Preservation and Disclosure of Lists.

 (a) The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and
addresses of the Noteholders contained in the most recent list furnished to it as provided in Section 4.01 or maintained by the Trustee in its capacity as Note Registrar, if so acting. The Trustee may destroy any list furnished to it as
provided in Section 4.01 upon receipt of a new list so furnished. 
 (b)     The rights of Noteholders
to communicate with other Noteholders with respect to their rights under this Indenture or under the Notes and the corresponding rights and duties of the Trustee, shall be as provided by the Trust Indenture Act. 

(c)     Every Noteholder, by receiving and holding the same, agrees with the Company and the Trustee that neither
the Company nor the Trustee nor any agent of either of them shall be held accountable by reason of any disclosure of information as to names and addresses of Noteholders made pursuant to the Trust Indenture Act. 

Section 4.03.    Reports by Trustee. 

(a)     Within sixty (60) days after April 1 of each year commencing with the year 2012, the Trustee shall
transmit to Noteholders such reports dated as of April 1 of each year in which such reports are made concerning the Trustee and its actions under this Indenture as may be required pursuant to the Trust Indenture Act at the times and in the
manner provided pursuant thereto. 
 (b)     A copy of such report shall, at the time of such transmission
to Noteholders, be filed by the Trustee with each stock exchange and automated quotation system upon which the Notes are listed and with the Company. The Company will notify the Trustee in writing within a reasonable time when the Notes are listed
on any stock exchange or automated quotation system and when any such listing is discontinued. 
 Section
4.04.    Reports by Company. 
 (a)     The Company shall file with the Trustee
and the Commission, and transmit to Noteholders, such information, documents and other reports and such summaries thereof, as may be required pursuant to the Trust Indenture Act at the times and in the manner provided pursuant to such Act;
provided that any such information, documents or reports required to be filed with the Commission pursuant to Section 13 or 15(d) of the Exchange Act shall be filed with the Trustee within fifteen (15) days after the same is
filed with the Commission. 
 (b)     Delivery of such reports, information and documents to the Trustee is
for informational purposes only, and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with
any of its covenants hereunder (as to which the Trustee is entitled to conclusively rely exclusively on an Officers’ Certificate). 

  
 32 

 ARTICLE 5 
 DEFAULTS AND REMEDIES 
 Section
5.01.    Events of Default. The following events shall be Events of Default with respect to the Notes: 
 (a)     default in any payment of interest, including any Additional Interest, on any Note when due and payable and the default continues for a period of thirty (30) days;

 (b)     default in the payment of principal of or any other amount under any Note when
due and payable on the Maturity Date, upon required repurchase, upon declaration of acceleration or otherwise; 

(c)     failure by the Company to comply with its obligation to convert the Notes in accordance with
this Indenture upon exercise of a holder’s conversion rights; 
 (d)     failure by the
Company to comply with its obligations under Article 10; 
 (e)     failure by the
Company to comply with its notice obligations under Section 14.01(b); 
 (f)
    failure by the Company for sixty (60) days to comply with any of its other agreements (other than a covenant or warranty or default in whose performance or whose breach is elsewhere in this Section specifically
provided for) contained in the Notes or this Indenture after written notice of such default from the Trustee or the holders of at least 25% in principal amount of the Notes then outstanding has been received by the Company; 

(g)     a default or defaults under any bond, debenture, note or other evidence of Debt (other than
Nonrecourse Debt or SPE Recourse Debt) by the Company or any subsidiary of the Company or under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Debt for money borrowed (other
than Nonrecourse Debt or SPE Recourse Debt) of the Company or any such subsidiary with a principal amount then outstanding in excess of $50 million, whether such Debt now exists or shall hereafter be created, which default or defaults shall
constitute a failure to pay any portion of the principal of such Debt when due and payable after the expiration of any applicable grace period with respect thereto and shall have resulted in such Debt becoming or being declared due and payable prior
to the date on which it would otherwise have become due and payable or constitutes the failure to pay any portion of the principal of such Debt when due and payable at maturity or by acceleration; 

(h)     a default or defaults under any bond, debenture, note or other evidence of Nonrecourse Debt
or SPE Recourse Debt by the Company or any majority owned subsidiary of the Company or under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Nonrecourse Debt or SPE Recourse
Debt of the Company or any such subsidiary with a principal amount then outstanding in excess of 20% of the aggregate principal or similar amount of 

  
 33 

 
all the outstanding Nonrecourse Debt and SPE Recourse Debt of the Company and its subsidiaries, whether such Nonrecourse Debt or SPE Recourse Debt now exists or shall hereafter be created, which
default or defaults shall constitute a failure to pay any portion of the principal of such Nonrecourse Debt or SPE Recourse Debt when due and payable after the expiration of any applicable grace period with respect thereto or shall have resulted in
such Nonrecourse Debt or SPE Recourse Debt becoming or being declared due and payable prior to the date on which it would otherwise have become due and payable; 

(i)     the Company or any of its Significant Subsidiaries shall commence a voluntary case or other
proceeding seeking liquidation, reorganization or other relief with respect to the Company or any of their respective Significant Subsidiaries or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking
the appointment of a trustee, receiver, liquidator, custodian or other similar official of the Company or any of its Significant Subsidiaries or any substantial part of its property, or shall consent to any such relief or to the appointment of or
taking possession by any such official in an involuntary case or other proceeding commenced against it, or shall make a general assignment for the benefit of creditors, or shall fail generally to pay its debts as they become due; or 

(j)     an involuntary case or other proceeding shall be commenced against the Company or any of its
Significant Subsidiaries seeking liquidation, reorganization or other relief with respect to the Company or any of its Significant Subsidiaries or their respective debts under any bankruptcy, insolvency or other similar law now or hereafter in
effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of the Company or any of its Significant Subsidiaries or any substantial part of its property, and such involuntary case or other proceeding
shall remain undismissed and unstayed for a period of ninety (90) consecutive days. 
 In case one or more Events of
Default shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order,
rule or regulation of any administrative or governmental body), then, and in each and every such case (other than an Event of Default specified in Section 5.01(i) or Section 5.01(j) with respect to the Company), unless the principal of all
of the Notes shall have already become due and payable, either the Trustee or the holders of at least 25% in aggregate principal amount of the Notes then outstanding determined in accordance with Section 7.04, by notice in writing to the
Company (and to the Trustee if given by Noteholders), may, and the Trustee at the request of such holders shall, declare 100% of the principal of, and accrued and unpaid interest (including Additional Interest, if any) on, all the Notes to be due
and payable immediately, and upon any such declaration the same shall become and shall be immediately due and payable, anything in this Indenture or in the Notes contained to the contrary notwithstanding. If an Event of Default specified in
Section 5.01(i) or Section 5.01(j) occurs and is continuing with respect to the Company, the principal of all the Notes and accrued and unpaid interest (including Additional Interest, if any) shall be immediately due and payable. This
provision, however, is subject to the conditions that if, at any time after the principal of the Notes shall have been so declared due and payable, and before any judgment or decree for the payment of the monies due shall have been

  
 34 

 
obtained or entered as hereinafter provided, the Company shall pay or shall deposit with the Trustee a sum sufficient to pay installments of accrued and unpaid interest (including Additional
Interest, if any) upon all Notes and the principal of any and all Notes that shall have become due otherwise than by acceleration (with interest on overdue installments of accrued and unpaid interest (including Additional Interest, if any, and to
the extent that payment of such interest is enforceable under applicable law) and on such principal at the rate borne by the Notes during the period of such Default) and amounts due to the Trustee pursuant to Section 6.06, and if
(1) rescission would not conflict with any judgment or decree of a court of competent jurisdiction and (2) any and all Events of Defaults under this Indenture, other than the nonpayment of principal of and accrued and unpaid interest
(including Additional Interest, if any) on Notes that shall have become due solely by such acceleration, shall have been cured or waived pursuant to Section 5.08, then and in every such case the holders of a majority in aggregate principal
amount of the Notes then outstanding, by written notice to the Company and to the Trustee, may waive all Defaults or Events of Default with respect to the Notes (except with respect to nonpayment of principal or interest or failure to deliver
amounts due upon conversion) and rescind and annul such declaration and its consequences and such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no
such waiver or rescission and annulment shall extend to or shall affect any subsequent Default or Event of Default, or shall impair any right consequent thereon. 
 Payments of any principal and interest that are not made when due shall accrue interest per annum at the then-applicable interest rate. 

The Company shall notify the Responsible Officer of the Trustee in writing, promptly upon becoming aware thereof, of any Event of
Default by delivering to the Trustee a statement specifying such Event of Default and any action the Company has taken, is taking or proposes to take with respect thereto. 
 In case the Trustee shall have proceeded to enforce any right under this Indenture and such proceedings shall have been discontinued or abandoned because of such waiver or rescission and annulment or for
any other reason or shall have been determined adversely to the Trustee, then and in every such case the Company, the Noteholders, and the Trustee shall, subject to any determination in such proceeding, be restored respectively to their several
positions and rights hereunder, and all rights, remedies and powers of the Company, the Noteholders, and the Trustee shall continue as though no such proceeding had been instituted. 

Section 5.02.    Additional Interest. Notwithstanding anything in this Indenture or in the Notes to the
contrary (except as provided in Section 3.06(d) or 3.06(e)), if the Company so elects, the sole remedy of Noteholders for an Event of Default relating to any obligation to file reports as required under Section 3.06 shall, for the first
365 days after the occurrence of such an Event of Default (which will be the sixtieth (60th) day after written notice is provided to the Company in accordance with an Event of Default under Section 5.01(f)), consist exclusively of the
right to receive Additional Interest on the Notes at an annual rate equal to (x) 0.25% of the outstanding principal amount of the Notes for the first 180 days an Event of Default is continuing in such 365-day period and (y) 0.50% of the
outstanding principal amount of the Notes for the remaining 185 days an Event of Default is continuing in such 365-day period. Additional Interest shall be payable in arrears on each Interest Payment Date following the occurrence of

  
 35 

 
such Event of Default in the same manner as regular interest on the Notes. The Company may elect to pay Additional Interest as the sole remedy under this Section 5.02 by giving notice to the
holders, the Trustee and Paying Agent of such election on or before the close of business on the fifth (5th) Business Day after the date on which such Event of Default otherwise would occur. If the Company fails to timely give such notice or
pay Additional Interest, the Notes will be immediately subject to acceleration as provided in Section 5.01. On the 366th day after such Event of Default (if such violation is not cured or waived prior to such 366th day), the Notes will be
subject to acceleration as provided in Section 5.01. This Section 5.02 shall not affect the rights of the Noteholders in the event of the occurrence of any other Event of Default. In the event the Company does not elect to pay Additional
Interest upon an Event of Default in accordance with this Section, the Notes will be subject to acceleration as provided in Section 5.01. 
 Section 5.03.    Payments of Notes on Default; Suit Therefor. In the event that the Trustee or the holders of not less than 25% in aggregate principal amount of the Notes then
outstanding hereunder have declared the principal of and accrued and unpaid interest (including Additional Interest, if any) on, the Notes, to be due and payable immediately in accordance with Section 5.01, and the Company shall have failed
forthwith to pay such amounts, the Trustee, in its own name and as trustee of an express trust, after being furnished suitable indemnity pursuant to Section 6.01, shall be entitled and empowered to institute any actions or proceedings at law or
in equity for the collection of the sums so due and unpaid (including such further amounts as shall be sufficient to cover the reasonable costs and expenses of collection, including reasonable compensation to the Trustee, its agents, attorneys and
counsel, and any expenses or liabilities incurred by the Trustee hereunder other than through its negligence or bad faith), and may prosecute any such action or proceeding to judgment or final degree, and may enforce any such judgment or final
decree against the Company and collect in the manner provided by law out of the property of the Company wherever situated the monies adjudged or decreed to be payable. 
 In case there shall be pending proceedings for the bankruptcy or for the reorganization of the Company under Title 11 of the United States Code, or any other applicable law, or in case a receiver,
assignee or trustee in bankruptcy or reorganization, liquidator, sequestrator or similar official shall have been appointed for or taken possession of the Company, the property of the Company, or in the event of any other judicial proceedings
relative to the Company, upon the Notes, or to the creditors or property of the Company, the Trustee, irrespective of whether the principal of the Notes shall then be due and payable as therein expressed or by declaration or otherwise and
irrespective of whether the Trustee shall have made any demand pursuant to the provisions of this Section 5.03, shall be entitled and empowered, by intervention in such proceedings or otherwise, to file and prove a claim or claims for the whole
amount of principal and accrued and unpaid interest (including Additional Interest, if any) and other amounts payable in respect of the Notes, and, in case of any judicial proceedings, to file such proofs of claim and other papers or documents and
to take such other actions as it may deem necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and of the
Noteholders allowed in such judicial proceedings relative to the Company on the Notes, its creditors, or its property, and to collect and receive any monies or other property payable or deliverable on any such claims, and to distribute the same
after the deduction of any amounts due the Trustee under Section 6.06; and any receiver, assignee or 

  
 36 

 
trustee in bankruptcy or reorganization, liquidator, custodian or similar official is hereby authorized by each of the Noteholders to make such payments to the Trustee, as administrative
expenses, and, in the event that the Trustee shall consent to the making of such payments directly to the Noteholders, to pay to the Trustee any amount due it for reasonable compensation, expenses, advances and disbursements, including agents and
counsel fees and including any other amounts due to the Trustee under Section 6.06 hereof, incurred by it up to the date of such distribution. To the extent that such payment of reasonable compensation, expenses, advances and disbursements out
of the estate in any such proceedings shall be denied for any reason, payment of the same shall be secured by a lien on, and shall be paid out of, any and all distributions, dividends, monies, securities and other property which the holders of the
Notes may be entitled to receive in such proceedings, whether in liquidation or under any plan of reorganization or arrangement or otherwise. 
 Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Noteholder any plan of reorganization, arrangement, adjustment or
composition affecting the Noteholder or the rights of any Noteholder thereof, or to authorize the Trustee to vote in respect of the claim of any Noteholder in any such proceeding. 

All rights of action and of asserting claims under this Indenture, or under any of the Notes, may be enforced by the Trustee without the
possession of any of the Notes, or the production thereof at any trial or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery
of judgment shall, after provision for the payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the holders of the Notes. 

In any proceedings brought by the Trustee (and in any proceedings involving the interpretation of any provision of this Indenture to
which the Trustee shall be a party) the Trustee shall be held to represent all the holders of the Notes, and it shall not be necessary to make any holders of the Notes parties to any such proceedings. 

Section 5.04.    Application of Monies Collected by Trustee. Any monies collected by the Trustee pursuant to
this Article 5 with respect to the Notes shall be applied in the order following, at the date or dates fixed by the Trustee for the distribution of such monies, upon presentation of the several Notes, and stamping thereon the payment, if only
partially paid, and upon surrender thereof, if fully paid: 
 First, to the payment of all amounts due the Trustee under
Section 6.06; 
 Second, in case the principal of and other amounts under the outstanding Notes shall not
have become due and be unpaid, to the payment of interest on the Notes (including Additional Interest, if any) in default in the order of the maturity of the installments of such interest, with interest (to the extent that such interest has been
collected by the Trustee) upon the overdue installments of interest at the rate borne by the Notes, such payments to be made ratably to the Persons entitled thereto; 

  
 37 

 Third, in case the principal of and other amounts under the outstanding
Notes shall have become due, by declaration or otherwise, and be unpaid to the payment of the whole amount (including, if applicable, the delivery of shares of Common Stock (and cash in lieu of fractional shares) upon conversion) then owing and
unpaid upon the Notes for principal, such other amounts and interest (including Additional Interest, if any), with interest on the overdue principal, such other amounts (to the extent that such interest has been collected by the Trustee), and upon
overdue installments of interest at the rate borne by the Notes, and in case such monies shall be insufficient to pay in full the whole amounts so due and unpaid upon the Notes, then to the payment of such principal, such other amounts and interest
without preference or priority of principal or such other amounts over interest, or of interest over principal, such other amounts or of any installment of interest over any other installment of interest, or of any Note over any other Note, ratably
to the aggregate of such principal, such other amounts and accrued and unpaid interest; and 
 Fourth, to the
payment of the remainder, if any, to the Company or as any court of competent jurisdiction may direct. 
 Section
5.05.    Proceedings by Noteholders. No holder of any Note shall have any right by virtue of or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity or at law upon or under
or with respect to this Indenture, or for the appointment of a receiver, trustee, liquidator, custodian or other similar official, or for any other remedy hereunder, unless such holder previously shall have given to the Trustee written notice of an
Event of Default and of the continuance thereof, as hereinbefore provided, and unless also the holders of not less than 25% in aggregate principal amount of the Notes then outstanding shall have made written request upon the Trustee to institute
such action, suit or proceeding in its own name as Trustee hereunder and shall have offered to the Trustee such security or indemnity reasonably satisfactory to it against any loss, liability or expense to be incurred therein or thereby, and the
Trustee for sixty (60) days after its receipt of such notice, request and offer of indemnity, shall have neglected or refused to institute any such action, suit or proceeding and no direction that, in the opinion of the Trustee, is inconsistent
with such written request shall have been given to the Trustee by the holders of a majority in principal amount of the Notes outstanding pursuant to Section 5.08; it being understood and intended, and being expressly covenanted by the taker and
holder of every Note with every other taker and holder and the Trustee, that no one or more Noteholders shall have any right in any manner whatever by virtue of or by availing of any provision of this Indenture to affect, disturb or prejudice the
rights of any other Noteholder, or to obtain or seek to obtain priority over or preference to any other such holder, or to enforce any right under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of
all Noteholders (except as otherwise provided herein). For the protection and enforcement of this Section 5.05, each and every Noteholder and the Trustee shall be entitled to such relief as can be given either at law or in equity. 

Notwithstanding any other provision of this Indenture and any provision of any Note, the right of any Noteholder to receive payment of
the principal of, other amounts under and accrued and unpaid interest (including Additional Interest, if any) on such Note, on or after the respective due dates expressed or provided in such Note or in this Indenture, or to institute

  
 38 

 
suit for the enforcement of any such payment on or after such respective dates against the Company shall not be impaired or affected without the consent of such Noteholder. 

Anything in this Indenture or the Notes to the contrary notwithstanding, the holder of any Note, without the consent of either the
Trustee or the holder of any other Note, in its own behalf and for his own benefit, may enforce, and may institute and maintain any proceeding suitable to enforce, its rights of conversion as provided herein. 

Section 5.06.    Proceedings by Trustee. In case of an Event of Default the Trustee may in its discretion
proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as are necessary to protect and enforce any of such rights, either by suit in equity or by action at law or by proceeding in bankruptcy
or otherwise, whether for the specific enforcement of any covenant or agreement contained in this Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by
this Indenture or by law. 
 Section 5.07.    Remedies Cumulative and Continuing. Except as provided
in the last paragraph of Section 2.07, all powers and remedies given by this Article 5 to the Trustee or to the Noteholders shall, to the extent permitted by law, be deemed cumulative and not exclusive of any thereof or of any other powers
and remedies available to the Trustee or the holders of the Notes, by judicial proceedings or otherwise, to enforce the performance or observance of the covenants and agreements contained in this Indenture, and no delay or omission of the Trustee or
of any holder of any of the Notes to exercise any right or power accruing upon any Default or Event of Default shall impair any such right or power, or shall be construed to be a waiver of any such Default or any acquiescence therein; and, subject
to the provisions of Section 5.05, every power and remedy given by this Article 5 or by law to the Trustee or to the Noteholders may be exercised from time to time, and as often as shall be deemed expedient by the Trustee or by the
Noteholders. 
 Section 5.08.    Direction of Proceedings and Waiver of Defaults by Majority of
Noteholders. The holders of a majority in aggregate principal amount of the Notes at the time outstanding determined in accordance with Section 7.04 shall have the right to direct the time, method, and place of conducting any proceeding for
any remedy available to the Trustee or exercising any trust or power conferred on the Trustee with respect to Notes; provided, however, that (a) such direction shall not be in conflict with any rule of law or with this Indenture,
and (b) the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such direction. The Trustee may refuse to follow any direction that it determines is unduly prejudicial to the rights of any other holder
or that would involve the Trustee in personal liability. The holders of a majority in aggregate principal amount of the Notes at the time outstanding determined in accordance with Section 7.04 may, on behalf of the holders of all of the Notes
waive any past Default or Event of Default hereunder and its consequences except (i) a Default in the payment of accrued and unpaid interest (including Additional Interest, if any) on, or the principal of or other amounts under, the Notes when
due which has not been cured pursuant to the provisions of Section 5.01, (ii) failure by the Company to deliver shares of Common Stock (and cash in lieu of fractional shares) upon conversion of the Notes; or (iii) a default in respect
of a covenant or provision hereof which under Article 9 cannot be modified or amended without the consent of each holder of an outstanding Note affected thereby. Upon any 

  
 39 

 
such waiver the Company, the Trustee and the holders of the Notes shall be restored to their former positions and rights hereunder, but no such waiver shall extend to any subsequent or other
Default or Event of Default or impair any right consequent thereon. Whenever any Default or Event of Default hereunder shall have been waived as permitted by this Section 5.08, said Default or Event of Default shall for all purposes of the
Notes and this Indenture be deemed to have been cured and to be not continuing; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon. 

Section 5.09.    Notice of Defaults. The Trustee shall, within ninety (90) days after the occurrence and
continuance of a Default of which a Responsible Officer has actual knowledge, mail to all Noteholders as the names and addresses of such holders appear upon the Note Register, notice of all Defaults known to a Responsible Officer, unless such
Defaults shall have been cured or waived before the giving of such notice; and provided that, except in the case of a Default in the payment of the principal of, accrued and unpaid interest (including Additional Interest, if any) on or other
amounts due under any of the Notes, then in any such event the Trustee shall be protected in withholding such notice if and so long as a committee of trust officers of the Trustee in good faith determine that the withholding of such notice is in the
interests of the Noteholders. 
 Section 5.10.    Undertaking to Pay Costs. All parties to this
Indenture agree, and each holder of any Note by its acceptance thereof shall be deemed to have agreed, that any court may, in its discretion, require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit
against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit and that such court may in its discretion assess reasonable costs, including
reasonable attorneys’ fees and expenses, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; provided that the provisions of this
Section 5.10 (to the extent permitted by law) shall not apply to any suit instituted by the Trustee, to any suit instituted by any Noteholder, or group of Noteholders, holding in the aggregate more than 10% in principal amount of the Notes at
the time outstanding determined in accordance with Section 7.04, or to any suit instituted by any Noteholder for the enforcement of the payment of the principal of, other amounts under and accrued and unpaid interest (including Additional
Interest, if any) on any Note on or after the due date expressed in such Note or to any suit for the enforcement of the conversion rights in accordance with the provisions of Article 13 or Article 14. 

ARTICLE 6 

CONCERNING THE TRUSTEE 

Section 6.01.    Duties and Responsibilities of Trustee. The Trustee, except during an Event of Default,
undertakes to perform such duties and only such duties as are specifically set forth in this Indenture. In case an Event of Default has occurred (which has not been cured or waived) the Trustee shall exercise such of the rights and powers vested in
it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs; provided that if an Event of Default occurs
and is continuing, the Trustee will be under no obligation to exercise any of the rights or powers under this Indenture at the request or direction of any of the 

  
 40 

 
holders unless such holders have offered to the Trustee indemnity or security reasonably satisfactory to it against loss, liability or expense. 

No provision of this Indenture shall be construed to relieve the Trustee from liability for its own grossly negligent action, its own
grossly negligent failure to act or its own willful misconduct, except that: 
 (a)
    prior to the occurrence of an Event of Default and after the curing or waiving of all Events of Default which may have occurred: 
 (i)     the duties and obligations of the Trustee shall be determined solely by the express provisions of this Indenture and, after it has been qualified thereunder, the Trust
Indenture Act, and the Trustee shall not be liable except for the performance of such duties and obligations as are specifically set forth in this Indenture and no implied covenants or obligations shall be read into this Indenture and the Trust
Indenture Act against the Trustee; and 
 (ii)     in the absence of bad faith and willful
misconduct on the part of the Trustee, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished to the Trustee and conforming to the
requirements of this Indenture; but, in the case of any such certificates or opinions which by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether
or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein); 

(b)     the Trustee shall not be liable for any error of judgment made in good faith by a Responsible
Officer or Officers of the Trustee, unless it shall be proved that the Trustee was grossly negligent in ascertaining the pertinent facts; 
 (c)     the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the holders of not less than a
majority in principal amount of the Notes at the time outstanding determined as provided in Section 7.04 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or
power conferred upon the Trustee, under this Indenture; 
 (d)     whether or not therein
provided, every provision of this Indenture relating to the conduct or affecting the liability of, or affording protection to, the Trustee shall be subject to the provisions of this Section; 

(e)     the Trustee shall not be liable in respect of any payment (as to the correctness of amount,
entitlement to receive or any other matters relating to payment) or notice effected by the Company or any Paying Agent or any records maintained by any co-registrar with respect to the Notes; 

  
 41 

 (f)     if any party fails to deliver a notice relating
to an event the fact of which, pursuant to this Indenture, requires notice to be sent to the Trustee, the Trustee may conclusively rely on its failure to receive such notice as reason to act as if no such event occurred, unless such Responsible
Officer of the Trustee had actual knowledge of such event; 
 (g)     in the absence of
written investment direction from the Company, all cash received by the Trustee shall be placed in a non-interest bearing trust account. In no event shall the Trustee be liable for the selection of investments or for investment losses incurred
thereon or for losses incurred as a result of the liquidation of any such investment prior to its stated maturity or the failure of the party directing such investments prior to its stated maturity or the failure of the party directing such
investment to provide timely written investment direction, and the Trustee shall have no obligation to invest or reinvest any amounts held hereunder in the absence of such written investment direction from the Company; and 

(h)     in the event that the Trustee is also acting as Custodian, Note Registrar, Paying Agent,
Conversion Agent or transfer agent hereunder, the rights and protections afforded to the Trustee pursuant to this Article 6 shall also be afforded to such Custodian, Note Registrar, Paying Agent, Conversion Agent or transfer agent. 

None of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur personal
financial liability in the performance of any of its duties or in the exercise of any of its rights or powers. 
 Section
6.02.    Reliance on Documents, Opinions, Etc. Except as otherwise provided in Section 6.01: 
 (a)     the Trustee may conclusively rely and shall be fully protected in acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, consent,
order, bond, note, coupon or other paper or document believed by it in good faith to be genuine and to have been signed or presented by the proper party or parties; 

(b)     any request, direction, order or demand of the Company mentioned herein shall be sufficiently
evidenced by an Officers’ Certificate (unless other evidence in respect thereof be herein specifically prescribed); and any resolution of the Board of Directors may be evidenced to the Trustee by a copy thereof certified by the Secretary or an
Assistant Secretary of the Company; 
 (c)     the Trustee may consult with counsel of its
selection and require an Opinion of Counsel and any advice of such counsel or Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken or omitted by it hereunder in good faith and in accordance with
such advice or Opinion of Counsel; 
 (d)     the Trustee shall be under no obligation to
exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the Noteholders pursuant to the provisions of this Indenture, unless such Noteholders shall

  
 42 

 
have offered to the Trustee security or indemnity satisfactory to it against the costs, expenses and liabilities which may be incurred therein or thereby; 

(e)     the Trustee shall not be bound to make any investigation into the facts or matters stated in
any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such
facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company, personally or by agent or attorney at the expense
of the Company and shall incur no liability of any kind by reason of such inquiry or investigation; 
 (f)
    the Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents, custodians, nominees or attorneys and the Trustee shall not be responsible for any
misconduct or negligence on the part of any agent, Custodian, nominee or attorney appointed by it with due care hereunder; 
 (g)     the permissive rights of the Trustee enumerated herein shall not be construed as duties; 

(h)     in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth
of the statements and the correctness of the opinions expressed therein, upon Officers’ Certificates or Opinions of Counsel furnished to the Trustee and conforming to the requirements of this Indenture; but in the case of any such Certificates
or Opinions which by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture (but need not
confirm or investigate the accuracy of mathematical calculations or other facts stated therein); 
 (i)
    the Trustee may request that the Company deliver an Officers’ Certificate setting forth the names of individuals and/or titles of officers’ authorized at such time to take specified actions pursuant to this
Indenture, which Officers’ Certificate may be signed by any person authorized to sign Officers’ Certificates, including any person specified as so authorized in any such certificate previously delivered and not superseded; 

(j)     whenever in the administration of this Indenture the Trustee shall deem it desirable that a
matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in the absence of bad faith on its part, conclusively rely upon an Officers’
Certificate; 
 (k)     the Trustee shall not be liable for any action taken, suffered, or
omitted to be taken by it in good faith and reasonably believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Indenture; and 

(l)     the rights, privileges, protections, immunities and benefits given to the Trustee, including,
without limitation, its right to be indemnified, are extended to, and 

  
 43 

 
shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, Custodian and other Person employed to act hereunder. 

In no event shall the Trustee be liable for any consequential loss or damage of any kind whatsoever (including but not limited to lost
profits), even if the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action other than through the Trustee’s willful misconduct or gross negligence. The Trustee shall not be charged with
knowledge of any Default or Event of Default with respect to the Notes, unless either (1) a Responsible Officer shall have actual knowledge of such Default or Event of Default or (2) written notice of such Default or Event of Default shall
have been given to the Trustee by the Company or by any holder of the Notes at the Corporate Trust Office of the Trustee, and such notice references the Notes and this Indenture; and the permissive rights of the Trustee enumerated herein shall not
be construed as duties. 
 Section 6.03.    No Responsibility for Recitals, Etc. The recitals
contained herein and in the Notes (except in the Trustee’s certificate of authentication) shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness of the same. The Trustee makes no
representations as to the validity or sufficiency of this Indenture or of the Notes. The Trustee shall not be accountable for the use or application by the Company of any Notes or the proceeds of any Notes authenticated and delivered by the Trustee
in conformity with the provisions of this Indenture. The Trustee shall not be responsible or liable for any loss suffered in connection with any investment of funds made by it in accordance with this Indenture or at the direction of the Company.
Except for information provided by the Trustee concerning the Trustee, the Trustee shall have no responsibility for any information in any offering memorandum, prospectus or other disclosure material distributed with respect to the Notes.

 Section 6.04.    Trustee, Paying Agents, Conversion Agents or Registrar May Own Notes. The
Trustee, any Paying Agent, any Conversion Agent or Note Registrar, in its individual or any other capacity, may become the owner or pledgee of Notes with the same rights it would have if it were not Trustee, Paying Agent, Conversion Agent or Note
Registrar. 
 Section 6.05.    Monies to be Held in Trust. Subject to the provisions
of Section 11.04, all monies received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they were received. Money held by the Trustee in trust hereunder need not be segregated from other
funds except to the extent required by law. The Trustee shall be under no liability for interest on any money received by it hereunder except as may be agreed from time to time by the Company and the Trustee. 

Section 6.06.    Compensation and Expenses of Trustee. The Company covenants and agrees to pay to the Trustee
from time to time, and the Trustee shall be entitled to, reasonable compensation for all services rendered by it hereunder in any capacity (which shall not be limited by any provision of law in regard to the compensation of a trustee of an express
trust) as mutually agreed to in writing between the Trustee and the Company, and the Company will pay or reimburse the Trustee upon its request for all reasonable expenses, disbursements and advances reasonably incurred or made by the Trustee in
accordance with any of the provisions of this Indenture (including the reasonable compensation and the expenses and disbursements of its agents and counsel and of all persons not regularly in its employ) except any such expense,

  
 44 

 
disbursement or advance as shall have been determined to have been caused by its own gross negligence, willful misconduct or bad faith. The Company also covenants to indemnify the Trustee in any
capacity under this Indenture and any other document or transaction entered into in connection herewith and its agents and any authenticating agent for, and to hold them harmless against, any loss, liability, claim, damage, expense or taxes incurred
without gross negligence, willful misconduct or bad faith on the part of the Trustee, its officers, directors, agents or employees, or such agent or authenticating agent, as the case may be, and arising out of or in connection with the acceptance or
administration of this trust or in any other capacity hereunder, including the costs and expenses of defending themselves against any claim of liability in the premises. The obligations of the Company under this Section 6.06 to compensate or
indemnify the Trustee and to pay or reimburse the Trustee for expenses, disbursements and advances shall be secured by a lien prior to that of the Notes upon all property and funds held or collected by the Trustee as such, except, subject to the
effect of Section 5.04, funds held in trust herewith for the benefit of the holders of particular Notes prior to the date of the accrual of such unpaid compensation or identifiable claim. The Trustee’s right to receive payment of any
amounts due under this Section 6.06 shall not be subordinate to any other liability or Debt of the Company. The obligation of the Company under this Section 6.06 shall survive the satisfaction and discharge of this Indenture and the
earlier resignation or removal or the Trustee. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld. The indemnification provided in this Section 6.06 shall extend to the
officers, directors, agents and employees of the Trustee. 
 When the Trustee and its agents and any authenticating agent incur
expenses or render services after an Event of Default specified in Section 5.01(i) or Section 5.01(j) with respect to the Company occurs, the expenses and the compensation for the services are intended to constitute expenses of
administration under any bankruptcy, insolvency or similar laws. 
 Section 6.07.    Officers’
Certificate as Evidence. Except as otherwise provided in Section 6.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to
taking or omitting any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of gross negligence, willful misconduct, recklessness and bad faith on the part of the Trustee, be
deemed to be conclusively proved and established by an Officers’ Certificate delivered to the Trustee, and such Officers’ Certificate, in the absence of gross negligence, willful misconduct, recklessness and bad faith on the part of the
Trustee, shall be full warrant to the Trustee for any action taken or omitted by it under the provisions of this Indenture upon the faith thereof. 
 Section 6.08.    Conflicting Interests of Trustee. If the Trustee has or shall acquire a conflicting interest within the meaning of the Trust Indenture Act, the Trustee shall
either eliminate such interest or resign, to the extent and in the manner provided by, and subject to the provisions of, the Trust Indenture Act and this Indenture. 
 Section 6.09.    Eligibility of Trustee. There shall at all times be a Trustee hereunder which shall be a Person that is eligible pursuant to the Trust Indenture Act to act as
such and has a combined capital and surplus of at least $50,000,000. If such Person publishes reports of condition at least annually, pursuant to law or to the requirements of any supervising 

  
 45 

 
or examining authority, then for the purposes of this Section, the combined capital and surplus of such Person shall be deemed to be its combined capital and surplus as set forth in its most
recent report of condition so published. If at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, it shall resign immediately in the manner and with the effect hereinafter specified in this Article.

 Section 6.10.    Resignation or Removal of Trustee. 

(a)     The Trustee may at any time resign by giving written notice of such resignation to the Company and by
mailing, at the expense of the Company, notice thereof to the Noteholders at their addresses as they shall appear on the Note Register. Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee by written
instrument, in duplicate, executed by order of the Board of Directors, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee. If no successor trustee shall have been so appointed and have
accepted appointment sixty (60) days after the mailing of such notice of resignation to the Noteholders, the resigning Trustee may petition any court of competent jurisdiction for the appointment of a successor trustee, or any Noteholder who
has been a bona fide holder of a Note or Notes for at least six (6) months may, subject to the provisions of Section 5.10, on behalf of itself and all others similarly situated, petition any such court for the appointment of a successor
trustee. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee. 
 (b)     In case at any time any of the following shall occur: 
 (i)     the Trustee shall fail to comply with Section 6.08 within a reasonable time after written request therefor by the Company or by any Noteholder who has been a bona fide
holder of a Note or Notes for at least six (6) months, or 
 (ii)     the Trustee shall
cease to be eligible in accordance with the provisions of Section 6.09 and shall fail to resign after written request therefor by the Company or by any such Noteholder, or 

(iii)     the Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent,
or a receiver of the Trustee or of its property shall be appointed, or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation, 

then, in any such case, the Company may by a Board Resolution remove the Trustee and appoint a successor trustee by written instrument, in duplicate,
executed by order of the Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or, subject to the provisions of Section 5.10, any Noteholder who has been a bona fide
holder of a Note or Notes for at least six (6) months may, on behalf of itself and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee. Such court
may thereupon, after such notice, if any, as it may deem proper and prescribe, remove the Trustee and appoint a successor trustee. 

  
 46 

 (c)     The holders of a majority in aggregate principal amount of the
Notes at the time outstanding, as determined in accordance with Section 7.04, may at any time remove the Trustee and nominate a successor trustee which shall be deemed appointed as successor trustee unless within ten (10) days after notice
to the Company of such nomination the Company objects thereto, in which case the Trustee so removed or any Noteholder, upon the terms and conditions and otherwise as in Section 6.10(a) provided, may petition any court of competent
jurisdiction for an appointment of a successor trustee. 
 (d)     Any resignation or removal of the
Trustee and appointment of a successor trustee pursuant to any of the provisions of this Section 6.10 shall become effective upon acceptance of appointment by the successor trustee as provided in Section 6.11. 

Section 6.11.    Acceptance by Successor Trustee. Any successor trustee appointed as provided in
Section 6.10 shall execute, acknowledge and deliver to the Company and to its predecessor trustee an instrument accepting such appointment hereunder, and thereupon the resignation or removal of the predecessor trustee shall become effective and
such successor trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, duties and obligations of its predecessor hereunder, with like effect as if originally named as trustee herein; but, nevertheless,
on the written request of the Company or of the successor trustee, the trustee ceasing to act shall, upon payment of any amounts then due it pursuant to the provisions of Section 6.06, execute and deliver an instrument transferring to such
successor trustee all the rights and powers of the trustee so ceasing to act. Upon request of any such successor trustee, the Company shall execute any and all instruments in writing for more fully and certainly vesting in and confirming to such
successor trustee all such rights and powers. Any trustee ceasing to act shall, nevertheless, retain a lien upon all property and funds held or collected by such trustee as such, except for funds held in trust for the benefit of holders of
particular Notes, to secure any amounts then due it pursuant to the provisions of Section 6.06. 
 No successor trustee
shall accept appointment as provided in this Section 6.11 unless at the time of such acceptance such successor trustee shall be qualified under the provisions of Section 6.08 and be eligible under the provisions of Section 6.09.

 Upon acceptance of appointment by a successor trustee as provided in this Section 6.11, each of the Company and the
successor trustee, at the written direction and at the expense of the Company shall mail or cause to be mailed notice of the succession of such trustee hereunder to the Noteholders at their addresses as they shall appear on the Note Register. If the
Company fails to mail such notice within ten (10) days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be mailed at the expense of the Company. 

Section 6.12.    Succession by Merger, Etc. Any corporation or other entity into which the Trustee may be
merged or converted or with which it may be consolidated, or any corporation or other entity resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation or other entity succeeding to all or
substantially all of the corporate trust business of the Trustee (including the administration of this Indenture), shall be the successor to the Trustee hereunder without the execution or filing of any paper or any further act on the part of any of
the parties hereto, provided that in the case of any corporation or 

  
 47 

 
other entity succeeding to all or substantially all of the corporate trust business of the Trustee such corporation or other entity shall be qualified under the provisions of Section 6.08
and eligible under the provisions of Section 6.09. 
 In case at the time such successor to the Trustee shall succeed to
the trusts created by this Indenture, any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee or authenticating agent appointed by
such predecessor trustee, and deliver such Notes so authenticated, and in case at that time any of the Notes shall not have been authenticated, any successor to the Trustee or an authenticating agent appointed by such successor trustee may
authenticate such Notes either in the name of any predecessor trustee hereunder or in the name of the successor trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Notes or in this Indenture
provided that the certificate of the Trustee shall have; provided, however, that the right to adopt the certificate of authentication of any predecessor Trustee or to authenticate Notes in the name of any predecessor Trustee shall
apply only to its successor or successors by merger, conversion or consolidation. 
 Section
6.13.    Limitation on Rights of Trustee as Creditor. If and when the Trustee shall be or become a creditor of the Company, the Trustee shall be subject to the provisions of the Trust Indenture Act regarding the collection
of the claims against the Company. 
 Section 6.14.    Trustee’s Application for Instructions from
the Company. Any application by the Trustee for written instructions from the Company (other than with regard to any action proposed to be taken or omitted to be taken by the Trustee that affects the rights of the holders of the Notes under this
Indenture) may, at the option of the Trustee, set forth in writing any action proposed to be taken or omitted by the Trustee under this Indenture and the date on and/or after which such action shall be taken or such omission shall be effective. The
Trustee shall not be liable for any action taken by, or omission of, the Trustee in accordance with a proposal included in such application on or after the date specified in such application (which date shall not be less than three (3) Business
Days after the date any officer of the Company actually receives such application, unless any such officer shall have consented in writing to any earlier date), unless, prior to taking any such action (or the effective date in the case of any
omission), the Trustee shall have received written instructions in response to such proposal specifying the action to be taken or omitted. 
 ARTICLE 7 
 CONCERNING THE NOTEHOLDERS

 Section 7.01.    Action By Noteholders. Whenever in this Indenture it is provided that the
holders of a specified percentage in aggregate principal amount of the Notes may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the
time of taking any such action, the holders of such specified percentage have joined therein may be evidenced (a) by any instrument or any number of instruments of similar tenor executed by Noteholders in person or by agent or proxy appointed
in writing, or (b) by the record of the Noteholders voting in favor thereof at any meeting of Noteholders duly called and held in accordance with the provisions of Article 8, or (c) by a combination of such instrument or instruments
and any such record of such a meeting of 

  
 48 

 
Noteholders and, except as herein otherwise expressly provided, such action shall become effective when such instrument or instruments are delivered to the Trustee and, where it is hereby
expressly required, to the Company. Proof of execution of any such instrument or of a writing appointing any such agent shall be sufficient for any purpose of this Indenture and conclusive in favor of the Trustee and the Company, if made in the
manner provided in this Section. Whenever the Company or the Trustee solicits the taking of any action by the holders of the Notes, the Company or the Trustee may fix, but shall not be required to, in advance of such solicitation, a date as the
record date for determining Noteholders entitled to take such action. The record date if one is selected shall be not more than fifteen (15) days prior to the date of commencement of solicitation of such action. Any request, demand,
authorization, direction, notice consent, waiver or other action by a holder of any Note shall bind every future holder of the same Note, and the holder of every Note issued upon the registration of transfer thereof or in exchange therefor or in
lieu thereof in respect of anything done, omitted, or suffered to be done by the Trustee or the Company in reliance thereon, whether or not notation of such action is made upon such Note. 

Section 7.02.    Proof of Execution by Noteholders. Subject to the provisions of Section 6.01,
Section 6.02 and Section 8.05, proof of the execution of any instrument by a Noteholder or his agent or proxy shall be sufficient if made in accordance with such reasonable rules and regulations as may be prescribed by the Trustee or in
such manner as shall be satisfactory to the Trustee. The holding of Notes shall be proved by the Note Register or by a certificate of the Note Registrar. The record of any Noteholders’ meeting shall be proved in the manner provided in
Section 8.06. 
 Section 7.03.    Who Are Deemed Absolute Owners. The Company, the Trustee, any
authenticating agent, any Paying Agent, any Conversion Agent and any Note Registrar may deem the Person in whose name such Note shall be registered upon the Note Register to be, and may treat it as, the absolute owner of such Note (whether or not
such Note shall be overdue and notwithstanding any notation of ownership or other writing thereon made by any Person other than the Company or any Note Registrar) for the purpose of receiving payment of or on account of the principal of, other
amounts under and accrued and unpaid interest (including Additional Interest, if any) on such Note, for conversion of such Note and for all other purposes; and neither the Company nor the Trustee nor any Paying Agent nor any Conversion Agent nor any
Note Registrar shall be affected by any notice to the contrary. All such payments so made to any holder for the time being, or upon its order, shall be valid, and, to the extent of the sum or sums so paid, effectual to satisfy and discharge the
liability for monies payable upon any such Note. Notwithstanding anything to the contrary in this Indenture or the Notes following an Event of Default, any holder of a beneficial interest in a Global Note may directly enforce against the Company,
without the consent, solicitation, proxy, authorization or any other action of the Depositary or any other Person, such holder’s right to exchange such beneficial interest for a Note in definitive form in accordance with the provisions of this
Indenture. 
 Section 7.04.    Company-owned Notes Disregarded. In determining whether the holders
of the requisite aggregate principal amount of Notes have concurred in any direction, consent, waiver or other action under this Indenture, Notes that are owned by the Company or by any Person directly or indirectly controlling or controlled by or
under direct or indirect common control with the Company shall be disregarded and deemed not to be outstanding for the purpose 

  
 49 

 
of any such determination; provided that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, consent, waiver or other action only Notes
that a Responsible Officer knows are so owned shall be so disregarded. Notes so owned that have been pledged in good faith may be regarded as outstanding for the purposes of this Section 7.04 if the pledgee shall establish to the satisfaction
of the Trustee the pledgee’s right to so act with respect to such Notes and that the pledgee is not the Company, or a Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company. In the
case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to the Trustee. Upon request of the Trustee, the Company shall furnish to the Trustee promptly an Officers’ Certificate
listing and identifying all Notes, if any, known by the Company to be owned or held by or for the account of any of the above described Persons; and, subject to Section 6.01, the Trustee shall be entitled to accept such Officers’
Certificate as conclusive evidence of the facts therein set forth and of the fact that all Notes not listed therein are outstanding for the purpose of any such determination. 
 Section 7.05.     Revocation of Consents; Future Holders Bound. At any time prior to (but not after) the evidencing to the Trustee, as provided in Section 7.01, of
the taking of any action by the holders of the percentage in aggregate principal amount of the Notes specified in this Indenture in connection with such action, any holder of a Note that is shown by the evidence to be included in the Notes the
holders of which have consented to such action may, by filing written notice with the Trustee at its Corporate Trust Office and upon proof of holding as provided in Section 7.02, revoke such action so far as concerns such Note. Except as
aforesaid, any such action taken by the holder of any Note shall be conclusive and binding upon such holder and upon all future holders and owners of such Note and of any Notes issued in exchange or substitution therefor or upon registration of
transfer, irrespective of whether any notation in regard thereto is made upon such Note or any Note issued in exchange or substitution therefor or upon registration of transfer thereof. 

ARTICLE 8 

NOTEHOLDERS’ MEETINGS 
 Section 8.01.     Purpose of Meetings. A meeting of Noteholders may be called at any time and from time to time pursuant to the provisions of this Article 8 for any of the
following purposes: 
 (a)     to give any notice to the Company or to the Trustee or to
give any directions to the Trustee permitted under this Indenture, or to consent to the waiving of any Default or Event of Default hereunder and its consequences, or to take any other action authorized to be taken by Noteholders pursuant to any of
the provisions of Article 5; 
 (b)     to remove the Trustee and nominate a successor
trustee pursuant to the provisions of Article 6; 
 (c)     to consent to the execution
of an indenture or indentures supplemental hereto pursuant to the provisions of Section 9.02; or 

  
 50 

 (d)     to take any other action authorized to be taken
by or on behalf of the holders of any specified aggregate principal amount of the Notes under any other provision of this Indenture or under applicable law. 
 Section 8.02.     Call of Meetings by Trustee. The Trustee may at any time call a meeting of Noteholders to take any action specified in Section 8.01, to be held at such
time and at such place as the Trustee shall determine. Notice of every meeting of the Noteholders, setting forth the time and the place of such meeting and in general terms the action proposed to be taken at such meeting and the establishment of any
record date pursuant to Section 7.01, shall be mailed to holders of such Notes at their addresses as they shall appear on the Note Register. Such notice shall also be mailed to the Company. Such notices shall be mailed not less than twenty
(20) nor more than ninety (90) days prior to the date fixed for the meeting. 
 Any meeting of Noteholders shall be
valid without notice if the holders of all Notes then outstanding are present in person or by proxy or if notice is waived before or after the meeting by the holders of all Notes outstanding, and if the Company and the Trustee are either present by
duly authorized representatives or have, before or after the meeting, waived notice. 
 Section 8.03.    
Call of Meetings by Company or Noteholders. In case at any time the Company, pursuant to a resolution of its Board of Directors, or the holders of at least 10% in aggregate principal amount of the Notes then outstanding, shall have
requested the Trustee to call a meeting of Noteholders, by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have mailed the notice of such meeting within twenty
(20) days after receipt of such request, then the Company or such Noteholders may determine the time and the place for such meeting and may call such meeting to take any action authorized in Section 8.01, by mailing notice thereof as
provided in Section 8.02. 
 Section 8.04.     Qualifications for Voting. To be entitled to
vote at any meeting of Noteholders a Person shall (a) be a holder of one or more Notes on the record date pertaining to such meeting or (b) be a Person appointed by an instrument in writing as proxy by a holder of one or more Notes. The
only Persons who shall be entitled to be present or to speak at any meeting of Noteholders shall be the Persons entitled to vote at such meeting and their counsel and any representatives of the Trustee and its counsel and any representatives of the
Company and its counsel. 
 Section 8.05.     Regulations. Notwithstanding any other
provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any meeting of Noteholders, in regard to proof of the holding of Notes and of the appointment of proxies, and in regard to the appointment
and duties of inspectors of votes, the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall think fit. 

The Trustee shall, by an instrument in writing, appoint a temporary chairman of the meeting, unless the meeting shall have been called
by the Company or by Noteholders as provided in Section 8.03, in which case the Company or the Noteholders calling the meeting, as the case may be, shall in like manner appoint a temporary chairman. A permanent chairman and

  
 51 

 
a permanent secretary of the meeting shall be elected by vote of the holders of a majority in principal amount of the Notes represented at the meeting and entitled to vote at the meeting.

 Subject to the provisions of Section 7.04, at any meeting of Noteholders each Noteholder or proxyholder shall be
entitled to one vote for each $1,000 principal amount of Notes held or represented by it; provided, however, that no vote shall be cast or counted at any meeting in respect of any Note challenged as not outstanding and ruled by the
chairman of the meeting to be not outstanding. The chairman of the meeting shall have no right to vote other than by virtue of Notes held by it or instruments in writing as aforesaid duly designating it as the proxy to vote on behalf of other
Noteholders. Any meeting of Noteholders duly called pursuant to the provisions of Section 8.02 or Section 8.03 may be adjourned from time to time by the holders of a majority of the aggregate principal amount of Notes represented at the
meeting, whether or not constituting a quorum, and the meeting may be held as so adjourned without further notice. 
 Section
8.06.     Voting. The vote upon any resolution submitted to any meeting of Noteholders shall be by written ballot on which shall be subscribed the signatures of the Noteholders or of their representatives by proxy
and the principal amount of the Notes held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any resolution and who shall make and file
with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record in duplicate of the proceedings of each meeting of Noteholders shall be prepared by the secretary of the meeting and there shall
be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that
said notice was mailed as provided in Section 8.02. The record shall show the principal amount of the Notes voting in favor of or against any resolution. The record shall be signed and verified by the affidavits of the permanent chairman and
secretary of the meeting and one of the duplicates shall be delivered to the Company and the other to the Trustee to be preserved by the Trustee, the latter to have attached thereto the ballots voted at the meeting. 

Any record so signed and verified shall be conclusive evidence of the matters therein stated. 

Section 8.07.     No Delay of Rights by Meeting. Nothing contained in this Article 8 shall be deemed or
construed to authorize or permit, by reason of any call of a meeting of Noteholders or any rights expressly or impliedly conferred hereunder to make such call, any hindrance or delay in the exercise of any right or rights conferred upon or reserved
to the Trustee or to the Noteholders under any of the provisions of this Indenture or of the Notes. 
 ARTICLE 9 

SUPPLEMENTAL INDENTURES 
 Section 9.01.     Supplemental Indentures Without Consent of Noteholders. The Company, when authorized by the resolutions of the Board of Directors, and the Trustee, at
the 

  
 52 

 
Company’s expense, may from time to time and at any time enter into an indenture or indentures supplemental hereto for one or more of the following purposes: 

(a)     to cure any ambiguity, omission, defect or inconsistency in this Indenture in a manner that
does not individually or in the aggregate adversely affect the rights of any Noteholder in any respect; 

(b)     to provide for the assumption by a Successor Company of the obligations of the Company under
this Indenture pursuant to Article 10; 
 (c)     to add guarantees with respect to the
Notes; 
 (d)     to secure the Notes; 

(e)     to add to the covenants of the Company for the benefit of the holders or surrender any right
or power conferred upon the Company; 
 (f)     to make any other change that does not
adversely affect the rights of any holder; provided that any amendment to conform the terms of the Notes to the description contained in the Offering Circular shall not be deemed to be adverse to any Noteholder; 

(g)     to comply with any requirements of the Commission in connection with the qualification of
this Indenture under the Trust Indenture Act; 
 (h)     to provide for a successor trustee;
or 
 (i)     to comply with the applicable procedures of the Depositary. 

Upon the written request of the Company, accompanied by a Board Resolution authorizing the execution of such supplemental indenture, the
Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture, to make any further appropriate agreements and stipulations which may be therein contained and to accept the conveyance, transfer and
assignment of any property thereunder, but the Trustee shall not be obligated to, but may in its discretion, enter into any supplemental indenture which affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise.

 Any supplemental indenture authorized by the provisions of this Section 9.01 may be executed by the Company and the
Trustee without the consent of the holders of any of the Notes at the time outstanding. 
 Section
9.02.     Supplemental Indentures With Consent of Noteholders. With the consent (evidenced as provided in Article 7) of the holders of at least a majority in aggregate principal amount of the Notes at the time
outstanding (determined in accordance with Article 7 and including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, Notes), the Company, when authorized by the resolutions of the
Board of Directors, and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this
Indenture or any 

  
 53 

 
supplemental indenture or of modifying in any manner the rights of the holders of the Notes; provided, however, that no such supplemental indenture shall: 

(a)     reduce the percentage in aggregate principal amount of Notes the holders of which must
consent to an amendment; 
 (b)     reduce the rate, or extend the stated time for payment,
of interest (including Additional Interest, if any) on any Note; 
 (c)     reduce the
principal of or other amount payable under, or extend the Maturity Date of, any Note; 

(d)     make any change that adversely affects the conversion rights of any Noteholder under
Article 13 or Article 14; 
 (e)     reduce the Fundamental Change Repurchase
Price of any Note or amend or modify in any manner adverse to the holders of the Notes the Company’s obligation to make such payments, whether through an amendment or waiver of provisions in the covenants, definitions or otherwise; 

(f)     change the place or currency of payment of principal or interest (including Additional
Interest, if any) or other amount payable in respect of any Note; 
 (g)     impair the
right of any holder to receive payment of principal of and interest (including Additional Interest, if any) on or other amount payable under such holder’s Notes on or after the due dates therefor or to institute suit for the enforcement of any
payment on or with respect to such holder’s Note; 
 (h)     adversely affect the
ranking of the Notes as the senior unsubordinated debt of the Company; or 
 (i)     make
any change in the provisions of this Article 9 that require each holder’s consent or in the waiver provisions in Section 5.01 and Section 5.08, 
 in each case without the consent of each holder of an outstanding Note affected. 

Upon the written request of the Company, accompanied by a copy of the Board Resolutions authorizing the execution of any such
supplemental indenture, and upon the filing with the Trustee of evidence of the consent of Noteholders as aforesaid, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects
the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture. 

It shall not be necessary for the consent of the Noteholders under this Section 9.02 to approve the particular form of any proposed
supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof. After an amendment under this Indenture becomes effective, the Company shall mail to the holders a notice briefly describing such

  
 54 

 
amendment. However, the failure to give such notice to all the holders, or any defect in the notice, will not impair or affect the validity of the amendment. 

Section 9.03.     Effect of Supplemental Indentures. Any supplemental indenture executed pursuant to
the provisions of this Article 9 shall comply with the Trust Indenture Act, as then in effect, provided that this Section 9.03 shall not require such supplemental indenture or the Trustee to be qualified under the Trust Indenture
Act prior to the time such qualification is in fact required under the terms of the Trust Indenture Act, nor shall it constitute any admission or acknowledgment by any party to such supplemental indenture that any such qualification is required
prior to the time such qualification is in fact required under the terms of the Trust Indenture Act. Upon the execution of any supplemental indenture pursuant to the provisions of this Article 9, this Indenture shall be and be deemed to be
modified and amended in accordance therewith and the respective rights, limitation of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the Noteholders shall thereafter be determined, exercised and
enforced hereunder subject in all respects to such modifications and amendments and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all
purposes. 
 Section 9.04.     Notation on Notes. Notes authenticated and delivered after the
execution of any supplemental indenture pursuant to the provisions of this Article 9 may bear a notation in form approved by the Trustee as to any matter provided for in such supplemental indenture. If the Company or the Trustee shall so
determine, new Notes so modified as to conform, in the opinion of the Trustee and the Board of Directors, to any modification of this Indenture contained in any such supplemental indenture may, at the Company’s expense, be prepared and executed
by the Company, authenticated by the Trustee (or an authenticating agent duly appointed by the Trustee pursuant to Section 15.10) and delivered in exchange for the Notes then outstanding, upon surrender of such Notes then outstanding.

 Section 9.05.     Evidence of Compliance of Supplemental Indenture to be Furnished to the
Trustee. In addition to the documents required by Section 15.05, the Trustee shall receive an Officers’ Certificate and an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant hereto
complies with the requirements of this Article 9. 
 ARTICLE 10 

CONSOLIDATION, MERGER, SALE, CONVEYANCE AND LEASE

 Section 10.01.     Company May Consolidate, Etc. on Certain Terms. Subject to the
provisions of Section 10.02, the Company shall not consolidate with, merge with or into, or convey, transfer or lease all or substantially all of its assets and properties to another Person, unless: 

(a)     the resulting, surviving or transferee Person (the “Successor Company”), if
not the Company, shall be a corporation organized and existing under the laws of the United States of America, any State thereof or the District of Columbia and the Successor Company (if not the Company) shall expressly assume, by supplemental
indenture, 

  
 55 

 
executed and delivered to the Trustee, in form satisfactory to the Trustee, all the obligations of the Company under the Notes and this Indenture; and 

(b)     immediately after giving effect to such transaction, no Default or Event of Default shall
have occurred and be continuing. 
 Upon any such consolidation, merger, conveyance, transfer or lease the resulting, surviving
or transferee (by conveyance, lease or otherwise) Person (if not the Company) shall succeed to, and may exercise every right and power of, the Company under this Indenture. 
 For purposes of this Section 10.01, the sale, lease, conveyance, assignment, transfer, or other disposition of all or substantially all of the properties and assets of one or more Subsidiaries of the
Company, which properties and assets, if held by the Company instead of such Subsidiaries, would constitute all or substantially all of the properties and assets of the Company on a consolidated basis, shall be deemed to be the transfer of all or
substantially all of the properties and assets of the Company. 
 Section 10.02.    Successor
Corporation to be Substituted. In case of any such consolidation, merger, conveyance, transfer or lease and upon the assumption by the Successor Company, by supplemental indenture, executed and delivered to the Trustee and satisfactory in form
to the Trustee, of the due and punctual payment of the principal of and accrued and unpaid interest (including Additional Interest, if any) on all of the Notes, the due and punctual settlement of the conversion of the Notes and the due and punctual
performance of all of the covenants and conditions of this Indenture to be performed by the Company, such Successor Company shall succeed to and be substituted for the Company and the Company shall be released from those obligations, with the same
effect as if it had been named herein as the party of the first part. Such Successor Company thereupon may cause to be signed, and may issue either in its own name or in the name of the Company any or all of the Notes issuable hereunder which
theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon the order of such Successor Company instead of the Company and subject to all the terms, conditions and limitations in this Indenture prescribed, the
Trustee shall authenticate and shall deliver, or cause to be authenticated and delivered, any Notes which previously shall have been signed and delivered by the officers of the Company to the Trustee for authentication, and any Notes which such
Successor Company thereafter shall cause to be signed and delivered to the Trustee for that purpose. All the Notes so issued shall in all respects have the same legal rank and benefit under this Indenture as the Notes theretofore or thereafter
issued in accordance with the terms of this Indenture as though all of such Notes had been issued at the date of the execution hereof. In the event of any such consolidation, merger, conveyance, transfer or lease, the Person named as the
“Company” in the first paragraph of this Indenture or any successor which shall thereafter have become such in the manner prescribed in this Article 10 may be dissolved, wound up and liquidated at any time thereafter and such
Person shall be released from its liabilities as obligor and maker of the Notes and from its obligations under this Indenture. 

In case of any such consolidation, merger, conveyance, transfer or lease, such changes in phraseology and form (but not in substance)
may be made in the Notes thereafter to be issued as may be appropriate. 

  
 56 

 Section 10.03.    Officers’ Certificate and Opinion of Counsel
to be Given Trustee. No merger, consolidation, sale transfer or lease shall be effective unless the Trustee shall receive an Officers’ Certificate and an Opinion of Counsel as conclusive evidence that any such consolidation, merger,
conveyance, transfer or lease and any such assumption complies with the provisions of this Article 10. 
 ARTICLE 11

 SATISFACTION AND DISCHARGE OF INDENTURE 

Section 11.01.    Discharge of Indenture. When (a) the Company shall deliver to the Note Registrar for
cancellation all Notes theretofore authenticated (other than any Notes that have been destroyed, lost or stolen and in lieu of or in substitution for which other Notes shall have been authenticated and delivered) and not theretofore canceled, or
(b) all the Notes not theretofore canceled or delivered to the Notes Registrar for cancellation shall have become due and payable, whether on the Maturity Date or on any earlier Fundamental Change Repurchase Date or otherwise, and the Company
shall deposit with the Trustee, in trust, cash or cash and shares of Common Stock, if applicable, sufficient to pay at maturity all of the Notes (other than any Notes that shall have been mutilated, destroyed, lost or stolen and in lieu of or in
substitution for which other Notes shall have been authenticated and delivered) not theretofore canceled or delivered to the Trustee for cancellation, including principal and accrued and unpaid interest (including Additional Interest, if any) due
thereon, and if the Company shall also pay or cause to be paid all other sums payable hereunder by the Company, then this Indenture shall cease to be of further effect except as to (i) the right of holders to receive payments of principal of
and accrued and unpaid interest (including Additional Interest, if any) and, if applicable, any shares of Common Stock (and cash in lieu of fractional shares) on the Notes and the other rights, duties and obligations of Noteholders, as beneficiaries
hereof with respect to the amounts, if any, so deposited with the Trustee, (ii) the rights, obligations and immunities of the Trustee hereunder and (iii) the obligations of the Company under Section 6.06, and the Trustee, on written
demand of the Company accompanied by an Officers’ Certificate and an Opinion of Counsel as required by Section 15.05 and at the cost and expense of the Company, shall execute proper instruments acknowledging satisfaction of and discharging
this Indenture; the Company, however, hereby agrees to reimburse the Trustee for any costs or expenses thereafter reasonably and properly incurred by the Trustee and to compensate the Trustee for any services thereafter reasonably and properly
rendered by the Trustee in connection with this Indenture or the Notes. 
 Section 11.02.    Deposited
Monies to be Held in Trust by Trustee. Subject to Section 11.04, all monies deposited with the Trustee pursuant to Section 11.01 shall be held in trust and applied by it to the payment, either directly or through any Paying
Agent (including the Company if acting as its own Paying Agent), to the holders of the particular Notes for the payment of which such monies have been deposited with the Trustee, of all sums due thereon for principal and accrued and unpaid interest
(including Additional Interest, if any). 
 Section 11.03.    Paying Agent to Repay Monies Held.
Upon the satisfaction and discharge of this Indenture, all monies then held by any Paying Agent of the Notes (other than the Trustee) shall, upon written request of the Company, be repaid to it or paid to the Trustee, and thereupon such Paying
Agent shall be released from all further liability with respect to such monies. 

  
 57 

 Section 11.04.     Return of Unclaimed Monies. Subject to
the requirements of applicable law, any monies deposited with or paid to the Trustee for payment of the principal of, other amounts payable under or accrued and unpaid interest (including Additional Interest, if any) on, Notes and not applied but
remaining unclaimed by the Noteholders for two years after the date upon which the principal of, other amounts payable under, or accrued and unpaid interest (including Additional Interest, if any) on such Notes, as the case may be, shall have become
due and payable, shall be repaid to the Company by the Trustee on written request and all liability of the Trustee shall thereupon cease with respect to such monies; and the holder of any of the Notes shall thereafter look only to the Company for
any payment which such holder may be entitled to collect unless an applicable abandoned property law designates another Person. The Trustee shall, promptly after such payment of the principal of, and any accrued and unpaid interest (including
Additional Interest, if any), on Notes, as described in this Section 11.04 and upon written request of the Company, return to the Company any funds in excess of the amount required for such payment. 

Section 11.05.     Reinstatement. If (i) the Trustee or the Paying Agent is unable to apply any money in
accordance with Section 11.02 by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application and (ii) the holders of at least a majority in principal amount of the
then outstanding Notes so request by written notice to the Trustee, the Company’s obligations under this Indenture shall be revived and reinstated as though no deposit had occurred pursuant to Section 11.01 until such time as the Trustee
or the Paying Agent is permitted to apply all such money in accordance with Section 11.02; provided, however, that if the Company makes any payment of interest on or principal of any Note following the reinstatement of its
obligations, the Company shall be subrogated to the rights of the Noteholders to receive such payment from the money held by the Trustee or Paying Agent. 
 ARTICLE 12 
 IMMUNITY OF INCORPORATORS,
SHAREHOLDERS, OFFICERS AND DIRECTORS 
 Section
12.01.     Indenture and Notes Solely Corporate Obligations. No recourse for the payment of the principal of, or accrued and unpaid interest (including Additional Interest, if any) on, any Note, or for any claim based
thereon or otherwise in respect thereof, and no recourse under or upon any obligation, covenant or agreement of the Company in this Indenture or in any supplemental indenture or in any Note, or because of the creation of any debt represented
thereby, shall be had against any past, present or future incorporator, shareholder, employee, agent, officer or director or Subsidiary of the Company as such or of any successor corporation, either directly or through the Company or any successor
corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that all such liability is hereby expressly waived and released as a condition
of, and as a consideration for, the execution of this Indenture and the issue of the Notes. 

  
 58 

 ARTICLE 13 
 CONVERSION 
 Section 13.01.     Right of
Convert. 
 (a)     Subject to and upon compliance with the provisions of this Article 13, each
Noteholder shall have the right, at such holder’s option, to convert all or any portion (if the portion to be converted is $1,000 principal amount or an integral multiple thereof) of such Note at any time prior to the close of business on the
Trading Day immediately preceding the Maturity Date at a rate (the “Conversion Rate”) of 46.1425 shares of Common Stock (subject to adjustment by the Company as provided in Sections 13.01(b) and 13.03) per $1,000
principal amount of Notes. The Notes may not be converted after the close of business on the Trading Day immediately preceding the Maturity Date. 
 (b)     (i)     If the Company is a party to any transaction or event that constitutes a Make-Whole Fundamental Change occurring prior to the Maturity Date, and a
Noteholder elects to convert its Notes in connection with such Make-Whole Fundamental Change, the Conversion Rate applicable to each $1,000 principal amount of Notes that are surrendered for conversion shall be increased by an additional number of
shares of Common Stock (the “Additional Shares”) as described below. A conversion of Notes by a holder shall be deemed for these purposes to be “in connection with” a Make-Whole Fundamental Change if the Conversion Notice
is received by the Conversion Agent on or subsequent to the Effective Date of the Make-Whole Fundamental Change, but before the related Fundamental Change Repurchase Date. The Company shall give notice in writing to all record Noteholders and the
Trustee of the anticipated Effective Date of the Make-Whole Fundamental Change as promptly as practicable following the date of the Company’s public announcement of such Make-Whole Fundamental Change, but in no event less than twenty
(20) days prior to such date (the “Make-Whole Fundamental Change Notice”). 

(ii)     The number of Additional Shares by which the Conversion Rate will be increased in the event
of a Make-Whole Fundamental Change pursuant to this Section 13.01(b) shall be determined by reference to the table attached as Schedule A hereto, based on the date on which the Make-Whole Fundamental Change occurs or becomes effective (the
“Effective Date”), and the Stock Price; provided that if the actual Stock Price is between two Stock Price amounts in the table or the Effective Date is between two Effective Dates in the table, the number of Additional
Shares shall be determined by a straight-line interpolation between the number of Additional Shares set forth for the next higher and next lower Stock Price amounts and the two nearest Effective Dates, as applicable, based on a 365-day year;
provided further that if (1) the Stock Price is greater than $100 per share of Common Stock (subject to adjustment in the same manner as set forth in Section 13.03), or (2) the Stock Price is less than $18.06 per share of
Common Stock (subject to adjustment in the same manner as set forth in Section 13.03), then, in each case, no adjustment to the Conversion Rate in respect of Additional Shares will be made pursuant to this Section 13.01(b). Notwithstanding
the foregoing, in no event will the total number of shares of Common Stock issuable upon the conversion exceed 55.3709 per $1,000 principal amount of Notes (subject to adjustment in the same manner as set forth in Section 13.03).

  
 59 

 Upon conversion in connection with a Make-Whole Fundamental Change, the
holders will receive a separate cash payment for accrued and unpaid interest (including Additional Interest, if any) to, but not including, the date upon which the related Conversion Notice is received by the Conversion Agent, unless such conversion
occurs after a regular record date and on or prior to the corresponding Interest Payment Date, in which case the Company will pay the full amount of accrued and unpaid interest (including Additional Interest, if any) payable on such Interest Payment
Date to the holder of record at the close of business on the corresponding regular record date. 

(iii)     The Stock Prices set forth in the first row of the table in Schedule A hereto shall be
adjusted by the Company as of any date on which the Conversion Rate of the Notes is adjusted (except for any adjustment pursuant to this Section 13.01(b)). The adjusted Stock Prices shall equal the Stock Prices applicable immediately prior to
such adjustment, multiplied by a fraction, the numerator of which is the Conversion Rate in effect immediately prior to the adjustment giving rise to the Stock Price adjustment and the denominator of which is the Conversion Rate as so adjusted. The
number of Additional Shares within the table shall be adjusted in the same manner as the Conversion Rate as set forth in Section 13.03 (except for any adjustment pursuant to this Section 13.01(b)). 

(iv)     For the avoidance of doubt, if a holder surrenders its Notes to the Company prior to the
Effective Date of the Make-Whole Fundamental Change, and the Make-Whole Fundamental Change does not occur, the holder will not be entitled to an increased Conversion Rate in connection with such conversion. 

Section 13.02.     Conversion Procedure. 

(a)     Upon any conversion of any Notes, on the third (3rd) Trading Day immediately following the Conversion
Date, the Company shall deliver a number of shares of Common Stock equal to (i) the aggregate principal amount of such Notes to be converted divided by $1,000, multiplied by (ii) the Conversion Rate in effect as of such Conversion Date;
provided that the Company will deliver cash in lieu of fractional shares of Common Stock as set forth pursuant to clause (j) below; provided, further for any conversion that occurs on or after the record date immediately preceding
the Maturity Date, the Company shall deliver such shares on the Maturity Date. 
 (b)     Before any holder
of a Note shall be entitled to a conversion as set forth above, such holder shall (i) in the case of a Global Note, comply with the procedures of the Depositary in effect at that time and, if required, pay funds equal to interest payable on the
next Interest Payment Date to which such holder is not entitled as set forth in Section 13.02(h) and, if required, pay all taxes or duties, if any, and (ii) in the case of a Note issued in definitive form, (A) complete and manually
sign and deliver an irrevocable written notice to the Conversion Agent in the form on the reverse of such definitive Note (or a facsimile thereof) (a “Conversion Notice”) at the office of the Conversion Agent and shall state in
writing therein the principal amount of Notes surrendered for conversion and the name or names (with addresses) in which such holder wishes the certificate or certificates for any shares of Common Stock to be delivered upon conversion of the Notes
to be registered, (B) surrender such Notes, duly endorsed to the 

  
 60 

 
Company or in blank (and accompanied by appropriate endorsement and transfer documents), at the office of the Conversion Agent, (C) if required, pay funds equal to interest payable on the
next Interest Payment Date to which such holder is not entitled as set forth in Section 13.02(h), and (D) if required, pay all taxes or duties, if any. A Note shall be deemed to have been converted immediately prior to the close of
business on the date (the “Conversion Date”) that the holder has complied with the requirements set forth in this Section 13.02(b). 
 No Conversion Notice with respect to any Notes may be delivered by a holder thereof if such holder has also tendered a Fundamental Change Repurchase Notice and not validly withdrawn such Fundamental
Change Repurchase Notice in accordance with the applicable provisions of Section 14.01. 
 If more than one Note shall be
converted at one time by the same holder, the number of shares of Common Stock deliverable upon conversion shall be computed on the basis of the aggregate principal amount of the Notes (or specified portions thereof to the extent permitted thereby)
so converted to the Company. 
 (c)     Delivery of the shares of Common Stock upon conversion shall be
made by the Company in no event later than the date specified in Section 13.02(a). The Company shall make such delivery by issuing, or causing to be issued, and delivering to the Conversion Agent or to such holder, or such holder’s nominee
or nominees, certificates or a book-entry transfer through the Depositary for the number of full shares of Common Stock to which such holder shall be entitled as part of such conversion (together with any cash in lieu of fractional shares).

 (d)     In case any Note shall be surrendered for partial conversion, the Company shall execute and the
Trustee shall authenticate and deliver to or upon the written order of the holder of the Note so surrendered, without charge to such holder, a new Note or Notes in authorized denominations in an aggregate principal amount equal to the portion of the
Notes not surrendered for conversion. 
 (e)     The Company shall pay all stamp and other duties, if any,
which may be imposed by the United States or any political subdivision thereof or taxing authority thereof or therein with respect to the issuance of shares of Common Stock upon the conversion. However, the holder shall pay any such tax which is due
because the holder requests any shares of Common Stock to be issued in a name other than the holder’s name. The Conversion Agent may refuse to deliver the certificates representing the shares of Common Stock being issued in a name other than
the holder’s name until the Trustee receives a sum sufficient to pay any tax which will be due because the shares are to be issued in a name other than the holder’s name. Nothing herein shall preclude any tax withholding required by law or
regulations. 
 (f)     Except as provided in Section 13.03, no adjustment shall be made for dividends
on any shares issued upon conversion by the Company with respect to any Note as provided in this Article. 

(g)     Upon the conversion with respect to an interest in a Global Note, the Trustee, or the Custodian at the
direction of the Trustee, shall make a notation on such Global 

  
 61 

 
Note as to the reduction in the principal amount represented thereby. The Company shall notify the Trustee in writing of any Notes surrendered for conversion through any Conversion Agent other
than the Trustee. 
 (h)     Except as set forth below or provided in Section 13.01(b)(ii) or
Section 13.11(b), upon conversion, a Noteholder shall not receive any separate cash payment for accrued and unpaid interest (including Additional Interest, if any). The Company’s settlement of the conversion as described above shall be
deemed to satisfy its obligation to pay the principal amount of the Note and accrued and unpaid interest (including Additional Interest, if any) to, but not including, the Conversion Date. As a result, accrued and unpaid interest (including
Additional Interest, if any) to, but not including, the Conversion Date shall be deemed to be paid in full rather than cancelled, extinguished or forfeited. Notwithstanding the preceding sentence, if Notes are converted after the close of business
on a record date, holders of such Notes as of the close of business on the record date will receive the interest (including Additional Interest, if any) payable on such Notes on the corresponding Interest Payment Date notwithstanding the conversion.
Notes surrendered for conversion during the period from the close of business on any regular record date to the opening of business on the corresponding Interest Payment Date must be accompanied by payment of an amount equal to the interest
(including Additional Interest, if any) payable on such Notes; provided, however, that no such payment need be made (i) if the Company has specified a Fundamental Change Repurchase Date that is after a record date and on or prior
to the corresponding Interest Payment Date; (ii) if the Company has specified a Conversion Termination Date that is prior to August 15, 2014 or after a record date and on or prior to the corresponding Interest Payment Date; (iii) in
respect of any conversion in connection with the Make-Whole Fundamental Change; (iv) in respect of any conversion that occurs after the record date immediately preceding the Maturity Date; or (v) to the extent of any overdue interest
existing at the time of conversion with respect to such Note. 
 (i)     Each conversion shall be deemed to
have been effected as to any such Notes (or portion thereof) surrendered for conversion on the relevant Conversion Date. The person in whose name the certificate or certificates for the number of shares of Common Stock that shall be issuable upon
such conversion shall become the holder of record of such shares of Common Stock as of the close of business on such Conversion Date; provided, however, that no surrender of Notes on any date when the stock transfer books of the
Company shall be closed shall be effective to constitute the Person or Persons entitled to receive the shares of Common Stock as the record holder or holders of such shares of Common Stock on such date, but such surrender shall be effective to
constitute the Person or Persons entitled to receive such shares of Common Stock as the record holder or holders thereof for all purposes at the close of business on the next succeeding day on which such stock transfer books are open; such
conversion shall be at the Conversion Rate in effect on the Conversion Date that such Notes shall have been surrendered for conversion, as if the stock transfer books of the Company had not been closed. Upon the conversion with respect to the Notes,
such Person shall no longer be a Noteholder. 
 (j)     No fractional shares of Common Stock shall be
issued upon conversion of any Note or Notes. If more than one Note shall be surrendered for conversion at one time by the same holder, the number of full shares that shall be issued by the Company shall be computed on the basis of the aggregate
principal amount of the Notes (or specified portions thereof) so surrendered. Instead of any fractional share of Common Stock that would otherwise be issued 

  
 62 

 
with respect to any Note or Notes (or specified portions thereof), the Company shall pay a cash adjustment in respect of such fraction (calculated to the nearest one-100th of a share) in an
amount equal to the same fraction of the Last Reported Sale Price of the Common Stock on the relevant Conversion Date. 

Section 13.03.     Adjustment of Conversion Rate. The Conversion Rate shall be adjusted from time to time by
the Company as follows: 
 (a)     In case the Company shall issue shares of Common Stock exclusively as a
dividend or distribution to all holders of the outstanding Common Stock on shares of Common Stock, or if the Company effects a share split or share combination, the Conversion Rate shall be adjusted based on the following formula: 

 

							
		 	CR' = 
CR0 ×	  	  OS'  	 	
	 	  	OS0	 	

 where, 
  

					
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the opening of business on the record date for such dividend or distribution or the effective date of such share split or
combination, as the case may be;
			
	CR'	  	=	  	the Conversion Rate in effect immediately after the opening of business on such record date or the effective date, as the case may be;
			
	OS0	  	=	  	the number of shares of Common Stock outstanding immediately prior to the opening of business on such record date or the effective date, as the case may be; and
			
	OS'	  	=	  	the number of shares of Common Stock that will be outstanding immediately after giving effect to such dividend or distribution or immediately after the effective date of such
share split or combination, as the case may be.

 Such adjustment shall become effective immediately after the opening of business on the record date for
such dividend or distribution or the effective date of such share split or combination, as the case may be. If any dividend or distribution of the type described in this Section 13.03(a) is declared but not so paid or made, or the outstanding
shares of Common Stock are not split or combined, as the case may be, the Conversion Rate shall be immediately readjusted, effective as of the date the Board of Directors determines not to pay such dividend or distribution, or split or combine the
outstanding shares of Common Stock, as the case may be, to the Conversion Rate that would then be in effect if such dividend or distribution, or share split or share combination, had not been declared. 

(b)     In case the Company shall issue to all or substantially all holders of its outstanding shares of Common
Stock any rights, options or warrants entitling them for a period of not more than sixty (60) days after the record date for such distribution to subscribe for or purchase shares of the Common Stock, at a price per share less than less than the
average of the 

  
 63 

 
Last Reported Sale Prices of the Common Stock over the ten (10) consecutive Trading Day period ending on the Trading Day immediately preceding the date of announcement of such issuance, the
Conversion Rate shall be adjusted based on the following formula: 
  

							
		 	CR' = 
CR0 ×	  	  OS0 + X  	  	
	 	  	  OS0 + Y  	  	

 where, 
  

					
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the opening of business on the record date for such issuance;
			
	CR'	  	=	  	the Conversion Rate in effect immediately after the opening of business on such record date;
			
	OS0	  	=	  	the number of shares of Common Stock outstanding immediately prior to the opening of business on such record date;
			
	X	  	=	  	the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and
			
	Y	  	=	  	the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants divided by the average of the Last Reported Sale Prices of
Common Stock over the ten (10) consecutive Trading Day period ending on the Trading Day immediately preceding the date of announcement of such issuance.

 Any increase made under this Section 13.03(b) shall be made successively whenever any such rights,
options or warrants are issued and shall become effective immediately after the opening of business on the record date for such issuance. To the extent that shares of Common Stock are not delivered after the expiration of such rights, options or
warrants, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of
Common Stock actually delivered. If such rights, options or warrants are not so issued, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such record date for such issuance had not occurred. 

In determining whether any rights, options or warrants entitle the holders to subscribe for or purchase shares of the Common Stock at
less than such Last Reported Sale Price of the Common Stock, and in determining the aggregate offering price of such shares of the Common Stock, there shall be taken into account any consideration received by the Company for such rights, options or
warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by the Board of Directors. 
 (c)     In case the Company shall distribute shares of its capital stock, evidences of its indebtedness or its other assets or property of the Company to all or substantially all
holders of the Common Stock other than (i) dividends, distributions or issuances referred to in 

  
 64 

 
Section 13.03(a) and Section 13.03(b), (ii) dividends or distributions paid exclusively in cash and referred to in Section 13.03(d), (iii) rights issued pursuant to
the Rights Plan adopted by the Company and referred to in Section 13.10, (iv) any dividends and distributions in connection with a reclassification, change, consolidation, merger, conveyance, transfer, sale, lease or other disposition
resulting in a change in the conversion consideration referred to in Section 13.06, and (v) Spin-Offs to which the provisions set forth below in this Section 13.03(c) shall apply (any of such shares of capital stock, evidences of
its indebtedness, or other asset or property may hereinafter in this Section 13.03(c) be referred to as the “Distributed Property”), to all or substantially all holders of its Common Stock, then, in each such case the
Conversion Rate shall be increased based on the following formula: 
  

							
		 	CR' = 
CR0 ×  	  	        SP0        	 	
	 	  	SP0 – FMV	 	

 where, 
  

					
	CR0	  	=	  	the Conversion Rate in effect immediately prior to opening of business on the record date for such distribution;
			
	CR'	  	=	  	the Conversion Rate in effect immediately after opening of business on such record date;
			
	SP0	  	=	  	the average of the Last Reported Sale Prices of Common Stock over the ten (10) consecutive Trading Day period ending on the Trading Day immediately preceding the Ex-Date for
such distribution; and
			
	FMV	  	=	  	the fair market value as determined by the Board of Directors of the shares of capital stock, evidences of indebtedness, assets or property to be distributed with respect to each
outstanding share of Common Stock as of such Ex-Date.

 Any increase made under the portion of this Section 13.03(c) above shall become effective
immediately after the opening of business on the record date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be decreased to be the Conversion Rate that would then be in effect if such dividend or
distribution had not been declared. Notwithstanding the foregoing, if “FMV” (as set forth above) is equal to or greater than “SPo” (as set forth above), in lieu of the foregoing increase, each Noteholder shall receive, in respect of each $1,000
principal amount of Notes, at the same time and upon the same terms as holders of Common Stock, the amount and kind of the Company’s capital stock, evidences of its indebtedness, other assets or property of the Company or rights, options or
warrants to acquire the Company’s capital stock or other securities that such holder would have received if such holder owned a number of shares of Common Stock equal to the Conversion Rate in effect on the record date for the distribution.

 With respect to an adjustment pursuant to this Section 13.03(c) where there has been a payment of a dividend or other
distribution on Common Stock in shares of capital stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business 

  
 65 

 
unit of the Company (a “Spin-Off”), the Conversion Rate shall be increased based on the following formula: 

 

							
		 	CR' = 
CR0 ×  	  	    FMV0 + MP0    	  	
	 	  	MP0	  	

 where, 
  

					
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the close of business on the effective date of the Spin-Off;
			
	CR'	  	=	  	the Conversion Rate in effect immediately after the close of business on the effective date of the Spin-Off;
			
	FMV0	  	=	  	the average of the Last Reported Sale Prices of the capital stock or similar equity interest distributed to holders of Common Stock applicable to one share of Common Stock
(determined by reference to the definition of Last Reported Sale Price as if references therein to Common Stock were to such capital stock or similar equity interest) over the first ten (10) consecutive Trading Day period immediately following,
and including, the date of the Spin-Off (the “valuation period”); and
			
	MP0	  	=	  	the average of the Last Reported Sale Prices of Common Stock over the valuation period.

 Such adjustment to the Conversion Rate under the preceding paragraph shall be determined after the close
of business on the tenth (10th) Trading Day immediately following, and including, the effective date of the Spin-Off; provided that in respect of any conversion within the ten (10) Trading Days immediately following, and including,
the effective date of any Spin-Off, references with respect to the Spin-Off to ten (10) Trading Days shall be deemed replaced with such lesser number of Trading Days as have elapsed between the effective date of such Spin-Off and the conversion
date in determining the applicable Conversion Rate. 
 Rights, options or warrants distributed by the Company to all holders of
Common Stock, entitling the holders thereof to subscribe for or purchase shares of the Company’s capital stock, including Common Stock (either initially or under certain circumstances), which rights, options or warrants, until the occurrence of
a specified event or events (“Trigger Event”): (i) are deemed to be transferred with such shares of Common Stock; (ii) are not exercisable; and (iii) are also issued in respect of future issuances of Common Stock,
shall be deemed not to have been distributed for purposes of this Section 13.03 (and no adjustment to the Conversion Rate under this Section 13.03 will be required) until the occurrence of the earliest Trigger Event, whereupon such rights,
options and warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Conversion Rate shall be made under this Section 13.03(c). If any such right, option or warrant, including any such existing
rights, options or warrants distributed prior to the date of this Indenture, are subject to events, upon the occurrence of which such rights, options or warrants become exercisable to purchase different securities, evidences of indebtedness or other
assets, then the date of the occurrence of any and 

  
 66 

 
each such event shall be deemed to be the date of distribution and record date with respect to new rights, options or warrants with such rights (and a termination or expiration of the existing
rights, options or warrants without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed distribution) of rights, options or warrants, or any Trigger Event or other event (of the type described in the
preceding sentence) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the Conversion Rate under this Section 13.03 was made, (1) in the case of any such rights, options or
warrants that shall all have been redeemed or repurchased without exercise by any holders thereof, the Conversion Rate shall be readjusted upon such final redemption or repurchase to give effect to such distribution or Trigger Event, as the case may
be, as though it were a cash distribution, equal to the per share redemption or repurchase price received by a holder or holders of Common Stock with respect to such rights, options or warrants (assuming such holder had retained such rights, options
or warrants), made to all holders of Common Stock as of the date of such redemption or repurchase, and (2) in the case of such rights, options or warrants that shall have expired or been terminated without exercise by any holders thereof, the
Conversion Rate shall be readjusted as if such rights, options and warrants had not been issued. 
 For purposes of this
Section 13.03(c), Section 13.03(a) and Section 13.03(b), any dividend or distribution to which this Section 13.03(c) is applicable that also includes shares of Common Stock to which Section 13.03(a) applies
and/or also includes rights, options or warrants to subscribe for or purchase shares of Common Stock to which Section 13.03(b) applies shall be deemed instead to be (1) a dividend or distribution of the Distributed Property other than
such shares of Common Stock to which Section 13.03(a) applies and/or other than such rights, options or warrants to which Section 13.03(b) applies and any Conversion Rate adjustment required by this
Section 13.03(c) with respect to such dividend or distribution shall then be made immediately followed by (2) a dividend or distribution of such shares of Common Stock or such rights or warrants (and any further Conversion Rate
adjustment required by Section 13.03(a) and/or Section 13.03(b) with respect to such dividend or distribution shall then be made), except (A) the record date of such dividend or distribution shall under this
Section 13.03(c) be substituted as “the record date” within the meaning of Section 13.03(a) and Section 13.03(b) and (B) any shares of Common Stock included in such dividend or distribution shall not be
deemed “outstanding immediately prior to the opening of business on such record date or the effective date, as the case may be” within the meaning of Section 13.03(a) or “outstanding immediately prior to the opening of
business on such record date” within the meaning of Section 13.03(b). 
 (d)     In case the
Company shall pay a dividend or make a distribution consisting exclusively of cash to all or substantially all holders of its Common Stock, the Conversion Rate shall be increased based on the following formula: 

 

							
		 	CR' = 
CR0 ×  	  	    SP0     	  	
	 	  	SP0 – C	  	

 where, 
  

					
	CRo	  	=	  	the Conversion Rate in effect immediately prior to the opening of business on the record date for such dividend or distribution;

  
 67 

					
	CR'	  	=	  	the Conversion Rate in effect immediately after the opening of business on such record date;
			
	SP0	  	=	  	the Last Reported Sale Price of Common Stock on the Trading Day immediately preceding such record date; and
			
	C	  	=	  	the amount in cash per share the Company distributes to holders of Common Stock.

 Any increase made under this Section 13.03(d) shall become effective immediately after the opening
of business on the record date for such dividend or distribution. If such dividend or distribution is not so paid, the Conversion Rate shall be decreased, effective as of the date the Board of Directors determines not to make or pay such dividend or
distribution, to be the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. Notwithstanding the foregoing, if “C” (as set forth above) is equal to or greater than “SPo” (as set forth above), in lieu of the foregoing increase, each
Noteholder shall receive, for each $1,000 principal amount of Notes, at the same time and upon the same terms as holders of shares of Common Stock, the amount of cash that such holder would have received if such holder owned a number of shares of
Common Stock equal to the Conversion Rate on the record date for such cash dividend or distribution. 
 For the avoidance of
doubt, for purposes of this Section 13.03(d), in the event of any reclassification of the Common Stock, as a result of which the Notes become convertible into more than one class of Common Stock, if an adjustment to the Conversion Rate is
required pursuant to this Section 13.03(d), references in this Section to one share of Common Stock or Last Reported Sale Price of one share of Common Stock shall be deemed to refer to a unit or to the price of a unit consisting of the
number of shares of each class of Common Stock into which the Notes are then exercisable equal to the numbers of shares of such class issued in respect of one share of Common Stock in such reclassification. The above provisions of this paragraph
shall similarly apply to successive reclassifications. 
 (e)     In case the Company or any of its
Subsidiaries makes a payment in respect of a tender offer or exchange offer for the Common Stock (other than an odd-lot tender offer), to the extent that the cash and value of any other consideration included in the payment per share of Common Stock
exceeds the average of the Last Reported Sale Prices of the Common Stock over the ten (10) consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the last date on which tenders or exchanges may be made
pursuant to such tender or exchange offer, as it may be amended (the “expiration date”), the Conversion Rate shall be increased based on the following formula: 

 

							
		 	CR' = 
CR0 ×  	  	    AC + (SP' x    

OS')
	 	
	 	  	OSo × SP'	 	

 where, 

  
 68 

							
	
CR0
	  	 	=	  	  	the Conversion Rate in effect immediately prior to the opening of business on the Trading Day next succeeding the expiration date;
			
	 CR'
	  	 	=	  	  	the Conversion Rate in effect immediately after the opening of business on the Trading Day next succeeding the expiration date;
			
	 AC
	  	 	=	  	  	the aggregate value of all cash and any other consideration as determined by the Board of Directors paid or payable for shares of Common Stock purchased in such tender or exchange
offer;
			
	
OS0
	  	 	=	  	  	the number of shares of Common Stock outstanding immediately prior to the expiration date (before giving effect to such tender offer or exchange offer);
			
	 OS'
	  	 	=	  	  	the number of shares of Common Stock outstanding immediately after the expiration date (after giving effect to such tender offer or exchange offer); and
			
	 SP'
	  	 	=	  	  	the average of the Last Reported Sale Prices of Common Stock over the ten (10) consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the
expiration date.

 Any increase in the Conversion Rate under this Section 13.03(e) shall be determined as of the close
of business on the tenth (10th) Trading Day next succeeding the expiration date but will be given effect as of the opening of business on the Trading Day next succeeding the expiration date. For purposes of determining the Conversion Rate, in
respect of any conversion during the ten (10) consecutive Trading Days commencing on the Trading Day next succeeding the expiration date, references within this Section 13.03(e) to ten (10) consecutive Trading Days shall be deemed
replaced with such lesser number of Trading Days as have elapsed from, and including, the Trading Day next succeeding the expiration date to, but excluding, the relevant conversion date. 

(f)     For purposes of this Section 13.03, the term “record date” shall mean, with respect to
any dividend, distribution or other transaction or event in which the holders of Common Stock have the right to receive any cash, securities or other property or in which the shares of Common Stock (or other applicable security) are exchanged for or
converted into any combination of cash, securities or other property, the date fixed for determination of shareholders entitled to receive such cash, securities or other property (whether such date is fixed by the Board of Directors or by statute,
contract or otherwise). 
 (g)     In addition to those required by clauses (a), (b), (c), (d), and
(e) of this Section 13.03, and to the extent permitted by applicable law and subject to the listing standards of The New York Stock Exchange, the Company from time to time may increase the Conversion Rate by any amount for a period of at
least twenty (20) calendar days if the Board of Directors determines that such increase would be in the Company’s best interest. If the Board of Directors makes such determination, it shall be binding and conclusive. In addition, subject
to the listing standards of The New York Stock Exchange, the Company may, but is not required to, increase the Conversion Rate to avoid or diminish any income tax to holders of Common Stock or rights to purchase Common Stock in connection with any
dividend or distribution of shares (or rights to 

  
 69 

 
acquire shares) or similar event. Whenever the Conversion Rate is increased pursuant to this Section 13.03(g), the Company shall mail to the holder of each Note at its last address appearing
on the Note Register provided for in Section 2.06 a notice of the increase at least fifteen (15) days prior to the date the increased Conversion Rate takes effect, in accordance with applicable law, and such notice shall state the
increased Conversion Rate and the period during which it will be in effect. 
 (h)     All calculations and
other determinations under this Article 13 shall be made by the Company and shall be made to the nearest cent or to the nearest one-ten thousandth (1/10,000) of a share, as the case may be. No adjustment shall be made for the
Company’s issuance of Common Stock or convertible or exchangeable securities or rights to purchase Common Stock or convertible or exchangeable securities, other than as provided in this Section 13.03 or Section 13.01(b). No adjustment
shall be made to the Conversion Rate unless such adjustment would require a change of at least 1% in the Conversion Rate then in effect at such time. The Company shall carry forward any adjustments that are less than 1% of the Conversion Rate, take
such carry-forward adjustments into account in any subsequent adjustment and make such carried forward adjustments, regardless of whether the aggregate adjustment is less than 1% (i) annually, on the anniversary of the first date of issue of
the Notes and (ii) upon conversion of any Note. 
 (i)     Whenever the Conversion Rate is adjusted as
herein provided, the Company shall promptly file with the Trustee and any Conversion Agent other than the Trustee an Officers’ Certificate setting forth the Conversion Rate after such adjustment and setting forth a brief statement of the facts
requiring such adjustment. The Trustee and Conversion Agent may conclusively rely on the accuracy of the Conversion Rate adjustment provided by the Company. Unless and until a Responsible Officer of the Trustee shall have received such
Officers’ Certificate, the Trustee shall not be deemed to have knowledge of any adjustment of the Conversion Rate and may assume without inquiry that the last Conversion Rate of which it has knowledge is still in effect. Promptly after delivery
of such certificate, the Company shall prepare a notice of such adjustment of the Conversion Rate setting forth the adjusted Conversion Rate and the date on which each adjustment becomes effective and shall mail such notice of such adjustment of the
Conversion Rate to the holder of each Note at his last address appearing on the Note Register provided for in Section 2.06 of this Indenture, within twenty (20) days of the effective date of such adjustment. Failure to deliver such notice
shall not affect the legality or validity of any such adjustment. 
 (j)     The applicable
Conversion Rate will not be adjusted: 
 (i)     upon the issuance of any shares of the
Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on the Company’s securities and the investment of additional optional amounts in shares of the Common Stock under any plan;

 (ii)     upon the issuance of any shares of the Common Stock or restricted stock units or
options or rights (including shareholder appreciation rights) to purchase those shares pursuant to any present or future employee, director or consultant benefit plan or program of or assumed by the Company or any of the Company’s Subsidiaries;

  
 70 

 (iii)     upon the issuance of any shares of the Common
Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible securities not described in clause (ii) of this subsection and outstanding as of the date the Notes were first issued; 

(iv)     for a change in the par value of the Common Stock; 

(v)     for accrued and unpaid interest, including Additional Interest, if any; or 

(vi)     for any transactions described in this Section 13.03 if Noteholders participate (as a
result of holding the Notes, and at the same time as holders of Common Stock participate) in such transactions as if such Noteholders held a number shares of Common Stock equal to the Conversion Rate at the time such adjustment would be required,
multiplied by the principal amount (expressed in thousands) of Notes held by such Noteholders, without having to surrender their Notes for conversion. 
 (k)     For purposes of this Section 13.03, the number of shares of Common Stock at any time outstanding shall not include shares held in the treasury of the Company but shall
include shares issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock. 
 (l)
    Notwithstanding the foregoing, if any adjustment to the Conversion Rate described in any of clauses (a) through (e) of this Section 13.03 becomes effective and, but for this provision, a holder that has
converted its Notes (i) would receive shares of Common Stock based on an adjusted Conversion Rate and (ii) would be a record holder of such shares of Common Stock on the record date, effective date or expiration date for the dividend,
distribution or other event giving rise to the adjustment or otherwise participates in such dividend, distribution or other event giving rise to the adjustment as a result of being treated as a holder of record of such shares of Common Stock, then,
in lieu of receiving shares of Common Stock at such an adjusted Conversion Rate, the Company shall adjust the number of shares of Common Stock that the Company delivers to such holder as the Company determines is appropriate to reflect such
holder’s participation in the related dividend, distribution or other event giving rise to such adjustment. 
 (m)
    If any dividend, distribution or issuance described in this Section 13.03 is declared but not so paid or made, the Conversion Rate shall again be adjusted to the Conversion Rate that would have been in effect if such
dividend, distribution or issuance had not been declared. If the application of any of the foregoing formulas (other than in connection with a share combination) would result in a decrease in the Conversion Rate, no adjustment to the Conversion Rate
shall be made. 
 Section 13.04.     Shares to Be Fully Paid. Upon conversion of Notes, the Company
shall provide, free from preemptive rights, out of its authorized but unissued shares or shares held in treasury, sufficient shares of Common Stock to settle the conversion of Notes. 

Section 13.05.     Certain Other Adjustments. To the extent not otherwise covered by Section 13.03,
whenever a provision of this Indenture requires the calculation of Last Reported Sale Prices over a span of multiple days, the Board of Directors shall make appropriate adjustments to such Last Reported Sale Prices, the Conversion Rate or the amount
due upon 

  
 71 

 
conversion to account for any adjustment to the Conversion Rate that becomes effective, or any event requiring an adjustment to the Conversion Rate where the applicable record date of the event
occurs, at any time during the period from which such Last Reported Sale Prices are to be calculated. Any such adjustment in accordance with the provisions of this Section 13.05 shall be determined in good faith by the Board of Directors in
order to give effect to the intent of Section 13.05 and the other provisions of this Article 13 and to avoid unjust or inequitable results. 
 Section 13.06.     Effect of Reclassification, Consolidation, Merger or Sale. 
 If any of the following events occur, namely (i) any reclassification or change of the outstanding shares of Common Stock (other than a change in par value, or from par value to no par value, or from
no par value to par value, or as a result of a split, subdivision or combination), (ii) any consolidation, merger or combination of the Company with another Person, or (iii) any sale or conveyance of all or substantially all of the
property and assets of the Company to any other Person, in each case as a result of which holders of Common Stock shall be entitled to receive cash, securities or other property or assets with respect to or in exchange for such Common Stock (any
such event a “Merger Event”), then: 
 (a)     the Company or the successor or purchasing
Person, as the case may be, shall execute with the Trustee a supplemental indenture (which shall comply with the Trust Indenture Act as in force at the date of execution of such supplemental indenture if such supplemental indenture is then required
to so comply) permitted under Section 9.01(a) providing for the conversion and settlement of the Notes as set forth in this Indenture. Such supplemental indenture shall provide for adjustments which shall be as nearly equivalent as may be
practicable to the adjustments provided for in this Article and the Trustee may conclusively rely on the determination by the Company of the equivalency of such adjustments. If, in the case of any Merger Event, the Reference Property includes
shares of stock or other securities and assets of a corporation other than the successor or purchasing corporation, as the case may be, in such reclassification, change, consolidation, merger, combination, sale or conveyance, then such supplemental
indenture shall also be executed by such other corporation and shall contain such additional provisions to protect the interests of the holders of the Notes as the Board of Directors shall reasonably consider necessary by reason of the foregoing,
including to the extent required by the Board of Directors and practicable the provisions providing for the repurchase rights set forth in Article 14 herein. 
 In the event the Company shall execute a supplemental indenture pursuant to this Section 13.06, the Company shall promptly file with the Trustee an Officers’ Certificate briefly stating the
reasons therefore, the kind or amount of cash, securities or property or asset that will constitute the Reference Property after any such Merger Event, any adjustment to be made with respect thereto and that all conditions precedent have been
complied with, and shall promptly mail notice thereof to all Noteholders. 
 (b)     Notwithstanding the
provisions of Section 13.02(a), and subject to the provisions of Section 13.01, at the effective time of such Merger Event, the right to convert a Note will be changed into a right to convert such Note as set forth in this Indenture into
the kind and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of Common Stock equal to the

  
 72 

 
Conversion Rate in effect prior to such Merger Event would have owned or been entitled to receive (the “Reference Property”) upon such Merger Event. For purposes of determining
the constitution of Reference Property, the type and amount of consideration that a holder of Common Stock would have been entitled to in the case of reclassifications, consolidations, mergers, sales or conveyance of assets or other transactions
that cause the Common Stock to be converted into the right to receive more than a single type of consideration (determined based in part upon any form of shareholder election) shall be deemed to be (i) the weighted average of the types and
amounts of consideration received by the holders of Common Stock that affirmatively make such an election or (ii) if no holders of Common Stock affirmatively make such an election, the types and amounts of consideration actually received by
such holders. The Company shall not become a party to any such transaction unless its terms are consistent with this Section 13.06. None of the foregoing provisions shall affect the right of a holder of Notes to surrender its Notes for
conversion to the Company in accordance with the provisions of Article 13 hereof prior to the effective date of the Merger Event. 
 (c)     The Company shall cause notice of the execution of such supplemental indenture to be mailed to each Noteholder, at its address appearing on the Note Register provided for in
this Indenture, within twenty (20) days after execution thereof. Failure to deliver such notice shall not affect the legality or validity of such supplemental indenture. 
 (d)     The above provisions of this Section shall apply to successive Merger Events. 
 Section 13.07.     Certain Covenants. 
 (a)
    Before taking any action which would cause an adjustment reducing the Conversion Rate below the then par value, of the shares of Common Stock issuable upon the conversion of the Notes, the Company will take all corporate
action which may, in the opinion of its counsel, be necessary in order that the Company may validly and legally issue shares of such Common Stock at such adjusted Conversion Rate. 

The Company covenants that all shares of Common Stock issued upon conversion of the Notes will be fully paid and non-assessable by the
Company and free from all taxes, liens and charges with respect to the issue thereof. 
 (b)     The
Company covenants that, if any shares of Common Stock to be provided for the purpose of conversion of the Notes hereunder require registration with or approval of any governmental authority under any federal or state law before such shares may be
validly issued upon such conversion, the Company will in good faith and as expeditiously as possible, to the extent then permitted by the rules and interpretations of the Commission (or any successor thereto), endeavor to secure such registration or
approval, as the case may be. 
 (c)     The Company further covenants that if at any time the Common Stock
shall be listed on any other national securities exchange or automated quotation system the Company will, if permitted and required by the rules of such exchange or automated quotation system, list and keep listed, so long as the Common Stock shall
be so listed on such exchange or automated quotation system, all Common Stock issuable upon the conversion of the Notes. 

  
 73 

 Section 13.08.     Responsibility of Trustee. Notwithstanding
any provision of this Indenture to the contrary, the Trustee and any other Conversion Agent shall not at any time be under any duty or responsibility to any Noteholder to determine the Conversion Rate or whether any facts exist which may require any
adjustment of the Conversion Rate, or with respect to the nature or extent or calculation of any such adjustment when made, or with respect to the method employed, or herein or in any supplemental indenture provided to be employed, in making the
same. The Trustee and any other Conversion Agent shall not be accountable with respect to the validity or value (or the kind or amount) of any shares of Common Stock, or of any securities or property, which may at any time be issued or delivered
upon the conversion of any Note; and the Trustee and any other Conversion Agent make no representations with respect thereto. Neither the Trustee nor any Conversion Agent shall be responsible for any failure of the Company to issue, transfer or
deliver any shares of Common Stock or stock certificates or other securities or property or cash upon the surrender of any Note for the purpose of conversion or to comply with any of the duties, responsibilities or covenants of the Company contained
in this Article. 
 Without limiting the generality of the foregoing, neither the Trustee nor any Conversion Agent shall be
under any responsibility to determine the correctness of any provisions contained in any supplemental indenture entered into pursuant to Section 13.06 relating either to the kind or amount of shares of stock or securities or property (including
cash) receivable by Noteholders upon the conversion of the Notes after any event referred to in such Section 13.06 or to any adjustment to be made with respect thereto, but, subject to the provisions of Section 6.01, may accept as
conclusive evidence of the correctness of any such provisions, and shall be protected in relying upon, the Officers’ Certificate (which the Company shall be obligated to file with the Trustee prior to the execution of any such supplemental
indenture) with respect thereto. 
 Section 13.09.     Notice to Holders Prior to Certain Actions.

 In case: 
 (a)     the Company shall declare a dividend (or any other distribution) on its Common Stock that would require an adjustment in the Conversion Rate pursuant to Section 13.03; or

 (b)     the Company shall authorize the granting to all of the holders of its Common
Stock of rights, options or warrants to subscribe for or purchase any share of any class or any other rights, options or warrants, or 
 (c)     of any reclassification of the Common Stock of the Company (other than a subdivision or combination of its outstanding Common Stock, or a change in par value, or from par value
to no par value, or from no par value to par value), or of any consolidation or merger to which the Company is a party and for which approval of any shareholders of the Company is required, or of the sale or transfer of all or substantially all of
the assets of the Company; or 
 (d)     of the voluntary or involuntary dissolution,
liquidation or winding-up of the Company; 

  
 74 

 
the Company shall cause to be filed with the Trustee and to be mailed to each Noteholder at its address appearing on the Note Register, provided for in Section 2.06 of this Indenture, as
promptly as possible but in any event at least twenty (20) days prior to the applicable date specified in clause (x) or (y) below, as the case may be, a notice stating (x) the date on which a record is to be taken for the purpose
of such dividend, distribution or rights, options or warrants, or, if a record is not to be taken, the date as of which the holders of Common Stock of record to be entitled to such dividend, distribution or rights, options or warrants are to be
determined, or (y) the date on which such reclassification, consolidation, merger, sale, transfer, dissolution, liquidation or winding-up is expected to become effective or occur, and the date as of which it is expected that holders of Common
Stock of record shall be entitled to exchange their Common Stock for securities or other property deliverable upon such reclassification, consolidation, merger, sale, transfer, dissolution, liquidation or winding-up. Failure to give such notice, or
any defect therein, shall not affect the legality or validity of such dividend, distribution, reclassification, consolidation, merger, sale, transfer, dissolution, liquidation or winding-up. 

Section 13.10.     Shareholder Rights Plans. To the extent that the Company has a shareholder rights plan
(the “Rights Plan”) in effect upon conversion of any Note into Common Stock, the holders shall receive, in addition to any shares of Common Stock, the associated rights issued under the Rights Plan or under any future shareholder
rights plan the Company adopts. If the rights have separated from the Common Stock, expired, terminated or been redeemed or exchanged in accordance with the Rights Plan prior to any delivery of shares by the Company in respect of any conversion of
the Notes into Common Stock, the Conversion Rate shall be adjusted at the time of separation as if the Company distributed to all holders of the Common Stock, shares of its capital stock, evidences of indebtedness or assets as set forth in
Section 13.03(c), subject to readjustment in the event of the expiration or termination of such rights. 
 Section 13.11.
    Termination of Conversion Rights by the Company. 
 (a)     The Company may
elect to terminate the rights of the holders to surrender their Notes to the Company for conversion (the “Conversion Rights”), provided that at any time the Daily VWAP of the Common Stock for twenty (20) or more Trading
Days in a period of thirty (30) consecutive Trading Days equals or exceeds 130% of the applicable Conversion Price then in effect (a “Conversion Rights Termination Trigger Event”). If the Company elects to terminate the
Conversion Rights upon a Conversion Rights Termination Trigger Event, the Company, or, at its request, the Trustee in the name of and at the expense of the Company, shall deliver an irrevocable notice to holders of Notes within five (5) Trading
Days of the date of the Conversion Rights Termination Trigger Event (the “Conversion Rights Termination Notice,” and the date of mailing of such Conversion Rights Termination Notice, the “Conversion Rights Termination Notice
Date”). Subject to the listing standards of The New York Stock Exchange (including the provisions restricting certain issuances to a Related Party unless the Company has obtained shareholder approval), Noteholders may convert all or a
portion of their Notes (other than those that the Company is required to repurchase under Article 14) at any time on or prior to the close of business on the date specified in the Conversion Rights Termination Notice, which shall be no less than
twenty (20) calendar days following the Conversion Rights Termination Notice Date (the “Conversion Termination Date”). During the period from the date of this Indenture until the date that is one year after the later of the
last date of original issuance of the 

  
 75 

 
Notes and the last date on which the Company or any Affiliate of the Company was the owner of the Notes, the Company may only terminate the Conversion Rights upon a Conversion Rights Termination
Trigger Event if a shelf registration statement that registers the resale of the Notes and the Common Stock issuable upon conversion of the Notes (the “Shelf Registration Statement”) has been filed by the Company and been declared
effective by the Commission or is automatically effective and is available for use, and the Company expects such Shelf Registration Statement to remain effective and available for use from the Conversion Rights Termination Notice Date until thirty
(30) days following the Conversion Termination Date. 
 (b)     If the Conversion Termination Date
occurs prior to August 15, 2014, each holder that elects to convert its Notes after the Conversion Rights Termination Notice Date and on or before the Conversion Termination Date will receive a separate cash payment for accrued and unpaid
interest (including Additional Interest, if any) from the last day through which interest was paid on the Notes, or, if no interest has been paid, from July 19, 2011, in each case to, but not including, the Conversion Date, plus an additional
payment (the “Make-Whole Premium Payment”) in cash with respect to the Notes converted in an amount equal to the aggregate amount of the remaining scheduled interest payments (including Additional Interest, if any) that would have
been payable on such Notes from the Conversion Date to, but not including, August 15, 2014 (excluding interest accrued to, but not including, the Conversion Date). The Make-Whole Premium Payment shall be calculated in accordance with the
foregoing as determined in good faith by the Company. Prior to or concurrently with such payment, the Company will provide the Trustee with an Officers’ Certificate setting forth the calculation of the payment required by this
Section 13.11(b). The Trustee shall have no obligation or liability with respect to the calculation of the payments required by this Section 13.11(b). 
 (c)     The Company shall mail the Conversion Rights Termination Notice to the Trustee and to each holder (and to Beneficial Owners as required by applicable law) at such holder’s
address as set forth in the Note Register of the Note Registrar. The Conversion Rights Termination Notice shall state: 
 (i)     the Conversion Termination Date; 

(ii)     briefly, the Conversion Rights of the Notes; 

(iii)     the name and address of each Paying Agent and Conversion Agent, if applicable; 

(iv)     the Make-Whole Premium Payment, if any; and 

(v)     the applicable Conversion Rate and any adjustments thereto. 

Whenever in the Notes or in this Indenture there is a reference, in any context, to any obligation of the Company with respect to an
election to convert and surrender of the Notes to the Company, such reference shall be qualified by the conversion rights termination provisions of this Section 13.11, and the Company will not be required to comply with any of the Conversion
Rights set forth in this Indenture (including, without limitation, in Article 13 (other than in this Section 13.11)) after the close of business on the Conversion Termination Date, and any express mention of the conversion rights
termination provisions of this Section 13.11 in any 

  
 76 

 
provision of this Indenture shall not be construed as excluding the conversion rights termination provisions of this Section 13.11 in those provisions of this Indenture when such express
mention is not made. 
 (d)     Concurrently with the mailing of any such Conversion Rights Termination
Notice, the Company shall issue a press release announcing such termination of the Conversion Rights, the form and content of which press release shall be determined by the Company in good faith, but in its sole discretion, and in accordance with
applicable securities laws. 
 During the period beginning on the Conversion Rights Termination Notice Date and ending on (and
including) the Conversion Termination Date, the Company shall not publicly offer to sell any shares of Common Stock or securities convertible into or exchangeable for Common Stock (other than the Common Stock and shares issued pursuant to employee
benefit plans, qualified stock option plans or other employee or non-employee director compensation plans existing prior to the Conversion Rights Termination Notice Date or pursuant to then outstanding options, warrants or rights), or publicly offer
to sell or grant options, rights or warrants with respect to any shares of Common Stock or securities convertible into or exchangeable for Common Stock (other than the grant of securities pursuant to benefit plans existing prior to the Conversion
Rights Termination Notice Date). 
 ARTICLE 14 
 REPURCHASE OF NOTES AT OPTION OF HOLDERS 

Section 14.01.     Repurchase at Option of Holders Upon a Fundamental Change. 

(a)     If a Fundamental Change occurs at any time, then each Noteholder shall have the right, at such holder’s
option, to require the Company to repurchase all of such holder’s Notes or any portion thereof that is a multiple of $1,000 principal amount, for cash on the date (the “Fundamental Change Repurchase Date”) specified by the
Company that is not less than twenty (20) Business Days and not more than thirty-five (35) Business Days after the date of the Fundamental Change Repurchase Right Notice (as hereinafter defined) at a repurchase price equal to 100% of the
principal amount thereof, together with accrued and unpaid interest (including Additional Interest, if any) thereon to, but excluding, the Fundamental Change Repurchase Date (unless the Fundamental Change Repurchase Date is between a regular record
date and the corresponding Interest Payment Date to which it relates, in which case, the Company will pay the full amount of accrued and unpaid interest (including Additional Interest, if any) payable on such Interest Payment Date to the Noteholders
of record at the close of business on the corresponding regular record date) (the “Fundamental Change Repurchase Price”). Any Notes purchased by the Company shall be paid in cash. 

A transaction or transactions described in clauses (1), (2), (3) or (4) of the definition of “Fundamental
Change” shall not constitute a Fundamental Change, however, if at least 90% of the consideration paid for Common Stock (excluding cash payments for fractional shares and cash payments made pursuant to dissenters’ appraisal rights) in
connection with such transaction or transactions consists of shares of Common Stock that are listed or quoted on any of The New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ

  
 77 

 
Global Market (or any of their respective successors) or will be so listed or quoted immediately following issuance or exchange in connection with such transaction or transactions and as a result
of such transaction or transactions the Notes become convertible into the Reference Property for the Notes subject to Article 13. In addition, no Notes may be repurchased by the Company at the option of the holders on a Fundamental Change Repurchase
Date if the principal amount of the Notes has been accelerated, and such acceleration has not been rescinded, on or prior to the Fundamental Change Repurchase Date (except in the case of an acceleration resulting from a Default by the Company in the
payment of the applicable Fundamental Change Repurchase Price with respect to such Notes). 
 Repurchases of Notes under this
Section 14.01 shall be made, at the option of the holder thereof, upon: 
 (i)
    delivery to the Trustee (or other Paying Agent appointed by the Company and, in the case of the Notes held in global form, in accordance with the procedures of the Depositary) by a holder of a duly completed repurchase notice
(the “Fundamental Change Repurchase Notice”) in the form set forth on the reverse of the Note on or prior to the Business Day prior to the Fundamental Change Repurchase Date, subject to extension to comply with applicable law (the
“Fundamental Change Expiration Time”); and 
 (ii)     delivery or
book-entry transfer of the Notes to the Trustee (or other Paying Agent appointed by the Company) at any time after delivery of the Fundamental Change Repurchase Notice (together with all necessary endorsements) at the Corporate Trust Office of the
Trustee (or other Paying Agent appointed by the Company) in the Borough of Manhattan, such delivery being a condition to receipt by the holder of the Fundamental Change Repurchase Price therefor; provided that such Fundamental Change
Repurchase Price shall be so paid pursuant to this Section 14.01 only if the Note so delivered to the Trustee (or other Paying Agent appointed by the Company) shall conform in all respects to the description thereof in the related Fundamental
Change Repurchase Notice. 
 The Fundamental Change Repurchase Notice shall state: 

(A)     if the Notes are in definitive form, the certificate numbers of Notes to be delivered for
repurchase, or if in global form, such notice must comply with appropriate procedures of the Depositary; 
 (B)
    the portion of the principal amount of Notes to be repurchased, which must be $1,000 or an integral multiple thereof; and 
 (C)     that the Notes are to be repurchased by the Company pursuant to the applicable provisions of the Notes and this Indenture. 

Any repurchase by the Company contemplated pursuant to the provisions of this Section 14.01 shall be consummated by the delivery of
the consideration to be received by the holder promptly following the later of the Fundamental Change Repurchase Date and the time of the book-entry transfer or delivery of the Note. 

  
 78 

 The Trustee (or other Paying Agent appointed by the Company) shall promptly notify the
Company of the receipt by it of a Fundamental Change Repurchase Notice or written notice of withdrawal thereof in accordance with the provisions of Section 14.01(c). 
 Any Note that is to be repurchased only in part shall be surrendered to the Trustee (with, if the Company or the Trustee so requires, due endorsement by, or a written instrument of transfer in form
satisfactory to the Company and the Trustee duly executed by the holder thereof or his attorney duly authorized in writing), and the Company shall execute, and the Trustee shall authenticate and make available for delivery to the holder of such Note
without service charge, a new Note or Notes, containing identical terms and conditions, each in an authorized denomination in aggregate principal amount equal to and in exchange for the unrepurchased portion of the principal of the Note so
surrendered. 
 (b)     After the occurrence of a Fundamental Change, but on or before the tenth
(10th) day following such occurrence, the Company shall provide to all holders of record of the Notes and the Trustee and Paying Agent a notice (the “Fundamental Change Repurchase Right Notice”) of the occurrence of such
Fundamental Change and of the repurchase right at the option of the holders arising as a result thereof. Such mailing shall be by first class mail. 
 Each Fundamental Change Repurchase Notice shall specify: 

(i)     the events causing the Fundamental Change and whether such Fundamental Change also
constitutes a Make-Whole Fundamental Change; 
 (ii)     the date of the Fundamental Change;

 (iii)     the last date on which a holder may exercise the repurchase right, if
applicable; 
 (iv)     the Fundamental Change Repurchase Date; 

(v)     the Fundamental Change Repurchase Price; 

(vi)      the name and address of the Paying Agent and the Conversion Agent; 

(vii)      the applicable Conversion Rate and any adjustments to the applicable Conversion Rate;

 (viii)     that the Notes with respect to which a Fundamental Change Repurchase Notice
has been previously delivered to the Company may be converted only if the holder withdraws the Fundamental Change Repurchase Notice in accordance with Section 14.01(c); 

(ix)      that the holder must exercise the repurchase right on or prior to the close of
business prior to the Fundamental Change Expiration Time; 
 (x)      that the holder
shall have the right to withdraw any Notes surrendered prior to the Fundamental Change Expiration Time; and 

  
 79 

 (xi)        the procedures that
holders must follow to require the Company to repurchase their Notes. 
 No failure of the Company to give the foregoing
notices and no defect therein shall limit the Noteholders’ repurchase rights or affect the validity of the proceedings for the repurchase of the Notes pursuant to this Section 14.01. 

(c)        A Fundamental Change Repurchase Notice (in whole or in part) may be withdrawn by
means of a written notice of withdrawal delivered to the Paying Agent in accordance with the Fundamental Change Repurchase Right Notice at any time prior to the Fundamental Change Expiration Time, specifying: 

(i)        if the Notes are in definitive form, the certificate numbers of the
withdrawn Notes, or if in global form, such notice must comply with appropriate procedures of the Depositary; 

(ii)        the principal amount of the Notes with respect to which such notice
of withdrawal is being submitted, and 
 (iii)        the principal
amount, if any, of such Note that remains subject to the original Fundamental Change Repurchase Notice, which portion must be in principal amounts of $1,000 or an integral multiple of $1,000; 

(d)        On or prior to 11:00 a.m. (local time in The City of New York) on the Business Day
following the Fundamental Change Repurchase Date, the Company will deposit with the Trustee (or other Paying Agent appointed by the Company or if the Company is acting as its own Paying Agent, set aside, segregate and hold in trust as provided in
Section 3.04(b)) an amount of money sufficient to repurchase on the Fundamental Change Repurchase Date all of the Notes to be repurchased on such date at the Fundamental Change Repurchase Price. Subject to receipt of funds and/or Notes by the
Trustee (or other Paying Agent appointed by the Company), payment for Notes surrendered for repurchase (and not withdrawn) prior to the Fundamental Change Expiration Time will be made promptly after the later of (x) the Fundamental Change
Repurchase Date with respect to such Note (provided the holder has satisfied the conditions to the payment of the Fundamental Change Repurchase Price in this Section 14.01), and (y) the time of book-entry transfer or the delivery of
such Note to the Trustee (or other Paying Agent appointed by the Company) by the holder thereof in the manner required by this Section 14.01, in each case subject to extension to comply with applicable law, by mailing checks for the amount
payable to the holders of such Notes entitled thereto as they shall appear in the Note Register, provided, however, that payments to the Depositary shall be made by wire transfer of immediately available funds to the account of the
Depositary or its nominee. The Trustee shall, promptly after such payment and upon written demand by the Company, return to the Company any funds in excess of the Fundamental Change Repurchase Price. 

(e)        Subject to a holder’s right to receive interest on the related Interest Payment
Date where the Fundamental Change Repurchase Date is between a regular record date and the related Interest Payment Date, if the Trustee (or other Paying Agent appointed by the Company) holds money sufficient to repurchase on the Fundamental Change
Repurchase Date 

  
 80 

 
all the Notes or portions thereof that are to be purchased as of the Business Day on the Fundamental Change Repurchase Date, then on and after the Fundamental Change Repurchase Date (i) such
Notes will cease to be outstanding and interest, including any Additional Interest, will cease to accrue on such Notes (whether or not book-entry transfer of the Notes has been made or the Notes have been delivered to the Trustee or Paying Agent);
and (ii) all other rights of the holders of such Notes will terminate (other than the right to receive the Fundamental Change Repurchase Price upon delivery of the Notes and previously accrued and unpaid interest upon delivery or transfer of
the Notes). 
 (f)        In connection with any repurchase under this
Section 14.01, the Company shall (a) comply with Rules 13e-4 and 14e-1 (and any successor provisions thereto) under the Exchange Act, if applicable, (b) file the related Schedule TO (or any successor schedule, form or
report) under the Exchange Act, if applicable, and (c) otherwise comply with all federal and state securities laws in connection with any offer by the Company to repurchase the Notes, in each case, so as to permit the rights and obligations
under this Article 14 to be exercised in the time and in the manner specified in this Indenture. To the extent that the provisions of any securities laws or regulations conflict with the provisions of this Indenture described in this
Section 14.01, compliance by the Company with such laws and regulations shall not in and of itself cause a breach of the Company’s obligations described in this Section 14.01. 

ARTICLE 15 

MISCELLANEOUS PROVISIONS 
 Section 15.01.     Provisions Binding on Company’s Successors. All the covenants, stipulations, promises and agreements of the Company contained in this Indenture shall
bind its successors and assigns whether so expressed or not. 
 Section 15.02.     Official Acts by
Successor Corporation. Any act or proceeding by any provision of this Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done and performed with like force and effect by
the like board, committee or officer of any corporation that shall at the time be the lawful sole successor of the Company. 

Section 15.03.     Addresses for Notices, Etc. Any notice or demand which by any provision of this Indenture
is required or permitted to be given or served by the Trustee or by the Noteholders on the Company shall be deemed to have been sufficiently given or made, for all purposes if given or served by being deposited postage prepaid by registered or
certified mail in a post office letter box addressed (until another address is filed by the Company with the Trustee) to Forest City Enterprises, Inc., 50 Public Square, Terminal Tower, Suite 1100, Cleveland, Ohio 44113-2203, Attention: General
Counsel. Any notice, direction, request or demand hereunder to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or served by being deposited postage prepaid by registered or certified mail in a
post office letter box addressed to the Corporate Trust Office. 
 The Trustee, by notice to the Company, may designate
additional or different addresses for subsequent notices or communications. 

  
 81 

 Any notice or communication mailed to a Noteholder shall be mailed to it by first class
mail, postage prepaid, at its address as its address appears on the Note Register and shall be sufficiently given to it if so mailed within the time prescribed. 
 Failure to mail a notice or communication to a Noteholder or any defect in it shall not affect its sufficiency with respect to other Noteholders. If a notice or communication is mailed in the manner
provided above, it is duly given, whether or not the addressee receives it. 
 Section 15.04.
    Governing Law. THIS INDENTURE AND EACH NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK
APPLICABLE TO CONTRACTS ENTERED INTO AND TO BE PERFORMED THEREIN (WITHOUT REGARD TO THE CONFLICTS OF LAWS PROVISIONS THEREOF). 

Section 15.05.     Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to
Trustee. Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture after the date hereof, the Company shall furnish to the Trustee an Officers’ Certificate stating that all
conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with, and an Opinion of Counsel stating that, in the opinion of such counsel, all such conditions precedent have been complied with.

 Each certificate or opinion provided for by or on behalf of the Company in this Indenture and delivered to the Trustee with
respect to compliance with a condition or covenant provided for in this Indenture shall include (1) a statement that the Person making such certificate or opinion has read such covenant or condition; (2) a brief statement as to the nature
and scope of the examination or investigation upon which the statement or opinion contained in such certificate or opinion is based; (3) a statement that, in the opinion of such Person, he has made such examination or investigation as is
necessary to enable it to express an informed opinion as to whether or not such covenant or condition has been complied with; and (4) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been complied
with. 
 Section 15.06.     Legal Holidays. In any case where (i) any Interest Payment Date,
Fundamental Change Repurchase Date or Maturity Date will not be a Business Day or (ii) any Conversion Date will not be a Trading Day, then any action to be taken on such date need not be taken on such date, but may be taken on the next
succeeding Business Day or Trading Day, as applicable, with the same force and effect as if taken on such date, and no interest shall accrue for the period from and after such date to the next succeeding Business Day or Trading Day, as applicable.

 Section 15.07.     No Security Interest Created. Nothing in this Indenture or in the Notes,
expressed or implied, shall be construed to constitute a security interest under the Uniform Commercial Code or similar legislation, as now or hereafter enacted and in effect, in any jurisdiction. 

  
 82 

 Section 15.08.     Benefits of Indenture. Nothing in this
Indenture or in the Notes, expressed or implied, shall give to any Person, other than the parties hereto, any Paying Agent, any Conversion Agent, any authenticating agent, any Note Registrar and their successors hereunder, and the Noteholders, any
benefit or any legal or equitable right, remedy or claim under this Indenture. 
 Section 15.09.
    Table of Contents, Headings, Etc. The table of contents and the titles and headings of the articles and sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part
hereof, and shall in no way modify or restrict any of the terms or provisions hereof. 
 Section 15.10.
    Authenticating Agent. The Trustee may appoint an authenticating agent which shall be authorized to act on its behalf and subject to its direction in the authentication and delivery of Notes in connection with the
original issuance thereof and transfers and exchanges of Notes hereunder, including under Section 2.05, Section 2.06, Section 2.07, and Section 2.08, as fully to all intents and purposes as though the authenticating agent had
been expressly authorized by this Indenture and those Sections to authenticate and deliver Notes. For all purposes of this Indenture, the authentication and delivery of Notes by the authenticating agent shall be deemed to be authentication
and delivery of such Notes “by the Trustee” and a certificate of authentication executed on behalf of the Trustee by an authenticating agent shall be deemed to satisfy any requirement hereunder or in the Notes for the Trustee’s
certificate of authentication. Such authenticating agent shall at all times be a Person eligible to serve as trustee hereunder pursuant to Section 6.09. 
 Any corporation into which any authenticating agent may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, consolidation or conversion to which any
authenticating agent shall be a party, or any corporation succeeding to the corporate trust business of any authenticating agent, shall be the successor of the authenticating agent hereunder, if such successor corporation is otherwise eligible under
this Section, without the execution or filing of any paper or any further act on the part of the parties hereto or the authenticating agent or such successor corporation. 

Any authenticating agent may at any time resign by giving written notice of resignation to the Trustee and to the Company. The
Trustee may at any time terminate the agency of any authenticating agent by giving written notice of termination to such authenticating agent and to the Company. Upon receiving such a notice of resignation or upon such a termination, or in
case at any time any authenticating agent shall cease to be eligible under this Section, the Trustee shall promptly appoint a successor authenticating agent (which may be the Trustee), shall give written notice of such appointment to the Company and
shall mail notice of such appointment to all Noteholders as the names and addresses of such holders appear on the Note Register. 
 The Company agrees to pay to the authenticating agent from time to time reasonable compensation for its services although the Company may terminate the authenticating agent, if it determines such
agent’s fees to be unreasonable. 

  
 83 

 The provisions of Section 6.02, Section 6.03, Section 6.04,
Section 7.03 and this Section 15.10 shall be applicable to any authenticating agent. 
 Section 15.11.
    Execution in Counterparts. This Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument.

 Section 15.12.     Waiver Of Jury Trial. Each of the Company and the Trustee hereby irrevocably
waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Indenture, the Notes or the transaction contemplated hereby. 

Section 15.13.     Force Majeure. In no event shall the Trustee be responsible or liable for any failure or
delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military
disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts which
are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 

  
 84 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of
the date first written above. 
  

					
	FOREST CITY ENTERPRISES, INC.
		
	By:  	 	  /s/ Robert G. O’Brien
		 	Name:    	 	Robert G. O’Brien
		 	Title:	 	Executive Vice President, Chief Financial Officer and Treasurer
	
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee
		
	By:  	 	  /s/ Linda E. Garcia
		 	Name:    	 	Linda E. Garcia
		 	Title:	 	Authorized Signatory

 [Indenture] 

 SCHEDULE A 

 

																											
	 	  	Stock Price
	Effective Date	  	  $18.06  	  	  $19.00  	  	  $20.00  	  	  $21.67  	  	  $23.00  	  	  $25.00  	  	  $28.17  	  	  $30.00  	  	  $35.00  	  	  $40.00  	  	  $50.00  	  	  $75.00  	  	  $100.00  
														
	 July 19, 2011
	  	9.2284	  	9.2284	  	8.1351	  	6.4330	  	5.4833	  	4.3643	  	3.2740	  	2.9317	  	2.1496	  	1.6493	  	1.1724	  	0.5701	  	0.2794
														
	 August 15, 2012
	  	9.2284	  	8.5049	  	7.3034	  	5.6441	  	4.5588	  	3.5617	  	2.5233	  	2.2185	  	1.6056	  	1.2092	  	0.8335	  	0.3624	  	0.1316
														
	 August 15, 2013
	  	9.2284	  	7.7723	  	6.5838	  	4.7612	  	3.6615	  	2.3541	  	1.3342	  	1.1207	  	0.8137	  	0.6092	  	0.4188	  	0.1832	  	0.0657
														
	 August 15, 2014
	  	9.2284	  	6.9460	  	5.9739	  	4.2304	  	3.1001	  	1.3890	  	-	  	-	  	-	  	-	  	-	  	-	  	-
														
	 August 15, 2015
	  	9.2284	  	6.4891	  	5.1510	  	3.9939	  	2.8852	  	1.4439	  	-	  	-	  	-	  	-	  	-	  	-	  	-
														
	 August 15, 2016
	  	9.2284	  	6.4891	  	4.5998	  	3.1875	  	2.5609	  	1.4308	  	-	  	-	  	-	  	-	  	-	  	-	  	-
														
	 August 15, 2017
	  	9.2284	  	6.4891	  	4.4266	  	2.5436	  	1.6343	  	0.9600	  	-	  	-	  	-	  	-	  	-	  	-	  	-
														
	 August 15, 2018
	  	9.2284	  	6.4891	  	3.8575	  	0.0043	  	-	  	-	  	-	  	-	  	-	  	-	  	-	  	-	  	-

 EXHIBIT A 
 [FORM OF FACE OF NOTE] 
 [UNLESS THIS CERTIFICATE IS PRESENTED BY AN
AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE,
OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.] 
 THE NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT IT IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT); (2) AGREES THAT
IT WILL NOT WITHIN THE LATER OF (X) SIX MONTHS (OR, IF THE COMPANY HAS NOT SATISFIED THE CURRENT PUBLIC INFORMATION REQUIREMENTS OF RULE 144, ONE YEAR) AFTER THE LAST DATE OF ORIGINAL ISSUANCE OF NOTES (INCLUDING THROUGH THE EXERCISE OF THE
OPTION TO PURCHASE ADDITIONAL NOTES) AND (Y) 90 DAYS AFTER IT CEASES TO BE AN AFFILIATE (WITHIN THE MEANING OF RULE 144 UNDER THE SECURITIES ACT) OF FOREST CITY ENTERPRISES, INC. (THE “COMPANY”), OFFER, RESELL, PLEDGE OR OTHERWISE
TRANSFER THE NOTE EVIDENCED HEREBY OR THE CLASS A COMMON STOCK ISSUABLE UPON CONVERSION OF SUCH NOTE, EXCEPT (A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF, (B) TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE
SECURITIES ACT, (C) UNDER ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, INCLUDING RULE 144 (IF AVAILABLE), OR (D) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE
SECURITIES ACT (AND THAT CONTINUES TO BE EFFECTIVE AT THE TIME OF SUCH TRANSFER); (3) PRIOR TO SUCH TRANSFER (OTHER THAN A TRANSFER PURSUANT TO CLAUSES 2(A), 2(B) AND 2(D) ABOVE), IT WILL FURNISH TO THE BANK OF NEW YORK MELLON TRUST COMPANY,
N.A., AS TRUSTEE (OR A SUCCESSOR TRUSTEE, AS APPLICABLE), SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS THE TRUSTEE MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT; AND (4) AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THIS NOTE IS TRANSFERRED (OTHER THAN A TRANSFER PURSUANT TO CLAUSE 2(D)

  
 A-1

 
ABOVE ) PRIOR TO EXPIRATION OF THE HOLDING PERIOD APPLICABLE TO SALES OF THE NOTE EVIDENCED HEREBY UNDER RULE 144 UNDER THE SECURITIES ACT (OR ANY SUCCESSOR PROVISION) A NOTICE SUBSTANTIALLY TO
THE EFFECT OF THIS LEGEND. THIS LEGEND WILL BE REMOVED UPON THE EARLIER OF THE TRANSFER OF THIS NOTE PURSUANT TO CLAUSE 2(D) ABOVE OR UPON ANY TRANSFER OF THIS NOTE UNDER RULE 144 SUCH THAT THE NOTE IS NO LONGER CONSIDERED “RESTRICTED
SECURITIES” AS DEFINED UNDER RULE 144 (OR ANY SUCCESSOR PROVISION). THE INDENTURE CONTAINS A PROVISION REQUIRING THE TRUSTEE TO REFUSE TO REGISTER ANY TRANSFER OF THIS NOTE IN VIOLATION OF THE FOREGOING RESTRICTION. 

  
 A-2

 FOREST CITY ENTERPRISES, INC. 

4.25% Convertible Senior Notes Due 2018 
 No. 001 
 CUSIP No. 345550AN7 
 ISIN No. US345550AN71 
 Forest City Enterprises, Inc., a corporation duly
organized and validly existing under the laws of the State of Ohio (herein called the “Company,” which term includes any successor corporation under the Indenture referred to on the reverse hereof), for value received hereby
promises to pay to CEDE & CO., or registered assigns, the principal sum of Three Hundred Fifty Million Dollars ($350,000,000) or such other principal amount as shall be set forth on the Schedule I hereto on August 15, 2018. 

This Note shall bear interest at the rate of 4.25% per year from July 19, 2011, or from the most recent date to which interest
had been paid or provided. Interest is payable semi-annually in arrears on each February 15 and August 15, commencing on February 15, 2012, to holders of record at the close of business on the preceding January 31 and
July 31 (whether or not such day is a Business Day), respectively. Interest payable on each Interest Payment Date shall equal the amount of interest accrued from and including the immediately preceding Interest Payment Date (or from and
including July 19, 2011 if no interest has been paid hereon) to but excluding such Interest Payment Date. 
 Payment of
the principal of and interest accrued (including Additional Interest, if any) on this Note shall be made at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, The City of New York, or, at the option of the
holder of this Note, at the Corporate Trust Office, in such lawful money of the United States of America as at the time of payment shall be legal tender for the payment of public and private debts; provided, however, interest
(including Additional Interest, if any) may be paid by check mailed to such holder’s address as it appears in the Note Register; provided, further, however, that, with respect to any Noteholder with an aggregate principal
amount in excess of $1,000,000, at the application of such holder in writing to the Note Registrar, interest on such holder’s Notes shall be paid by wire transfer in immediately available funds to such holder’s account in the United States
supplied by such holder from time to time to the Trustee and Paying Agent (if different from the Trustee) not later than the applicable record date; provided that any payment to the Depositary or its nominee shall be paid by wire transfer in
immediately available funds in accordance with the wire transfer instruction supplied by the Depositary or its nominee from time to time to the Trustee and Paying Agent (if different from Trustee). 

Reference is made to the further provisions of this Note set forth on the reverse hereof, including, without limitation, provisions
giving the holder of this Note the right to receive with respect to this Note Common Stock of the Company on the terms and subject to the limitations referred to on the reverse hereof and as more fully specified in the Indenture. Such further
provisions shall for all purposes have the same effect as though fully set forth at this place. 

  
 A-3

 This Note shall be deemed to be a contract made under the laws of the State of New York,
and for all purposes shall be construed in accordance with the laws of the State of New York applicable to contracts entered into and to be performed therein (without regard to the conflicts of laws provisions thereof). 

This Note shall not be valid or become obligatory for any purpose until the certificate of authentication hereon shall have been
manually signed by the Trustee or a duly authorized authenticating agent under the Indenture. 
 [Remainder of page intentionally
left blank] 

  
 A-4

 IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. 

 

			
		 	FOREST CITY ENTERPRISES, INC.
		
	By:  	 	 
		 	Name:
		 	Title:

 Dated: July 19, 2011 

TRUSTEE’S CERTIFICATE OF AUTHENTICATION 
  

			
	 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,
 as Trustee, certifies that this is one of the Notes described in the within-named Indenture.

		
	By:        	 	 
		 	Name:
		 	Authorized Officer

  
 A-6

 [FORM OF REVERSE OF NOTE] 

FOREST CITY ENTERPRISES, INC. 
 4.25% Convertible Senior Notes due 2018 
 This Note is one of a duly authorized
issue of Notes of the Company, designated as its 4.25% Convertible Senior Notes due 2018 (herein called the “Notes”), issued under and pursuant to an Indenture dated as of July 19, 2011 (herein called the
“Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A. (herein called the “Trustee”), to which Indenture and all indentures supplemental thereto reference is hereby made for a
description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the holders of the Notes. Additional Notes may be issued in an unlimited aggregate principal amount, subject to certain
conditions specified in the Indenture. 
 In case an Event of Default, as defined in the Indenture, shall have occurred and be
continuing, the principal of, and accrued and unpaid interest (including Additional Interest, if any) on, all Notes, may be declared, and upon said declaration shall become, due and payable, in the manner, with the effect and subject to the
conditions provided in the Indenture. 
 Subject to the terms and conditions of the Indenture, the Company will make all
payments and deliveries in respect of the Fundamental Change Repurchase Price and the principal amount on the Maturity Date, as the case may be, to the holder who surrenders a Note to a Paying Agent to collect such payments in respect of the Note.
The Company will pay cash amounts in money of the United States that at the time of payment is legal tender for payment of public and private debts. 
 The Indenture contains provisions permitting the Company and the Trustee in certain circumstances, without the consent of the holders of the Notes, and in other circumstances, with the consent of the
holders of not less than a majority in aggregate principal amount of the Notes at the time outstanding, evidenced as in the Indenture provided, to execute supplemental indentures modifying the terms of the Indenture and the Notes as described
therein; provided, however, that no such supplemental indenture shall make any of the changes set forth in Section 9.02 of the Indenture, without the consent of each holder of an outstanding Note affected thereby. It is also
provided in the Indenture that, prior to any declaration accelerating the maturity of the Notes, the holders of a majority in aggregate principal amount of the Notes at the time outstanding may on behalf of the holders of all of the Notes waive any
past Default or Event of Default under the Indenture and its consequences except as provided in the Indenture. Any such consent or waiver by the holder of this Note (unless revoked as provided in the Indenture) shall be conclusive and binding upon
such holder and upon all future holders and owners of this Note and any Notes which may be issued in exchange or substitution hereof or upon registration of transfer, irrespective of whether or not any notation thereof is made upon this Note or such
other Notes. 
 No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair
the obligation of the Company, which is absolute and unconditional, to pay the principal of, and accrued and unpaid interest (including Additional 

  
 A-7

 
Interest, if any) on, this Note, at the place, at the respective times, at the rate and in the lawful money herein prescribed. 

The Notes are issuable in registered form without coupons in denominations of $1,000 principal amount and integral multiples thereof.
Upon due presentment for registration of transfer of this Note at the office or agency of the Company in the Borough of Manhattan, The City of New York, a new Note or Notes of other authorized denominations for an equal aggregate principal amount
will be issued to the transferee in exchange thereof, subject to the limitations provided in the Indenture, without charge except for any tax, assessments or other governmental charges imposed in connection therewith. 

The Notes are not subject to redemption prior to maturity through the operation of any sinking fund. 

Upon the occurrence of a Fundamental Change, the holder has the right, at such holder’s option, to require the Company to
repurchase for cash all of such holder’s Notes or any portion thereof (in principal amounts of $1,000 or integral multiples thereof) on the Fundamental Change Repurchase Date at a repurchase price equal to 100% of the principal amount of the
Notes such holder elects to require the Company to repurchase, together with accrued and unpaid interest (including Additional Interest, if any) to, but excluding, the Fundamental Change Repurchase Date. The Company or, at the written request of the
Company, the Trustee shall mail to all holders of record of the Notes a notice of the occurrence of a Fundamental Change and of the repurchase right arising as a result thereof on or before the tenth (10th) day after the occurrence of any
Fundamental Change. 
 Subject to the provisions of the Indenture, the holder shall have the right, at such holder’s
option, to convert all or any portion (if the portion to be converted is $1,000 principal amount or an integral multiple thereof) of such Note at any time prior to the close of business on the Trading Day immediately preceding the Maturity Date at a
Conversion Rate specified in the Indenture, as adjusted from time to time as provided in the Indenture, upon surrender of this Note, together with a Conversion Notice, a form of which is attached to the Note, as provided in the Indenture and this
Note, to the Company at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, The City of New York, or at the option of such holder, the Corporate Trust Office. The initial Conversion Rate shall be 46.1425
shares for each $1,000 principal amount of Notes. No fractional shares of Common Stock will be issued upon conversion of the Note, but an adjustment in cash will be paid to the holder, as provided in the Indenture, in respect of any fraction of a
share which would otherwise be issuable upon the surrender of any Note or Notes after conversion. No adjustment shall be made for dividends or any shares issued upon conversion except as provided in the Indenture. The Company may elect to terminate
the Conversion Rights of holders if at any time the Daily VWAP of the Common Stock equals or exceeds 130% of the applicable Conversion Price. If the Company elects to terminate the Conversion Rights of holders at any time prior to August 15,
2014, upon conversion holders shall receive a separate cash payment for accrued and unpaid interest (including Additional Interest, if any) to but not including the Conversion Date plus the Make-Whole Premium Payment. 

  
 A-8

 The Company, the Trustee, any authenticating agent, any Paying Agent, any Conversion Agent
and any Note Registrar may deem and treat the registered holder hereof as the absolute owner of this Note (whether or not this Note shall be overdue and notwithstanding any notation of ownership or other writing hereon), for the purpose of receiving
payment hereof, or on account hereof, for the conversion hereof and for all other purposes, and neither the Company nor the Trustee nor any other authenticating agent nor any Paying Agent nor any other Conversion Agent nor any Note Registrar shall
be affected by any notice to the contrary. All payments made to or upon the order of such registered holder shall, to the extent of the sum or sums paid, satisfy and discharge liability for monies payable on this Note. 

No recourse for the payment of the principal of, or accrued and unpaid interest (including Additional Interest, if any) on, this Note,
or for any claim based hereon or otherwise in respect hereof, and no recourse under or upon any obligation, covenant or agreement of the Company in the Indenture or any indenture supplemental thereto or in any Note, or because of the creation of any
debt represented thereby, shall be had against any incorporator, shareholder, employee, agent, officer, director or Subsidiary, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company
or any successor corporation, whether by virtue of any constitution, statute or rule of law or by the enforcement of any assessment or penalty or otherwise, all such liability being, by the acceptance hereof and as part of the consideration for the
issue hereof, expressly waived and released. 
 Terms used in this Note and defined in the Indenture are used herein as therein
defined. 
 Customary abbreviations may be used in the name of a Holder or an assignee, such as TEN COM (=tenants in common),
TENANT (=tenants by the entireties), JT TEN (joint tenants with right of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). 

  
 A-9

 [FORM OF ASSIGNMENT AND TRANSFER] 

 

	To:	THE BANK OF NEW YORK MELLON TRUST 

	COMPANY,	N.A., as Trustee 

 For value received
                                        
hereby sell(s), assign(s) and transfer(s) unto                              (Please insert social
security or Taxpayer Identification Number of assignee) the within Note, and hereby irrevocably constitutes and appoints
                         attorney to transfer the said Note on the books of the Company, with full power of substitution
in the premises. 
 In connection with any transfer of the within Note occurring prior to the Resale Restriction Termination Date, as defined in
the Indenture governing such Note, the undersigned confirms that such Note is being transferred: 

 ̈    To Forest City Enterprises, Inc. or a subsidiary thereof; or 

 ̈    Pursuant to a registration statement that has been declared effective under the
Securities Act of 1933, as amended; or 
  ̈    Pursuant to and in compliance
with Rule 144A under the Securities Act of 1933, as amended; or 

 ̈    Pursuant to and in compliance with Rule 144 under the Securities Act of
1933, as amended, or any other available exemption from the registration requirements of the Securities Act of 1933, as amended. 
 Dated:
                                         
                
  

	
	
	  
	Signature(s)
	
	  
	Signature Guarantee

 Signature(s) must be guaranteed by an eligible Guarantor Institution (banks, stock brokers, savings and loan
associations and credit unions) with membership in an approved signature guarantee medallion program pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934, as amended, if shares of Common Stock are to be issued, or Notes to be
delivered, other than to and in the name of the registered holder. 
 NOTICE: The signature on the assignment must correspond with the name as
written upon the face of the Note in every particular without alteration or enlargement or any change whatever. 

  
 A-10

 [FORM OF CONVERSION NOTICE] 

 

	To:	FOREST CITY ENTERPRISES, INC. (THE “COMPANY”) 

 The undersigned registered owner of this Note hereby converts this Note, or the portion hereof (which is $1,000 principal amount or an integral multiple thereof) below designated, in exchange for shares
of Common Stock (and cash in lieu of fractional shares), in accordance with the terms of the Indenture referred to in this Note, and directs that the shares issuable and deliverable upon such conversion, together with any Notes representing any
principal amount hereof not converted, be issued and delivered to the registered holder hereof unless a different name has been indicated below. If shares or any portion of this Note not converted are to be issued in the name of a Person other than
the undersigned, the undersigned will pay all transfer taxes payable with respect thereto. Any amount required to be paid to the undersigned on account of interest accompanies this Note. 
 Dated:
                                         
                    
  

	
	
	  
	Signature(s)
	
	  
	Signature Guarantee

  

	
	Signature(s) must be guaranteed by an eligible Guarantor Institution (banks, stock brokers, savings and loan associations and credit unions) with membership in an approved signature
guarantee medallion program pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934, as amended, if shares of Common Stock are to be issued, or Notes to be delivered, other than to and in the name of the registered
holder.

  
 A-11

	
	Fill in for registration of shares of Common Stock if to be issued, and Notes if to be delivered, other than to and in the name of the registered holder:
	
	  
	(Name)
	  
	(Street Address)
	  
	(City, State and Zip Code)
	Please print name and address

  

	
	 Principal amount to be converted

(if less than all): $___,000

	  
	
	Social Security or Other Taxpayer Identification Number:

  
 A-12

 [FORM OF FUNDAMENTAL CHANGE REPURCHASE NOTICE] 

 

	To:	Forest City Enterprises, Inc. 

The undersigned registered owner of this Note hereby acknowledges receipt of a notice from Forest City Enterprises, Inc. (the
“Company”) as to the occurrence of a Fundamental Change with respect to the Company and requests and instructs the Company to repay the entire principal amount of this Note, or the portion thereof (which is $1,000 principal amount
or an integral multiple thereof) below designated, in accordance with the terms of the Indenture referred to in this Note, to the registered holder hereof. 
 Dated:
                                         
        
  

	
	
	  
	Signature(s)
	
	  
	Social Security or Other Taxpayer Identification Number
	
	Principal amount to be repaid (if less than all): $_,000
	
	NOTICE: The above signatures of the holder(s) hereof must correspond with the name as written upon the face of the Note in every particular without alteration or enlargement or any
change whatever.

  
 A-13

 Schedule I 
 FOREST CITY ENTERPRISES, INC. 
 4.25% CONVERTIBLE SENIOR NOTES DUE 2018 

No. 001 
  

											
	Date	 	 	Principal Amount	 	 	Notation
Explaining
Principal Amount
Recorded	 	Authorized
Signature of
Trustee or Custodian
	 	July 19, 2011	  	 	$	350,000,000.00	  	 		 	

  
 A-14Amendment One to the License Agreement

 Exhibit 10.22 
 AMENDMENT ONE TO THE 
 EXCLUSIVE LICENSE 

(CMCC-10665) 
 This amendment is
made and entered into as of May 12, 2011 (the “Amendment”) by and between Children’s Medical Center Corporation, a corporation duly organized and existing under the laws of the Commonwealth of Massachusetts and having offices
located at 300 Longwood Avenue, Boston, MA (“CMCC”) and InVivo Therapeutics Corporation, a business corporation organized and existing under the laws of the State of Delaware and having its principal office at One Broadway, 14th Floor,
Cambridge, MA “Licensee”). 
 WHEREAS, CMCC and Licensee have entered into that certain Exclusive License Agreement with an effective
date of July 2, 2007 and identified as agreement number CMCC-6748 (the “Agreement”); 
 WHEREAS CMCC and Licensee wish to amend
such Agreement through this Amendment; and 
 WHEREAS the Agreement otherwise remains unchanged. 

In consideration of these premises and of the mutual promises set forth below, the parties agree to amend the Agreement as follows: 

Amendments to the Agreement: 

1. Article I. Definitions, Paragraph F of the Agreement, “Field of Use”, is hereby deleted in its entirety and replaced as follows:

  

	F.	“Field of Use” shall mean the following three subfields: i) treatment of nerve injury of the central nervous system including the brain, and spinal cord; ii)
treatment of nerve injury of the retina and the cranial nerves; and iii) treatment of the following pathologic conditions: nerve root impingement from musculoskeletal elements, demyelinated tissue, damage to neural elements exiting the spinal cord
and lumbosacral region of spinal cord by administering a Licensed Product to the peripheral nerves in the intraspinal location, foraminal and extraspinal areas, extrapyramidal regions, areas of peripheral bony impingement, and for repair or
treatment of neural elements following damage from prostate surgery; excluding the development and commercialization of tissue engineered products for human and animal therapeutics in the field of genitourinary. 

2. In consideration for expanding the Field of Use, Licensee shall pay to CMCC a license amendment fee of $75,000 within thirty (30) days of
the full execution of this Amendment in addition to any other payments due under the Agreement and/or this Amendment. 

 3. In each of the following paragraphs, the term “Development Plan” shall be replaced with
the terms “Development Plan and Commercialization Plan”: 
 Article II, Paragraph A 

Article III, Paragraphs C, F and G 
 Article V, Paragraphs C and D 
 4. Article III Due Diligence and Related Matters, Paragraph
B of the Agreement, is hereby deleted in its entirety and replaced as follows: 
  

	 	B.	The parties acknowledge that Licensee had provided to CMCC prior to the date of execution of the Agreement an initial written development plan setting forth for a
period of five (5) years beginning July 2, 2007, projections for the initial indications and markets for Licensed Products and Licensed Processes for the subfield of Spinal Cord Injury in the Field of Use. Licensee represents that Licensee
has used diligent efforts during the first three (3) years of the Agreement as described in Article III, Section D of the Agreement of having (i) raised and allocated a cumulative total of investment capital and/or research and development
funds of at least $1,000,000 during the year of September 26, 2006 and September 26, 2007 and (ii) expended at least $6 million to implement such initial development plan. The parties acknowledge that Licensee has provided to CMCC
prior to the date of execution of this Amendment a written development plan (“Development Plan”) setting forth for a period of two (2) years beginning November 16, 2010, projections for the initial indications and markets for
Licensed Products and Licensed Processes in the Field of Use, including (i) time-delimited targets for pre-clinical development, clinical trials, regulatory approval, manufacturing and marketing that represent reasonable efforts, consistent
with industry norms for similar technology and applications, to bring Licensed Products to the marketplace; and (ii) actual or projected financial resources and/or strategic alliances that will be required to implement the Development Plan and
(iii) identified project management structure calculated to meet the objectives and commitments in the Development Plan. The Development Plan is attached hereto as Appendix 2 and is hereby incorporated herein by reference. In addition, prior to
submission of the first regulatory filing relating to the first Licensed Product, but in any event no later than July 2, 2012, which is five years from the Effective Date of the Agreement, Licensee shall submit a commercialization plan
(“Commercialization Plan”) setting forth projected (i) time delimited commercialization milestones for bringing Licensed Products to the marketplace and (ii) strategic alliances (including but not limited to alliances with
Distributors) required to achieve the goals outlined in the Commercialization Plan. The Commercialization Plan shall be attached to the Agreement as Appendix 3. 

 5. Article IV Paragraph A.3 of the Agreement, is hereby deleted in its entirety and replaced as
follows: 
 3. Licensee shall make the following payments to CMCC upon the occurrence of the following events
(“Milestones”): 
  

	 	(a)	$50,000 upon the filing with the United States Food and Drug Administration (“FDA”) of the first Investigational New Drug (“IND”) application,
Investigational Device Exemption (“IDE”) application, or comparable application for the first_Licensed Product in the first subfield of the Field of Use, and $25,000 for filing such an application for the first_Licensed Products in each of
the second and third subfields of the Field of Use; 

  

	 	(b)	$75,000 upon the enrollment of the first patient in Phase II testing of the first Licensed Product in the first subfield of the Field of Use, and $37,500 for enrollment
of the first patient in phase II testing of the first_Licensed Products each of the second and third subfields of the Field of Use; 

  

	 	(c)	$100,000 upon the enrollment of the first patient in Phase III testing of the first Licensed Product in the first subfield of the Field of Use, and $50,000 for the
enrollment of the first patient in Phase III testing of the first Licensed Products each of the second and third subfields of the Field of Use; 

  

	 	(d)	$250,000 upon filing with the FDA of each first New Drug Application (“NDA”), 510(k) application, Pre-Market Approval (“PMA”) application or PMA
Supplement, or BLA, or comparable application in each of the three subfields of the Field of Use; 

  

	 	(e)	$500,000 upon approval fby the FDA of the first NDA, 510(k), PMA or PMA Supplement, BLA, or comparable application within the United States with respect to any Licensed
Product; 

  

	 	(f)	$500,000 upon first marketing approval in the first country outside of the United States; and 

 

	 	(g)	Running royalties in an amount equal to three percent (3%) of Net Sales of Licensed Products used, leased or sold by and/or for Licensee (including its
Affiliates). 

 6. Article VI Patent Prosecution, Paragraph B of the Agreement, is hereby deleted in its entirety and
replaced as follows: 
  

	 	B.	Licensee shall reimburse CMCC for all patent costs, past, present and future incurred by CMCC for the preparation, filing, prosecution and maintenance of patents
underlying the Patent Rights. Licensee shall pay 

	 	
such costs for the patents and applications in Appendix 1A within thirty (30) days after receipt of an invoice covering such costs. Upon request of CMCC, and only upon such CMCC request,
Licensee agrees to have CMCC’s patent counsel directly bill Licensee and Licensee shall directly pay such invoices in compliance with such counsel’s customary business terms, but in any event not greater than thirty (30) days from
receipt of invoice which is not disputed in good faith. If Licensee elects to no longer pay the expenses of a patent application or patent included within Patent Rights, Licensed Products or Licensed Processes, Licensee shall notify CMCC, and MIT
(at the address specified below), not less than sixty (60) days prior to such action and shall thereby surrender its rights under such patent or patent application. Such notice shall not relieve Licensee from responsibility to reimburse CMCC
for patent-related expenses incurred prior to the expiration of the (60)-day notice period (or such longer period specified in Licensee’s notice). CMCC and MIT shall each then be free to license its rights to that patent or patent application
to any other party on any other terms. Notice to MIT described herein shall be sent consistent with Article XV to: 

 Massachusetts Institute of Technology 
 Technology Licensing Office, Room NE18-501

 One Cambridge Center, Kendall Square 
 Cambridge, MA 02142-1601 
 Attention: Director 

Tel: 617-253-6966 
 Fax: 617-258-6790 
 7. Article VI Patent Prosecution, Paragraph D of the Agreement, is
hereby deleted in its entirety and replaced as follows: 
 D. MIT shall prepare, file, prosecute, and maintain all of the Patent
Rights in Appendix 1B. Licensee shall reimburse MIT, as enumerated in Articles VI(D)(i), VI(D)(ii), and VI(D)(iii) below, for patent costs, past, present and future incurred by MIT for the preparation, filing, prosecution and maintenance of patents
underlying the Patent Rights in Appendix 1B. MIT shall directly submit invoices for payment to Licensee. Licensee shall reimburse all amounts due pursuant to this Section within thirty (30) days of invoicing. Any payments by Licensee that are
not paid on or before the date such payments are due under this Article VI( D) shall bear interest, to the extent permitted by law, at two percentage points above the Prime Rate of interest as reported by the Federal Reserve Bank of St. Louis on the
date payment is due. In all instances, MIT shall pay the fees prescribed for large entities to the United States Patent and Trademark Office. 

 (i) Payment of Patent Costs Incurred by MIT from July 2, 2007
through May 12, 2011. Licensee shall be responsible for payment of Twenty Five Percent (25%) of the total patent costs incurred by MIT from the Effective Date through May 12, 2011, for the Patent Rights in Appendix 1B. 

(ii) Additional Payment of Patent Costs Incurred Prior to May 12, 2011. In addition to the amounts due in
Article VI(D)(i), Licensee shall be responsible for payment of One Hundred Percent (100%) of the total unreimbursed patent costs incurred by MIT prior to May 12, 2011, for the Patent Rights in Appendix 1B. The amount due under this section
VI(D)(ii), shall not exceed Fifty Thousand dollars ($50,000). 
 (iii) Payment of Patent Costs Incurred by
MIT on and After May 12, 2011 
 For the purpose of this section, “Co-Licensed Cases” shall mean
CMCC Case 23 (MIT Case 4973) and CMCC Case 30 (MIT Case 4279) 
  

	 	(a)	Co-Licensed Cases. Licensee shall be responsible for payment of Fifty Percent (50%) of the total unreimbursed patent costs incurred by MIT on and after
May 1, 2011, for the Patent Rights in the Co-Licensed Cases. As of May 1, 2011, there is another licensee paying Fifty Percent (50%) of the total unreimbursed patent costs incurred by MIT for the Patent Rights in the Co-Licensed Cases
(“Third Party”). In the event that the Third Party abandons its rights to the Co-Licensed Cases, Licensee shall pay One Hundred Percent (100%) of the costs of the Co-Licensed Cases from the date of abandonment of such rights by the
Third Party. 

  

	 	(b)	Patent Rights listed in Appendix 1B except for Co-Licensed Cases. Licensee shall be responsible for payment of One Hundred Percent (100%) of the total
unreimbursed patent costs incurred by MIT on and after May 1, 2011, for the Patent Rights in Appendix 1B (excluding the Co-Licensed Cases). 

 8. Article XV. Payments, Notices, And Other Communications, notice to Licensee shall be made to the following: 
 Attn: Chief Executive Officer 
 InVivo Therapeutics Corporation 

One Broadway, 14th Floor 
 Cambridge, MA 02142 

 9. The following two (2) sentences are hereby added as the last sentences to Article III,
Paragraph G of the Agreement: 
 The parties acknowledge and agree that the Field of Use is comprised of the three
(3) subfields identified as i) through iii) in the definition thereof (each a “Subfield”). If Licensee fails to meet a requirement set forth in the Development Plan and/or Commercialization Plan pertaining to a Subfield and CMCC
terminates the rights granted to Licensee in accordance with this Paragraph G, such termination of rights shall apply only to such Subfield and not to any other Subfields which license granted under such Subfields shall continue pursuant to the
terms of the Agreement. For clarity, any loss of Subfields under this section does not relieve Licensee of obligations under this agreement in any other Subfields. 
 10 Appendix 1A shall be deleted and replaced in its entirety with Appendix 1A of this Amendment One. 
 11. Appendix 1B shall be deleted and replaced in its entirety with Appendix 1B of this Amendment One. 
 IN WITNESS WHEREOF, the parties have hereunto set their hands and seals and duly executed this Amendment the day and year set forth below. 

 

									
	CHILDREN’S MEDICAL CENTER CORPORATION	 		 	INVIVO THERAPEUTICS CORPORATION
					
	By	 	/s/ Erik Halvorsen	 		 	By	 	/s/ Frank Reynolds
		 	Erik Halvorsen Ph.D.	 		 		 	Frank Reynolds
		 	Director of Technology & Business Development	 		 		 	Chief Executive Officer
		 		 		 		 	
	Date	 	5-25-11	 		 	Date	 	May 12 2011

  

 Appendix 1A: Patent Rights 

The following patents and patent applications based on CMCC case 1455 (M.I.T. Case 

Number 12084) and CMCC case 1456 (M.I.T. Case 13490Q): 
  

									
	Country	  	Serial Number	  	Filing Date	  	Status	  	Issue Date
	 U.S.
	  	60/794,986	  	4/25/2006	  	Expired	  	00/00/00
	 U.S.
	  	11/789,538	  	4/25/2007	  	Pend	  	00/00/00
	 U.S.
	  	12/186,346	  	8/5/2008	  	Pend	  	00/00/00
	 PCT
	  	PCT/US08/72226	  	8/5/2008	  	Expired	  	00/00/00
	 Australia
	  	2008360388	  	8/5/2008	  	Pend	  	00/00/00
	 Brazil
	  	TBA-BR	  	8/5/2008	  	Pend	  	00/00/00
	 Canada
	  	TBA-CA	  	8/5/2008	  	Pend	  	00/00/00
	 China
	  	TBA-CN	  	8/5/2008	  	Pend	  	00/00/00
	 India
	  	TBA-IN	  	8/5/2008	  	Pend	  	00/00/00
	 Japan
	  	TBA-JP	  	8/5/2008	  	Pend	  	00/00/00
	 Singapore
	  	TBA-SG	  	8/5/2008	  	Pend	  	00/00/00
	 South Korea
	  	10-2011-7005148	  	8/5/2008	  	Pend	  	00/00/00
	 EPO
	  	EP-TBA	  	8/5/2008	  	Pend	  	00/00/00
	 PCT
	  	PCT/US07/067403	  	4/25/2007	  	Expired	  	00/00/00
	 Australia
	  	TBA- AU	  	4/25/2007	  	Pend	  	00/00/00
	 Brazil
	  	PI 0709638-0	  	10/23/2008	  	Pend	  	00/00/00
	 Canada
	  	2650804	  	4/25/2007	  	Pend	  	00/00/00
	 China
	  	200780022752.6	  	4/25/2007	  	Pend	  	00/00/00
	 India
	  	TBA	  	10/24/2008	  	Pend	  	00/00/00
	 Japan
	  	0	  	10/23/2008	  	Pend	  	00/00/00
	 Singapore
	  	200807854-5	  	4/25/2007	  	Pend	  	00/00/00
	 South Korea
	  	10-2008-7028672	  	11/24/2008	  	Pend	  	00/00/00
	 EPO
	  	7761270.3	  	4/25/2007	  	Pend	  	00/00/00
	 Hong Kong
	  	9106081.8	  	4/25/2007	  	Pend	  	00/00/00

 Appendix 1B: Additional Patent Rights 

 

	I.	United States Patents and Applications 

CMCC Case No. 23 (M.I.T. Case No. 4973) 
 United States of America Patent No. 5804178, Issued September 8,1998 
 “IMPLANTATION
OF CELL-MATRIX STRUCTURE ADJACENT MESENTERY, OMENTUM OR PERITONEUM TISSUE” 
 by Linda G. Griffith, Lynt Johnson, Robert S. Langer and
Joseph P. Vacanti 
 CMCC Case No. 25 (M.I.T. Case No. 5573) 
 United States of America Patent No. 5514378, Issued May 7, 1996 
 “BIOCOMPATIBLE
POLYMER MEMBRANES AND METHODS OF PREPARATION OF THREE DIMENSIONAL MEMBRANE STRUCTURES” 
 by Linda G. Griffith, Robert S. Langer, Antonios
G. Mikos, Georgios Sarakinos and Joseph P. Vacanti 
 CMCC Case Nos. 20 and 30 (M.I.T. Case No. 4279) 

United States of America Patent No. 5759830, Issued June 2, 1998 
 United States of America Patent No. 5770417, Issued June 23,1998 

“THREE-DIMENSIONAL FIBROUS SCAFFOLD CONTAINING 
 ATTACHED CELLS FOR PRODUCING VASCULARIZED TISSUE IN VIVO” 
 by Robert S. Langer and Joseph P.
Vacanti 
 United States of America Patent No. 5770193, Issued June 23, 1998 “PREPARATION OF THREE-DIMENSIONAL FIBROUS SCAFFOLD
CONTAINING ATTACHED CELLS FOR PRODUCING VASCULARIZED TISSUE IN VIVO” 
 by Robert S. Langer and Joseph P. Vacanti 

CMCC Case No. 26 (M.I.T. Case No. 5729) 
 United States of America Patent No. 6309635, Issued October 30, 2011 

“PREVASCULARIZED POLYMERIC IMPLANTS FOR ORGAN TRANSPLANTATION” 
 by James C. Gilbert, Donald E. Ingber, Robert S. Langer, James E. Stein and Joseph P. Vacanti 

CMCC Case No. 389 (M.I.T. Case No. 6560) 
 United States of America Patent No. 7462471, Issued December 9, 2008 

 “POROUS BIODEGRADABLE POLYMERIC MATERIALS FOR CELL TRANSPLANTATION” 

by Linda G. Griffith, Robert S. Langer, Antonios G. Mikos, Georgios Sarakinos and Joseph P. Vacanti 

CMCC Case No. 415 (M.I.T. Case No. 6798) 
 United States of America Patent No. 6281015, Issued August 28, 2001 
 “LOCALIZED
DELIVERY OF FACTORS ENHANCING SURVIVAL OF TRANSPLANTED CELLS” 
 by Robert S. Langer, David J. Mooney and Joseph P. Vacanti 

CMCC Case No. 505 (M.I.T. Case No. 7138) 
 United States of America Patent No. 6095148, Issued August 1, 2000 
 “NEURONAL
STIMULATION USING ELECTRICALLY CONDUCTING POLYMERS” 
 by Robert S. Langer, Christine E. Schmidt, Venkatiam P. Shastri and Joseph P. Vacanti

 M.I.T. Case No. 6984 

United States of America Patent No. 5654381, Issued August 5, 1997 
 “FUNCTIONALIZED POLYESTER GRAFT COPOLYMERS” 
 by Jeffrey S. Hrkach, Robert S. Langer and
Noah Lotan 
 M.I.T. Case No. 13525 (CMCC Case No. 26) 
 United States of America Patent No. 6689608, Issued February 10, 2004 
 United States of
America Serial No. 12/218448, Filed July 15, 2008 
 “POROUS BIODEGRADABLE POLYMERIC MATERIALS FOR CELL TRANSPLANTATION”

 by Linda G. Griffith, Robert S. Langer, Antonios G. Mikos, Georgios Sarakinos and Joseph P. Vacanti 

 

	II.	International (non-U.S.) Patents and Applications 

 CMCC Case No. 26 (M.I.T. Case No. 5729) 
 European Patent Convention Patent
No. 0610423, Issued May 7, 1997 
 Japan Patent No. 3524919, Issued February 20, 2004 

Austria Patent No. 0610423, Issued May 7, 1997 
 Belgium Patent No. 0610423, Issued May 7, 1997 
 France Patent No. 0610423, Issued
May 7, 1997 
 Germany Patent No. 69219613, Issued May 7, 1997 
 Italy Patent No. 0610423, Issued May 7, 1997 

 Luxembourg Patent No. 0610423, Issued May 7,1997 

Netherlands Patent No. 0610423, Issued May 7, 1997 
 Sweden Patent No. 0610423, Issued May 7, 1997 
 United Kingdom Patent No. 0610423,
Issued May 7, 1997 
 “PREVASCULARIZED POLYMERIC IMPLANTS FOR ORGAN TRANSPLANTATION” 

by James C. Gilbert, Donald E. Ingber, Robert S. Langer, James E. Stein and Joseph P. Vacanti 
 CMCC Case No. 30 (M.I.T. Case No. 4279) 
 Canada Patent No. 1340581, Issued
June 8, 1999 
 “CHIMERIC NEOMORPHOGENESIS OF ORGANS BY CONTROLLED CELLULAR IMPLANTATION USING ARTIFICIAL MATRICES” 

by Robert S. Langer and Joseph P. Vacanti 

CMCC Case No. 415 (M.I.T. Case No. 6798) 
 European Patent Convention Patent No. 0794790, Issued April 17, 2002 
 Japan Patent
No. 4361134, Issued August 21, 2009 
 Canada Patent No. 2207286, Issued October 7, 2003 

Ireland Patent No. 0794790, Issued April 17, 2002 
 Belgium Patent No. 0794790, Issued April 17, 2002 
 Switzerland Patent No. 0794790,
Issued April 17, 2002 
 Germany Patent No. 0794790, Issued April 17, 2002 

Denmark Patent No. 0794790, Issued April 17, 2002 
 Spain Patent No. 0794790, Issued April 17, 2002 
 France Patent No. 0794790, Issued
April 17, 2002 
 Austria Patent No. 0794790, Issued April 17, 2002 
 Greece Patent No. 3039884, Issued April 17, 2002 
 Sweden Patent No. 0794790, Issued
April 17, 2002 
 Italy Patent No. 0794790, Issued April 17, 2002 
 Luxembourg Patent No. 0794790, Issued April 17, 2002 
 Monaco Patent No. 0794790,
Issued April 17, 2002 
 Netherlands Patent No. 0794790, Issued April 17, 2002 

Portugal Patent No. 0794790, Issued April 17, 2002 
 United Kingdom Patent No. 0794790, Issued April 17, 2002 
 “LOCALIZED DELIVERY OF
FACTORS ENHANCING SURVIVAL OF TRANSPLANTED CELLS” 
 by Robert S. Langer, David J. Mooney and Joseph P. Vacanti 

CMCC Case No. 505 (M.I.T. Case No. 7138) 
 New Zealand Patent No. 321886, Issued June 8, 2000 
 Japan Patent No. 4451929,
Issued February 5,2010 
 South Korea Serial No. 98-703320, Filed October 31, 1996 

 Australia Patent No. 720275, Issued September 11, 2000 

Canada Serial No. 2236749, Filed October 31, 1996 
 Japan Serial No. 2008-287194, Filed October 31, 1996 
 Japan Serial No. 2009-244981,
Filed October 31, 1996 
 “NEURONAL STIMULATION USING ELECTRICALLY CONDUCTING POLYMERS” 

by Robert S. Langer, Christine E. Schmidt, Venkatram P. Shastri and Joseph P. Vacanti 

 Appendix 2 
 Development Plan 
 May 12, 2011 

Children’s Hospital Boston 
 300 Longwood
Avenue 
 Boston, MA 02115 
 To Whom it
May Concern: 
 Licensee shall use good faith and diligent efforts to accomplish the milestones set forth in this Development Plan and to
manufacture and distribute Licensed Products. 
 Our Development Plan for the patents licensed from CMCC is as follows. 

Licensee agrees to achieve the following specific requirements: 
 Spinal Cord Injury 
  

	 	1.	Rodent Study for scaffold implantation optimization (2010 through no later than November 2, 2012) 

 

	 	a.	Understanding the lesion volume associated with a contusion spinal cord injury 

 

	 	b.	Understanding the technique for implantation of a scaffold into an acute spinal cord contusion injury 

 

	 	c.	Understanding the safety and efficacy of scaffold implantation into a contusion injury in a rat 

 

	 	2.	Primate studies in acute SCI (2010 through no later than November 2, 2012) 

 

	 	a.	Further electromyographic, kinematic and histologic studies on the safety and efficacy of scaffold implantation in a spinal cord injury in a non-human primate

 Brain 
 Motor
pathways in mammals generally consist of two neuron systems where an upper motor neuron originates in the motor cortex and travels downwards and synapses in the spinal cord to the lower motor neuron that then exits the spinal cord. There are
occasions where study of the motor neurons and spinal cord will require brain/cerebral applications to assess for effects of any plasticity, sprouting, regeneration, or on the converse side, atrophy or dieback. Consequently, there may be occasions
where biotinylated dextran 

 amines (BDA) will be injected in the motor cortex with assessments conducted at the levels of the brain,
brain stem, and spinal cord. 
  

	1.	Rodent study using BDA tracing (2011 through no later than November 2, 2012) 

 

	 	a.	Study will label motor neurons with emphasis on the spinal cord and components of neurons originating from the motor cortex in the brain 

Peripheral Nervous System 
 Applications
related to acute, subacute, and chronic neurologic conditions and syndromes of the peripheral nerves to include those caused by trauma, impingement, inflammation, complex regional pain syndrome, and causalgia that can be treated using using these
patents. Pathologic conditions appropriate for treatment would include nerve root impingement from musculoskeletal elements, demyelinated tissue, damage to neural elements exiting the spinal cord and lumbosacral region of spinal cord. Target areas
include any part of the peripheral nerves in the intraspinal location, foraminal and extraspinal areas, extrapyramidal regions, and all locations of entrapment and impingement to include peripheral bony impingement, and repair or treatment of
cavernous nerves following damage from prostate surgery. Graft site support following primary peripheral nerve repair may also be appropriate for application of these technologies. 
 Currently the majority of compressive peripheral nerves injuries (such as disc herniation with nerve root impingement) are treated with injections of naked steroids and/or local anesthesia. One well-known
shortcoming in this area is the ability to maintain a consistent presence of the drug near the nerve for any sustained period beyond 1-3 days. We will perform pilot exploratory studies on the use of drug releasing hydrogel in the treatment of
compressive peripheral nerve injuries in the rodent. These studies will consist of the use of well-established compressive peripheral nerve injury models, likely of the rodent sciatic nerve, with application of injected hydrogel around the nerve and
possibly directly into the nerve depending on treatment arm. There are well-established models for assessing behavioral improvement after these experimental treatments and relatively well-established histological methodologies for assessing repair,
plasticity, and regeneration in peripheral nerve. 
  

	1.	Rodent pilot study for peripheral nerve regeneration (2011 through no later than November 2, 2012) 

 

	 	a.	The utility of drug-releasing hydrogels to protect and repair peripheral nerves will be assessed in a model injury in a rat. 

Retina 
 Primary sources of vision loss
are due to loss of: 

	 	•	 	 Photoreceptors: age-related macular degeneration, retinitis pigmentosa and retinal detachment. 

 

	 	•	 	 Retinal ganglion degeneration: glaucoma 

  

	1.	Porcine model of photoreceptor transplantation using biomaterials (2009 through 2011) 

 

	 	a.	Scaffold and stem cells will be transplanted subretinally in a porcine model to assess photoreceptor replacement using histological evaluation.

  

	2.	Nerve regeneration model in rodents using neural cell transplantation (2011 through no later than November 2, 2012) 

 

	 	a.	An optic nerve crush model will be used and scaffold and stem cells transplanted subretinally to assess regeneration of retinal ganglion cells histologically.

 Cranial Nerves 

Cranial nerves 2, 5, 7 and 8 (optic, trigeminal, facial, vestibulecochlear) are targets for regenerative therapies using biomaterials for cell delivery.

  

	1.	Cranial nerve regeneration pilot study in a rodent model (using optic nerve results to guide) (2011 through no later than November 2, 2012)

  

	 	a.	Intracranial injection of drug-releasing hydrogel to assess nerve regeneration in one or more rodent cranial nerve injury models with an initial emphasis on cranial
nerve 2 

 The actual or projected financial resources and/or strategic alliances that will be required to implement the
Development Plan beginning May 12, 2011 are: 
  

	 	1)	Licensee shall expend at least $3,000,000 in the aggregate during each calendar year 2011 and 2012 to implement the Development Plan and pay salaries and payroll
expenses. 

 Our future Research and Development plans will support our regulatory efforts to gain FDA approval for our range of
neurological devices. Therefore, the details of our research for 2011 and beyond will be determined through our meetings with the FDA and outlined in our Commercialization Plan. 
 Since we will be treating the same tissue for multiple central nervous system conditions, we are concurrently developing all of the technologies. As a result, we are cutting costs and development time,
for example by using tissue analysis results from spinal cord injuries to support human studies for retina repair, peripheral nerve repair, and the brain. 

 Please let me know if you have any questions. 

 

	
	Best Regards,
	
	/s/ Frank Reynolds
	 Frank Reynolds, CEO
 InVivo
Therapeutics Corporation

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}]]